ondansetron has been researched along with Emesis, Postoperative in 453 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study's purpose was to determine if ondansetron can prevent pruritus after administration of intrathecal morphine in children, as has been demonstrated in adults." | 9.51 | Intravenous ondansetron reduced nausea but not pruritus following intrathecal morphine in children: Interim results of a randomized, double-blinded, placebo-control trial. ( Hong, RA; Leis, A; Li, Y; Malviya, S; Park, JM; Putnam, EM, 2022) |
| " PONV incidence, complete response, 80 mg aprepitant combined with dexamethasone and ondansetron, vomiting, nausea, and analgesic dose-response were the main outcomes measured." | 9.41 | The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis. ( Chen, X; He, H; Hu, W; Liao, Y; Liu, W; Liu, Y; Pan, Z; Wang, X; Zheng, F; Zhong, H, 2023) |
| "Based on the results of this study, ondansetron had a significant effect on the alleviation of postoperative nausea and vomiting, as compared to dexamethasone in C-section surgical candidates." | 9.41 | Comparison of the Effects of Dexamethasone and Ondansetron on the Reduction of Postoperative Nausea and Vomiting following Cesarean Section under Spinal Anesthesia. ( Birjandi, M; Karimi, A; Nejadi, JR; Ronasi, N; Shamseh, M, 2021) |
| " This study aimed to evaluate the effectiveness of ramosetron or ondansetron to relieve postoperative nausea and vomiting (PONV) and pain after arthroscopic rotator cuff repair." | 9.34 | The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial. ( Kim, YS; Lee, HJ; Lee, SU, 2020) |
| "Akathisia, a distressing movement disorder induced by butyrophenones, has been described with low doses of droperidol used for postoperative nausea and vomiting (PONV) prophylaxis, but the incidence remains unclear." | 9.27 | Incidence of akathisia after postoperative nausea and vomiting prophylaxis with droperidol and ondansetron in outpatient surgery: A multicentre controlled randomised trial. ( Charton, A; Diemunsch, P; Faitot, V; Greib, N; Joshi, GP; Meyer, N; Noudem, Y; Ruimy, A, 2018) |
| "One hundred and five patients (aged 18-60 years) undergoing strabismus surgery were allocated randomly to one of the three groups: placebo, ondansetron, or ramosetron." | 9.22 | Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients. ( Joo, J; Park, HJ; Park, S; Shin, SY, 2016) |
| "Postoperative nausea and vomiting (PONV) is common; ondansetron is often used as prophylaxis or for breakthrough episodes." | 9.20 | Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron. ( Brigandi, RA; Dalby, PL; Eberhart, LH; Johnson, BM; Kranke, P; Noble, R; Novikova, E; Russ, SF; Thompson, JP, 2015) |
| "Prophylactic administration of ondansetron to parturients receiving intrathecal morphine for post-operative analgesia provides a significant reduction of intrathecal morphine-induced pruritus and nausea and vomiting." | 9.20 | Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. ( Dongol, Y; Gurung, BS; Koju, RB, 2015) |
| "Combination of ondansetron and dexamethasone was more efficacious compared to ondansetron alone in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy." | 9.19 | Comparison of efficacy of ondansetron and dexamethasone combination and ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. ( Abbas, N; Ahsan, K; Murtaza, G; Naqvi, SM; Tariq, S, 2014) |
| "Healthy paturients undergoing cesarean delivery with intrathecal morphine 250μg and fentanyl 25μg were randomized to receive: prophylaxis (ondansetron 8mg at cord clamping, normal saline 4mL for treatment of pruritus in the post-anaesthesia care unit); treatment (normal saline 4mL at cord clamping, ondansetron 8mg as required in the post-anesthesia care unit) or control (normal saline 4mL in both)." | 9.19 | Prevention versus treatment of intrathecal morphine-induced pruritus with ondansetron. ( Hess, P; Kung, AT; Li, Y; Pratt, S; Vasudevan, A; Yang, X, 2014) |
| "This study compared palonosetron and ondansetron as rescue medications for postoperative nausea and vomiting (PONV) in patients who received prophylactic ondansetron." | 9.19 | Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study. ( Ahmed, SR; Candiotti, KA; Cox, D; Gan, TJ, 2014) |
| "A prospective, double-blinded, randomized, two-arm evaluation of 150 ambulatory plastic surgery patients receiving a standardized general anesthetic, including postoperative nausea and vomiting prophylaxis with ondansetron and either aprepitant or placebo, was performed." | 9.16 | Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery. ( Barnes, LR; Ibinson, JW; Milord, PJ; Phelps, AL; Romeo, RC; Sah, N; Vallejo, MC; Williams, BA, 2012) |
| " We designed this study to compare the effects of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic operations." | 9.15 | A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting. ( Aydın, N; Ekinci, O; Işıtmangil, G; Malat, I, 2011) |
| "To compare intravenous dexamethasone and ondansetron for the prophylaxis of postoperative nausea and vomiting (PONV), a main complaint that affects almost 40%-75% of patients undergoing laparoscopic gynecologic surgery." | 9.15 | Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery. ( Bhagwat, S; D'souza, N; Swami, M, 2011) |
| "This randomized, double-blind study evaluated the relative efficacy of palonosetron (a new, selective 5-hydroxytryptamine type 3 [5-HT(3)] receptor antagonist) and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynaecological laparoscopic surgery." | 9.15 | A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. ( Cho, EJ; Park, SK, 2011) |
| "To compare the efficacy of ondansetron and granisetron in the prevention of postoperative nausea and vomiting (PONV) in high-risk patients." | 9.15 | [Preventive efficacy of ondansetron and granisetron for postoperative nausea and vomiting in high risk patients]. ( Quan, X; Ye, TH; Zhu, B, 2011) |
| "Patients identified as high risk for postoperative nausea and vomiting (PONV) are often treated prophylactically with intravenous (IV) ondansetron and an additional agent." | 9.15 | Prophylactic isopropyl alcohol inhalation and intravenous ondansetron versus ondansetron alone in the prevention of postoperative nausea and vomiting in high-risk patients. ( Bushey, B; Daniel, C; Fuller, TN; Pellegrini, JE; Radford, KD, 2011) |
| "The purpose of this study was to compare the effects of ondansetron combined with dexamethasone on Post-Operative Nausea and Vomiting (PONV) and pain with ondansetron alone in patients with laparoscopy assisted vaginal hysterectomy under general anesthesia." | 9.14 | [Effect of ondansetron combined with dexamethasone on postoperative nausea & vomiting and pain of patients with laparoscopic hysterectomy]. ( Nam, M; Yoon, H, 2009) |
| "To determine the efficacy of transdermal scopolamine in addition to ondansetron in decreasing the incidence of postoperative nausea and vomiting (PONV)." | 9.14 | Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. ( Dalby, P; Kaul, B; Ramesh, V; Sah, N; Shestak, K; Vallejo, MC, 2009) |
| " The purpose of this study was to evaluate the efficacy of ramosetron for the prevention of postoperative nausea and vomiting (PONV) with that of ondansetron or placebo in high-risk patients undergoing gynaecological surgery." | 9.14 | Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. ( Baek, YH; Kim, SC; Kim, SH; Kim, SI; Ok, SY, 2009) |
| "Frequently, patients identified as high risk for postoperative nausea and vomiting (PONV) are treated prophylactically with intravenous (IV) ondansetron and postoperatively with IV promethazine." | 9.14 | Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. ( Bennett, J; DeLoge, J; Kelly, J; Pellegrini, J, 2009) |
| " reduces the severity of pruritus and the use of rescue anti-pruritic medication, and improves satisfaction but does not reduce the overall incidence of pruritus in women who have received subarachnoid morphine 150 microg compared to ondansetron 8 mg i." | 9.14 | Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron. ( Carey, M; Choroszczak, P; Immani, S; Ojo, R; Tan, T, 2010) |
| "Prophylactic administration of either of either granisetron, ondansetron, midazolam combined with dexamethasone markedly decreases the incidence of PONV following strabismus surgery in pediatrics." | 9.14 | Combination therapy in the prevention of PONV after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone. ( Marouf, H; Riad, W, 2009) |
| "We compared the prophylactic effects of intravenously administered azasetron (10 mg) and ondansetron (8 mg) on postoperative nausea and vomiting (PONV) in patients undergoing gynecological laparoscopic surgery under general anesthesia." | 9.14 | Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery. ( Kim, AR; Kim, YH; Yun, MJ, 2010) |
| "Ondansetron is as effective as diphenhydramine in relieving pruritus caused by SA morphine in patients undergoing a cesarean delivery." | 9.14 | Ondansetron is as effective as diphenhydramine for treatment of morphine-induced pruritus after cesarean delivery. ( Adham, AM; Aouad, MT; Dagher, CM; Saasouh, WA; Siddik-Sayyid, SM; Yazbeck-Karam, VG; Zahreddine, BW, 2010) |
| "We compared the prophylactic anti-emetic efficacy of ramosetron, a newly developed 5-HT(3) antagonist, and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement." | 9.14 | Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. ( Choi, SJ; Gwak, MS; Hahm, TS; Ko, JS, 2010) |
| "In a prospective randomized double-blind study, we compared the effectiveness of dexamethasone 8 mg with either granisetron 1 mg or ondansetron 4 mg in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery." | 9.14 | Dexamethasone with either granisetron or ondansetron for postoperative nausea and vomiting in laparoscopic surgery. ( Baraka, AS; Dabbous, AS; El-Khatib, MF; Jabbour-Khoury, SI; Khouzam, NE; Moussa, AA; Nasr, VG; Zbeidy, RA, 2010) |
| "To compare the clinical efficacy of acupressure with treatment induced by ondansetron and metoclopramide on reduction of the severity of postoperative nausea and vomiting (PONV) after strabismus surgery." | 9.14 | Acupressure using ondansetron versus metoclopramide on reduction of postoperative nausea and vomiting after strabismus surgery. ( Afkham, K; Arbabi, S; Darabi, ME; Ebrahim Soltani, A; Goudarzi, M; Mohammadinasab, H; Mohtaram, R; Momenzadeh, S, 2010) |
| "The purpose of this study was to determine if giving 50 mg of meclizine the night before and on the day of surgery would effectively reduce postoperative nausea and vomiting (PONV) for the entire 24 hours after surgery in patients identified as being at high risk for PONV Subjects were randomly assigned to receive either 50 mg of oral meclizine (experimental group) or a placebo (control group) the night before and the day of surgery." | 9.14 | Biphasic dosing regimen of meclizine for prevention of postoperative nausea and vomiting in a high-risk population. ( Bopp, EJ; Daniel, C; Estrada, TJ; Kilday, JM; Pellegrini, JE; Spradling, JC, 2010) |
| "To compare the efficacy of combination of dexamethasone plus ondansetron with dexamethasone alone for postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy." | 9.13 | Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone. ( Aftab, S; Bano, F; Haider, S; Zafar, S, 2008) |
| "To compare total intravenous anesthesia (TIVA) with ondansetron, and metoclopramide in preventing postoperative nausea and vomiting (PONV) in laparoscopic cholecystectomy patients." | 9.13 | Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy. ( Abd El-Hakeem, EE; Kaki, AM, 2008) |
| "Haloperidol is effective for postoperative nausea and vomiting prophylaxis, but there are almost no data comparing it to 5-HT(3) antagonists." | 9.13 | Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. ( Bittner, EA; Grecu, L; Haspel, KL; Rosow, CE; Smith, SE, 2008) |
| "Haloperidol 1 mg and ondansetron 4 mg are equally safe and effective for postoperative nausea and vomiting prophylaxis." | 9.13 | Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. ( Bittner, EA; Grecu, L; Kher, J; Rosow, CE; Smith, SE, 2008) |
| "In an effort to determine the most effective timing of ondansetron administration to prevent postoperative nausea and vomiting (PONV), a prospective, randomized, double-blind study was performed." | 9.13 | Timing of ondansetron administration to prevent postoperative nausea and vomiting. ( Cruz, NI; Portilla, P; Vela, RE, 2008) |
| "To compare the efficacy of prophylactic ondansetron and tropisetron for postoperative nausea and vomiting (PONV)." | 9.12 | Comparison of ondansetron and tropisetron in preventing postoperative nausea and vomiting: A meta-analysis of randomized controlled trials. ( Chen, Y; Song, X; Wang, J; Wang, N; Wang, R, 2021) |
| "Neither ondansetron nor tropisetron prevent itching caused by intrathecal morphine with fentanyl." | 9.12 | Ondansetron and tropisetron do not prevent intraspinal morphine- and fentanyl-induced pruritus in elective cesarean delivery. ( Halonen, PM; Kainu, JP; Korttila, KT; Sarvela, PJ; Soikkeli, AI, 2006) |
| "Ondansetron is widely used for the prophylaxis of postoperative nausea and vomiting, while haloperidol is an antiemetic that lacks recent data on efficacy and adverse effects." | 9.12 | Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. ( Aouad, MT; Azar, MS; Baraka, AS; Hakki, MA; Nasr, VG; Siddik-Sayyid, SM; Taha, SK; Zoorob, DG, 2007) |
| "Prophylactic ondansetron or droperidol reduces the incidence of postoperative nausea and vomiting (PONV)." | 9.12 | The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. ( Apfel, CC; Chan, MT; Choi, KC; Chui, PT; Gan, TJ; Gin, T; Poon, AH; Short, TG; Yuen, PM, 2006) |
| " This is the first study evaluating the efficacy and tolerability of the neurokinin-1 receptor antagonist, aprepitant, for the prevention of postoperative nausea and vomiting." | 9.12 | A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. ( Apfel, CC; Carides, AD; Evans, JK; Gan, TJ; Habib, AS; Horgan, KJ; Knighton, J; Kovac, A; Lawson, FC; Minkowitz, H; Philip, BK; Singla, N; Zhang, H, 2007) |
| " The aim of this study was to compare the prophylactic antiemetic efficacy of haloperidol vs ondansetron for the prevention of postoperative nausea and vomiting (PONV) after general anesthesia." | 9.12 | Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. ( Chu, CC; Lai, HY; Lee, Y; Wang, JJ; Wang, PK; Yang, YL, 2007) |
| " The incidence of pruritus and nausea was significantly lower in the epidural ondansetron group than in the intravenous ondansetron group at 24 and 48 h postoperatively." | 9.12 | Epidural ondansetron is more effective to prevent postoperative pruritus and nausea than intravenous ondansetron in elective cesarean delivery. ( Han, DW; Hong, SW; Kim, KJ; Kwon, JY; Lee, JW, 2007) |
| " We compared aprepitant with ondansetron for prevention of postoperative nausea and vomiting." | 9.12 | Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. ( Carides, AD; Chelly, JE; Diemunsch, P; Eberhart, L; Evans, JK; Gan, TJ; Girao, MJ; Irwin, MG; Lawson, FC; Philip, BK; Pueyo, J; Reiss, T, 2007) |
| "5 mg of dolasetron were equally effective in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynecological procedures." | 9.11 | Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. ( Browning, BA; Fort, CA; Kemp, KD; Shimata, MF; Strube, MD, 2004) |
| "The present study was to evaluate the efficacy of ondansetron, 5-HT3 receptor antagonist, versus placebo in the prevention of postoperative nausea and vomiting (PONV) in a homogenous group of female patients undergoing breast reduction surgery under general anaesthesia." | 9.11 | Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study. ( Ambesh, SP; Sinha, PK, 2004) |
| "Fentanyl is commonly used for spinal analgesia during labour but it is associated with a high incidence of pruritus." | 9.11 | Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron. ( Evans, SF; Paech, MJ; Wells, J, 2004) |
| "In this study we evaluated the efficacy of electro-acupoint stimulation, ondansetron versus placebo for the prevention of postoperative nausea and vomiting (PONV)." | 9.11 | A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. ( Gan, TJ; Georgiade, G; Jiao, KR; Zenn, M, 2004) |
| " Overall nausea and vomiting were significantly lower in the ondansetron prophylaxis group than in the group without prophylaxis (52." | 9.11 | Postoperative nausea and vomiting in patients undergoing total abdominal hysterectomy under spinal anaesthesia: a randomized study of ondansetron prophylaxis. ( Baublys, A; Ivaskevicius, J; Kontrimaviciute, E, 2005) |
| "In this study we compared the efficacy of orally disintegrating tablets (ODT) and IV ondansetron for preventing spinal morphine-induced pruritus and postoperative nausea and vomiting (PONV) in healthy young male patients." | 9.11 | Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting, and pruritus in young males. ( Arslan, G; Candan, S; Pirat, A; Torgay, A; Tuncay, ŞF, 2005) |
| " We evaluated the ability of intraoperative IV ondansetron followed by postoperative ondansetron in an orally disintegrating tablet formulation to reduce the frequency and severity of postoperative nausea and vomiting in a prospective, randomized, placebo-controlled double-blind trial of 60 patients undergoing acoustic neuroma resection." | 9.11 | The efficacy of postoperative ondansetron (Zofran) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery. ( Hartsell, T; Kirsch, JR; Long, D, 2005) |
| "Pruritus is the most common side effect of intrathecal morphine for postoperative pain relief." | 9.11 | Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: a randomized, double-blinded, placebo-controlled study. ( Dimitriou, VK; Dragoumanis, CK; Iatrou, CA; Simopoulos, CE; Vogiatzaki, TD; Vretzakis, GI, 2005) |
| "This study evaluated the clinical efficacy and cost-effectiveness of prophylactic ondansetron versus early ondansetron treatment in the management of postoperative nausea and vomiting (PONV) in children undergoing strabismus repair using clinically meaningful outcomes and value-based principles." | 9.10 | Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes. ( Ilavajady, S; Jagan, D; Sadhasivam, S; Sennaraj, B; Shende, D, 2002) |
| "This study was designed to evaluate transcutaneous electrical acupoint stimulation (acustimulation) using the ReliefBand compared with ondansetron for the treatment of established postoperative nausea and vomiting (PONV) after outpatient laparoscopic surgery." | 9.10 | Comparison of acustimulation and ondansetron for the treatment of established postoperative nausea and vomiting. ( Berrisford, SB; Brown, PM; Coloma, M; Issioui, T; Jones, DB; Jones, SB; Lee, AQ; Markowitz, SD; Ogunnaike, BO; Wakefield, CA; White, PF, 2002) |
| "In this prospective, randomized, double-blinded study, we compared the prophylactic efficacy of nalbuphine and ondansetron for the prevention of intrathecal morphine-induced pruritus after cesarean delivery." | 9.10 | Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. ( Charuluxananan, S; Kyokong, O; Narasethakamol, A; Promlok, P; Somboonviboon, W, 2003) |
| "Ondansetron 4 mg or dexamethasone 4 mg are equally effective in the prevention of postoperative nausea and vomiting following breast surgery." | 9.10 | Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. ( Gupta, A; Liljegren, G; Lövqvist, A; Thörn, SE; Wattwil, L; Wattwil, M, 2003) |
| "In a randomized, placebo-controlled, double-blind trial, we compared the efficacy of oral dolasetron and ondansetron in preventing postoperative nausea and vomiting in children after various surgical operations." | 9.10 | Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children. ( Karamanlioglu, B; Memis, D; Süt, N; Turan, A, 2003) |
| "We conclude that iv ondansetron 4 mg is effective in the prevention of nausea, vomiting, and pruritus following epidural morphine for postoperative pain control." | 9.10 | Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control. ( Cheng, KI; Chu, KS; Ho, ST; Liu, KS; Tzeng, JI; Wang, JJ, 2003) |
| "Ondansetron has a well documented antiemetic prophylactic effect, whereas in most studies of postoperative nausea and vomiting (PONV), metoclopramide is less efficacious." | 9.10 | Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. ( Quaynor, H; Raeder, JC, 2002) |
| "Routine use of ondansetron does not reduce the incidence of postoperative nausea and vomiting after laparoscopic cholecystectomy." | 9.10 | Ondansetron in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study. ( Cheah, WK; Cheong, KF; Goh, P; Sng, C; So, JB, 2002) |
| " Our hypothesis is that coinduction with clonidine reduces the incidence of PONV in adult patients undergoing breast cancer surgery." | 9.10 | Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. ( Bergendahl, HT; Eksborg, S; Lönnqvist, PA; Muhrbeck, O; Oddby-Muhrbeck, E, 2002) |
| " Intravenous ondansetron and tropisetron prevent postoperative nausea and vomiting (PONV) at least as efficiently as traditional antiemetics, droperidol and metoclopramide." | 9.10 | Oral ondansetron, tropisetron or metoclopramide to prevent postoperative nausea and vomiting: a comparison in high-risk patients undergoing thyroid or parathyroid surgery. ( Alahuhta, S; Jokela, R; Kangas-Saarela, T; Koivuranta, M; Purhonen, S, 2002) |
| "To assess the safety and efficacy of ondansetron for prevention of pruritus, nausea and vomiting after cesarean delivery with intrathecal sufentanil-morphine." | 9.10 | Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine. ( Chalhoub, V; Haddad, F; Hayek, G; Madi-Jebara, S; Yazigi, A, 2002) |
| "The purpose of this investigation was to evaluate the efficacy of ondansetron in controlling postoperative nausea and vomiting (PONV) when used prophylactically in patients undergoing routine dentoalveolar surgery performed under general anesthesia." | 9.09 | The effect of preoperative ondansetron on the incidence of postoperative nausea and vomiting in patients undergoing outpatient dentoalveolar surgery and general anesthesia. ( Hackett, C; Haug, RH; Wagley, C, 1999) |
| ") dosing of ondansetron 4 mg with placebo for the treatment of postoperative nausea and vomiting (PONV) in patients for whom prophylactic, preoperative ondansetron 4 mg i." | 9.09 | Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. ( Angel, JJ; Baughman, VL; Campbell, C; Creed, MR; Edmondson, D; Jense, HG; Kekoler, LJ; Kovac, AL; Mingus, M; O'Connor, TA; Pearman, MH; Shahvari, MB, 1999) |
| "This prospective, randomized, double-blinded study evaluated the effect of the timing of ondansetron administration on its antiemetic efficacy in children undergoing elective strabismus surgery." | 9.09 | Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery. ( Garg, S; Madan, R; Perumal, T; Sadashivam, S; Sadhasivam, S; Shende, D; Subramaniam, K, 2000) |
| "This prospective, randomized and double-blinded study was designed to evaluate the anti-emetic efficacy of a combination of ondansetron and metoclopramide in 100 ASA physical status I and II children of either sex and 1-15 years of age undergoing elective surgery for strabismus." | 9.09 | Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus. ( Kathirvel, S; Madan, R; Shende, D, 1999) |
| "This study evaluated the antiemetic effectiveness, dose-response, and clinical usefulness of prophylactic ondansetron in the prevention of postoperative nausea and vomiting (PONV) in children undergoing strabismus repair." | 9.09 | Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study. ( Madan, R; Sadhasivam, S; Shende, D, 2000) |
| " Compared with either propofol or sevoflurane alone, sevoflurane with ondansetron resulted in a decreased incidence of postoperative nausea and vomiting." | 9.09 | Postoperative nausea and vomiting after sevoflurane with or without ondansetron compared with propofol in female patients undergoing breast surgery. ( Alahuhta, SM; Jokela, RM; Kangas-Saarela, TA; Koivuranta, MK; Ranta, PO; Valanne, JV, 2000) |
| "Supplemental oxygen reduces the risk of postoperative nausea and vomiting (PONV) as well or better than 8 mg of ondansetron." | 9.09 | Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. ( Akça, O; Arkiliç, CF; Freitag, H; Goll, V; Greif, R; Krieger, G; Kurz, A; Lenhardt, R; Scheck, T; Sessler, DI; Zoeggeler, A, 2001) |
| " There was a statistically significant decrease in the chance of vomiting with increasing dose of ondansetron (P=0." | 9.09 | A randomized controlled trial of the antiemetic effect of three doses of ondansetron after strabismus surgery in children. ( Booker, PD; Bowhay, AR; May, HA; Rudnicka, AR, 2001) |
| "Droperidol 15 microg kg(-1) in combination with ondansetron 100 microg kg(-1), administered at the induction and end of the operative procedure respectively, is more effective than either drug given individually in reducing the incidence of PONV after strabismus surgery." | 9.09 | Combination of droperidol and ondansetron reduces PONV after pediatric strabismus surgery more than single drug therapy. ( Bharti, N; Kathirvel, S; Madan, R; Shende, D, 2001) |
| "This study evaluated the antiemetic efficacy, cost-effectiveness and clinical utility of prophylactic ondansetron and dexamethasone compared with placebo in the prevention of postoperative nausea and vomiting (PONV) in 135 children (2-15 yr, ASA I-II) undergoing strabismus repair." | 9.09 | Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. ( Jagan, D; Madan, R; Rajeshwari, S; Sadhasivam, S; Sennaraj, B; Shende, D; Subramaniam, B; Tamilselvan, P, 2001) |
| "There was a remarkably low incidence of postoperative vomiting of 5%; with the combination of dexamethasone plus a low-dose of ondansetron which more effectively decreased vomiting after strabismus surgery in children when compared with dexamethasone alone." | 9.09 | Prevention of vomiting after strabismus surgery in children: dexamethasone alone versus dexamethasone plus low-dose ondansetron. ( Splinter, WM, 2001) |
| " ondansetron, before induction of anaesthesia, on intraocular pressure (IOP) in patients undergoing cataract surgery was investigated." | 9.09 | Randomized prospective double-blind placebo-controlled trial of effect of intravenous ondansetron on intraocular pressure during ophthalmic surgery. ( Mostafa, SM; Robin, NM, 2001) |
| "Limited data are available on the efficacy of ondansetron hydrochloride compared with prochlorperazine maleate for the treatment of postoperative nausea and vomiting (PONV)." | 9.08 | Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial. ( Chen, JJ; Frame, DG; White, TJ, 1998) |
| " ondansetron efficacy in preventing postoperative nausea and vomiting were as follows: Risk ratio [95% confidence interval] = 0." | 8.95 | Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis. ( Goto, T; Ka, K; Mihara, T; Yokoi, A, 2017) |
| "Palonosetron is a second-generation 5-HT3 receptor antagonist with proposed higher efficacy and sustained action for prophylaxis of postoperative nausea and vomiting (PONV)." | 8.93 | Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis. ( Arora, MK; Borle, A; Gouda, D; Goudra, B; Makkar, JK; Singh, PM; Sinha, A; Trikha, A, 2016) |
| "A comprehensive literature search was conducted to identify RCTs that investigated the efficacy and safety of intravenous dexamethasone or ondansetron on PONV in pediatric strabismus surgical patients." | 8.90 | Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: a meta-analysis of randomized controlled trials. ( Chen, CY; Cherng, YG; Shen, YD; Tam, KW; Wu, CH, 2014) |
| "Ramosetron has been shown to have a very strong effect for preventing postoperative nausea and vomiting (PONV) in previous meta-analyses." | 8.89 | Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. ( Goto, T; Mihara, T; Morita, S; Tojo, K; Uchimoto, K, 2013) |
| "The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42." | 8.89 | Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013) |
| "The total incidence of postoperative nausea and vomiting within 24 hours after laparoscopic cholecystectomy was 31% (74 of 235) in the ondansetron group and 56% (127 of 225) in the metoclopramide group (OR=0." | 8.88 | Efficacy of ondansetron vs. metoclopramide in prophylaxis of postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Cheng, TY; Lin, YX; Wu, SJ; Xiong, XZ, 2012) |
| "To justify the use of ondansetron as a preventive treatment for postoperative nausea and vomiting (PONV) of adults and children in neurosurgery." | 8.86 | [Ondansetron: a meta-analysis on its efficacy to prevent postoperative nausea and vomiting after craniotomy in adults and children]. ( Dailler, F; Duflo, F; Frost, F, 2010) |
| "We performed a systematic review of published, randomized, controlled trials to determine the relative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting." | 8.80 | Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. ( Anderson, EA; Domino, KB; Polissar, NL; Posner, KL, 1999) |
| "The objective of this study was to compare, by means of meta-analysis, the postoperative antiemetic efficacy of ondansetron in patients with and without antecedents of postoperative nausea and vomiting." | 8.80 | Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. ( Canosa, L; Figueredo, E, 1999) |
| "The post-operative anti-emetic efficacy of 4 and 8 mg of ondansetron in adult patients with and without a previous history of motion sickness (PHMS) was assessed by meta-analysis." | 8.80 | Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. ( Canosa, L; Figueredo, E, 1999) |
| "To determine the efficacy and safety of ondansetron for the prevention and treatment of postoperative nausea and vomiting (PONV) in adults." | 8.80 | Systematic review of ondansetron for the prevention and treatment of postoperative nausea and vomiting in adults. ( Cox, F, 1999) |
| "Objective To evaluate the application of adding ondansetron in morphine intravenous analgesia pump for prevention of postoperative nausea and vomiting(PONV)in women." | 7.88 | [Adding Ondansetron in Morphine Intravenous Analgesia Pump for Prevention of Postoperative Nausea and Vomiting in Women]. ( Bai, B; Huang, YG; Pei, LJ; Sang, NE; Zhang, XH; Zhang, YL, 2018) |
| "We investigated whether the 2677G>T/A and 3435C>T polymorphisms of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) affect the efficacy of ondansetron to prevent postoperative nausea and vomiting." | 7.76 | Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting. ( Choi, EM; Choi, KW; Choi, SH; Lee, MG; Lee, SH, 2010) |
| "To provide further evidence of cardiovascular adverse effects of ondansetron, including new-onset atrial fibrillation, ST segment elevation, and chest pain subsequent to ondansetron administration, and to review cardiovascular adverse events related to several 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonists." | 7.75 | Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. ( Havrilla, PL; Kane-Gill, SL; Reis, SE; Seybert, AL; Verrico, MM, 2009) |
| "Some patients treated with ondansetron for postoperative nausea and vomiting do not respond to therapy." | 7.73 | The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? ( Andrews, D; Birnbach, DJ; Candiotti, KA; Kamat, A; Koch, WH; Lubarsky, DA; Nhuch, F; Nikoloff, M; Wu, L, 2005) |
| "To compare the cost-effectiveness of 2 antiemetic agents, ondansetron and prochlorperazine, for the prevention of postoperative nausea and vomiting (PONV) in patients undergoing total hip replacement or total knee replacement procedures." | 7.73 | Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting. ( Chang, P; Chen, J; Frame, D; Okamoto, M, 2005) |
| "In this study, a cost-consequence analysis (CCA) is used to estimate the economic benefit of ondansetron and dimenhydrinate as antiemetics administered prophylactically in children undergoing strabismus surgery." | 7.73 | Economic evaluation of ondansetron vs dimenhydrinate for prevention of postoperative vomiting in children undergoing strabismus surgery. ( Alanezi, K; Coyte, PC; Lasry, A; Piwko, C; Ungar, WJ, 2005) |
| " She received 4 mg of ondansetron intravenously for postoperative nausea and vomiting prophylaxis at the end of the procedure and an additional 4 mg in the recovery room for nausea." | 7.72 | Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. ( Kasinath, NS; Malak, O; Tetzlaff, J, 2003) |
| "Acupuncture combined with ondansetron as a multimodal prophylaxis approach is more effective than ondansetron alone in preventing postoperative nausea in high-risk patients." | 7.30 | Acupuncture combined with ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic gynaecological surgery: A randomised controlled trial. ( Cao, W; Li, H; Liu, C; Xiong, Z; Xu, M; Yan, S; Yang, J; Zhu, Z; Zou, X, 2023) |
| "Ondansetron was beneficial for PON prophylaxis in patients under the age of 50, whereas preoperative intravenous fluid loading was considered a risk factor for PON in this population." | 7.11 | A randomized controlled trial comparing incidences of postoperative nausea and vomiting after laparoscopic cholecystectomy for preoperative intravenous fluid loading, ondansetron, and control groups in a regional hospital setting in a developing country. ( Charoensawan, S; Peanpanich, P; Wongyingsinn, M, 2022) |
| "PONV was assessed in recovery and 24 hours after surgery in the ward." | 7.01 | Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial. ( Aghabagheri, M; Khajavi, MR; Najjari, K; Pourfakhr, P; Talebpour, M; Zabihi Mahmoudabadi, H, 2021) |
| "In obese patients, the incidence of postoperative nausea and vomiting (PONV) following sleeve gastrectomy under titration of total intravenous anaesthesia (TIVA) and the relevance of risk factors to indicate prophylaxis is unknown." | 6.82 | Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind place ( Bataille, A; Charmeau, A; Chazot, T; Diemunsch, P; Fischler, M; Le Guen, M; Léger, P; Lemedioni, P; Letourneulx, JF; Liu, N, 2016) |
| "Ondansetron is a 5-HT3 receptor antagonist which is generally used for the prophylactic management of nausea and vomiting; however, studies have found that ondansetron might decrease the incidence of PDPH." | 6.80 | Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study. ( Fattahi, Z; Hadavi, SM; Sahmeddini, MA, 2015) |
| "Postoperative nausea and vomiting is a major cause of patient dissatisfaction towards surgery." | 6.79 | Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. ( Goudra, BG; Ochroch, EA; Singh, PM; Sinha, AC; Williams, NW, 2014) |
| "The incidence of postoperative nausea and vomiting (PONV) is 30-50% after surgery." | 6.79 | The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: a prospective, randomized, double-blinded study. ( Hamaguchi, E; Kakuta, N; Kume, K; Soga, T; Tanaka, K; Tsutsumi, R; Tsutsumi, YM, 2014) |
| "Ramosetron at 0." | 6.79 | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. ( Baik, HJ; Do, SH; Han, JI; Hong, DM; Kim, HZ; Lee, JE; Lim, YJ; Min, KT; Park, HP; Ryu, JH, 2014) |
| "Many patients may experience postoperative nausea and vomiting (PONV) following laparoscopic sleeve gastrectomy (LSG)." | 6.78 | The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. ( Benevides, ML; de Aguilar-Nascimento, JE; Oliveira, SS, 2013) |
| "Aprepitant is a neurokin-1 receptor antagonist with a long duration of action and no sedative side effect." | 6.76 | A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. ( Borel, CO; Gan, TJ; Habib, AS; Keifer, JC; White, WD, 2011) |
| "Ramosetron was found safe and more effective antiemetic than ondansetron in patients undergoing lap chole." | 6.75 | Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy. ( Akhtar, S; Ansari, MM; Haleem, S; Khan, FA; Siddiqui, OA; Varshney, R, 2010) |
| "The incidence of postoperative nausea and vomiting was significantly smaller in both groups than predicted according to the patients' underlying risks (midazolam group: p = 0." | 6.73 | Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial. ( Chen, A; Lai, HY; Lee, Y; Wang, JJ; Yang, YL, 2007) |
| "Patients at high risk of postoperative nausea and vomiting often receive more than one prophylactic antiemetic drug." | 6.73 | Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting. ( Bennett, EJ; Dodd, PH; Doherty, DA; Lain, J; Paech, MJ; Rucklidge, MW, 2007) |
| "Unlike patients with chemotherapy-induced nausea and vomiting, perioperative patients who failed ondansetron prophylaxis did not have a significant response to cross-over dosing with granisetron." | 6.73 | Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study. ( Arheart, KL; Birnbach, DJ; Candiotti, KA; Deepika, K; Kamat, A; Lubarsky, DA; Nhuch, F, 2007) |
| "The exact incidence of postoperative nausea and vomiting (PONV) in patients on steroids undergoing neurosurgical procedures is not known." | 6.73 | Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors. ( Chandrashekharappa, KN; Mukherjee, KK; Nakra, D; Wig, J; Yaddanapudi, LN, 2007) |
| "Short term efficacy of dexamethasone to treat PONV was similar to ondansetron, but inferior to droperidol." | 6.72 | [Controlled trial of dexamethasone compared with droperidol and ondansetron for the treatment of postoperative nausea and vomiting]. ( Ibacache, ME; Mertz, VF; Muñoz, HR, 2006) |
| "Rates of previous postoperative nausea and vomiting and motion sickness were comparable across the groups." | 6.71 | A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children. ( O'Brien, CM; Titley, G; Whitehurst, P, 2003) |
| "The management of postoperative nausea and vomiting (PONV) remains a persistent problem." | 6.71 | Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. ( Davis, J; McLeskey, CH; Meyer, TA; Rajab, MH; Roberson, CR, 2005) |
| "Data on postoperative nausea and vomiting were collected at 0, 2, 6, and 24 h." | 6.71 | A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. ( Coop, A; Gan, TJ; Philip, BK, 2005) |
| "Postoperative nausea and vomiting are observed in increased frequency after laparoscopic surgery." | 6.70 | Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study. ( Argiriadou, H; Georgiou, M; Papagiannopoulou, P; Papaziogas, B; Papaziogas, T; Parlapani, A; Pavlidis, T, 2002) |
| "The incidence of postoperative nausea and vomiting was 33% for group C, 44% for group O and 41% for group D." | 6.70 | The addition of antiemetics to the morphine solution in patient controlled analgesia syringes used by children after an appendicectomy does not reduce the incidence of postoperative nausea and vomiting. ( Dickson, U; Fisher, S; Morton, N; Munro, FJ, 2002) |
| "With the use of volatile anesthetics, postoperative nausea and vomiting (PONV) are common, with an incidence of emesis as frequent as 60%." | 6.70 | Postoperative nausea and vomiting in children and adolescents undergoing radiofrequency catheter ablation: a randomized comparison of propofol- and isoflurane-based anesthetics. ( Erb, TO; Gan, TJ; Hall, JM; Ing, RJ; Kanter, RJ; Kern, FH; Schulman, SR, 2002) |
| "The anti-emetic efficacy of prophylactic ondansetron and tropisetron in combination with a low dose of droperidol in patients with high probability for post-operative nausea and vomiting undergoing gynaecological laparoscopy was compared." | 6.69 | Comparison of ondansetron and tropisetron combined with droperidol for the prevention of emesis in women with a history of post-operative nausea and vomiting. ( Ala-Kokko, TI; Jokela, R; Koivuranta, M; Ranta, P, 1999) |
| "The incidence of postoperative nausea, emesis, pain and sedation scores, and rescue antiemetic use were recorded at 0, 0." | 6.69 | A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. ( Borel, CO; El-Moalem, HE; Fabling, JM; Gan, TJ; Warner, DS, 2000) |
| "PONV was analysed by a linear nausea/vomiting score, incidence of nausea and vomiting, and the need for antiemetic rescue." | 6.69 | Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial. ( Barros, MA; Celich, MF; Leães, LF; Peixoto Filho, AJ; Peixoto, AJ, 2000) |
| "Postoperative nausea and vomiting is a common side effect of general anesthesia." | 6.52 | Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials. ( Cao, G; Gao, C; Li, B; Lv, F; Wang, F; Wang, H; Wu, G; Xu, L, 2015) |
| "Palonosetron was superior to ondansetron in the reduction of early PON [RR, 0." | 6.52 | Efficacy of palonosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. ( Liu, G; Ma, R; Wu, A; Xiong, C; Xue, J, 2015) |
| "Previous studies have determined ondansetron's efficacy in preventing and treating postoperative nausea and vomiting (PONV)." | 5.69 | Preoperative versus intraoperative antiemetic strategies in patients undergoing laparoscopic cholecystectomy: A randomised double-blind study. ( Fassoulaki, A; Staikou, C; Theodosopoulou, P, 2023) |
| "The primary objective of this retrospective safety study was to determine the incidence of torsades de pointes (TdP) or death following perioperative administration of low-dose, 4 mg, ondansetron for postoperative nausea and vomiting." | 5.51 | The incidence of torsades de pointes with peri-operative low-dose ondansetron administration. ( Ackerman, MJ; Danke, H; Marienau, MS; Nuttall, GA; Oyen, LJ; Voogd, SC; Warner, PA, 2022) |
| " No differences between the two groups were detected for postoperative consumption of tramadol, pain score (NRS), intensity of nausea (NRS), presence of vomiting, consumption of rescue analgesics and antiemetics, and patient satisfaction." | 5.51 | The Effect of Ondansetron on the Analgesic Efficacy of Tramadol in Patients Undergoing Laparoscopic Cholecystectomy. ( Bilgen, S; Erdoğan Ari, D; Özveri, E, 2022) |
| "This study's purpose was to determine if ondansetron can prevent pruritus after administration of intrathecal morphine in children, as has been demonstrated in adults." | 5.51 | Intravenous ondansetron reduced nausea but not pruritus following intrathecal morphine in children: Interim results of a randomized, double-blinded, placebo-control trial. ( Hong, RA; Leis, A; Li, Y; Malviya, S; Park, JM; Putnam, EM, 2022) |
| "This study was conducted in order to compare the efficacy and safety of dexamethasone and ondansetron, alone or in combination, for prevention of postoperative nausea and vomiting in a sample of Iraqi women undergoing gynecological surgeries." | 5.51 | Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation. ( Abdulhussain, AS, 2022) |
| "Ondansetron 0." | 5.42 | Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting. ( Choi, EM; Choi, SH; Kim, EH; Kim, MS; Lee, JR, 2015) |
| " PONV incidence, complete response, 80 mg aprepitant combined with dexamethasone and ondansetron, vomiting, nausea, and analgesic dose-response were the main outcomes measured." | 5.41 | The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis. ( Chen, X; He, H; Hu, W; Liao, Y; Liu, W; Liu, Y; Pan, Z; Wang, X; Zheng, F; Zhong, H, 2023) |
| "Based on the results of this study, ondansetron had a significant effect on the alleviation of postoperative nausea and vomiting, as compared to dexamethasone in C-section surgical candidates." | 5.41 | Comparison of the Effects of Dexamethasone and Ondansetron on the Reduction of Postoperative Nausea and Vomiting following Cesarean Section under Spinal Anesthesia. ( Birjandi, M; Karimi, A; Nejadi, JR; Ronasi, N; Shamseh, M, 2021) |
| "To describe a case of ventricular tachycardia after co-administration of ondansetron and dimenhydrinate to a child with occult congenital QT prolongation." | 5.36 | Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome. ( Froese, A; McKechnie, K, 2010) |
| " This study aimed to evaluate the effectiveness of ramosetron or ondansetron to relieve postoperative nausea and vomiting (PONV) and pain after arthroscopic rotator cuff repair." | 5.34 | The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial. ( Kim, YS; Lee, HJ; Lee, SU, 2020) |
| "Promethazine was significantly more effective than ondansetron for treating PONV after failed ondansetron prophylaxis." | 5.34 | A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. ( Gan, TJ; Habib, AS; Reuveni, J; Taguchi, A; White, WD, 2007) |
| "When used in treatment of postoperative nausea and vomiting, a situation where prolongation of the QTc interval seems to occur, the safety of 5-hydroxytryptamine type 3 antagonists may not be superior to that of low-dose droperidol." | 5.33 | Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. ( Albaladejo, P; Charbit, B; Funck-Brentano, C; Legrand, M; Marty, J; Samain, E, 2005) |
| "Because practitioners have taken widely differing approaches to the selection and dosing of agents in this class, this retrospective study assessed the relative efficacy of i." | 5.31 | Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting. ( Walker, JB, 2001) |
| "Palonosetron is a new, potent and long-acting 5HT3-receptorsantagonist that had been approved by the FDA for use in postoperative nausea and vomiting (PONV) prophylaxis." | 5.30 | Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients. ( Ahamed, S; Begum, M; Begum, R; Chowdhury, MG; Hossain, M; Hossain, MM; Shuvo, FR, 2019) |
| "incidence of postoperative nausea and vomiting without prophylaxis) of between 10 and 90%." | 5.30 | Cost-effectiveness of ondansetron for postoperative nausea and vomiting. ( McQuay, HJ; Moore, RA; Phillips, C; Reynolds, DJ; Tramèr, MR, 1999) |
| "Akathisia, a distressing movement disorder induced by butyrophenones, has been described with low doses of droperidol used for postoperative nausea and vomiting (PONV) prophylaxis, but the incidence remains unclear." | 5.27 | Incidence of akathisia after postoperative nausea and vomiting prophylaxis with droperidol and ondansetron in outpatient surgery: A multicentre controlled randomised trial. ( Charton, A; Diemunsch, P; Faitot, V; Greib, N; Joshi, GP; Meyer, N; Noudem, Y; Ruimy, A, 2018) |
| ": The combination of dexamethasone (DEX), ondansetron (OND) and droperidol (DRO) is efficacious in preventing postoperative nausea and vomiting in adults, but has not been well assessed in children." | 5.24 | Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study. ( Bouazza, N; Bourdaud, N; Boutin, F; Devys, JM; Engrand-Donal, C; François, C; Guye, ML; Guyot, E; Jacqmarcq, O; Jean, J; Orliaguet, GA; Studer, C; Treluyer, JM, 2017) |
| "A novel treatment, chewing gum, may be non-inferior to ondansetron in inhibiting postoperative nausea and vomiting (PONV) in female patients after laparoscopic or breast surgery." | 5.24 | Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial. ( Darvall, JN; Handscombe, M; Leslie, K, 2017) |
| "One hundred and five patients (aged 18-60 years) undergoing strabismus surgery were allocated randomly to one of the three groups: placebo, ondansetron, or ramosetron." | 5.22 | Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients. ( Joo, J; Park, HJ; Park, S; Shin, SY, 2016) |
| "Postoperative nausea and vomiting (PONV) is common; ondansetron is often used as prophylaxis or for breakthrough episodes." | 5.20 | Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron. ( Brigandi, RA; Dalby, PL; Eberhart, LH; Johnson, BM; Kranke, P; Noble, R; Novikova, E; Russ, SF; Thompson, JP, 2015) |
| "Prophylactic administration of ondansetron to parturients receiving intrathecal morphine for post-operative analgesia provides a significant reduction of intrathecal morphine-induced pruritus and nausea and vomiting." | 5.20 | Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. ( Dongol, Y; Gurung, BS; Koju, RB, 2015) |
| "Ondansetron, sometimes combined with acustimulation at PC6 (Neiguan), is commonly used for preventing postoperative nausea and vomiting, but PC6 is not the only point that can be used for this purpose." | 5.19 | Ondansetron combined with ST36 (Zusanli) acupuncture point injection for postoperative vomiting. ( Chen, ZY; Guo, QL; Huang, YL; Lin, L; Wang, HH; Yan, JQ; Zhou, Y, 2014) |
| "Combination of ondansetron and dexamethasone was more efficacious compared to ondansetron alone in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy." | 5.19 | Comparison of efficacy of ondansetron and dexamethasone combination and ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. ( Abbas, N; Ahsan, K; Murtaza, G; Naqvi, SM; Tariq, S, 2014) |
| "Healthy paturients undergoing cesarean delivery with intrathecal morphine 250μg and fentanyl 25μg were randomized to receive: prophylaxis (ondansetron 8mg at cord clamping, normal saline 4mL for treatment of pruritus in the post-anaesthesia care unit); treatment (normal saline 4mL at cord clamping, ondansetron 8mg as required in the post-anesthesia care unit) or control (normal saline 4mL in both)." | 5.19 | Prevention versus treatment of intrathecal morphine-induced pruritus with ondansetron. ( Hess, P; Kung, AT; Li, Y; Pratt, S; Vasudevan, A; Yang, X, 2014) |
| "This study compared palonosetron and ondansetron as rescue medications for postoperative nausea and vomiting (PONV) in patients who received prophylactic ondansetron." | 5.19 | Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study. ( Ahmed, SR; Candiotti, KA; Cox, D; Gan, TJ, 2014) |
| " This prospective, randomized, double blind study was carried out to compare the effectiveness of a combination of dexamethasone and ondansetron with dexamethasone alone for prevention of postoperative nausea and vomiting (PONV) following intrathecal morphine injection for caesarean section." | 5.19 | Dexamethasone versus a combination of dexamethasone and ondansetron as prophylactic antiemetic in patients receiving intrathecal morphine for caesarean section. ( Imeh, A; Olaniyi, O; Omotola, O; Simeon, O, 2014) |
| "A prospective, double-blinded, randomized, two-arm evaluation of 150 ambulatory plastic surgery patients receiving a standardized general anesthetic, including postoperative nausea and vomiting prophylaxis with ondansetron and either aprepitant or placebo, was performed." | 5.16 | Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery. ( Barnes, LR; Ibinson, JW; Milord, PJ; Phelps, AL; Romeo, RC; Sah, N; Vallejo, MC; Williams, BA, 2012) |
| " ondansetron and palonosetron administered at the end of surgery in preventing postoperative nausea and vomiting (PONV) in high-risk patients receiving i." | 5.16 | Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. ( Joo, J; Kim, JE; Lee, Y; Moon, YE, 2012) |
| " We designed this study to compare the effects of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic operations." | 5.15 | A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting. ( Aydın, N; Ekinci, O; Işıtmangil, G; Malat, I, 2011) |
| "To compare intravenous dexamethasone and ondansetron for the prophylaxis of postoperative nausea and vomiting (PONV), a main complaint that affects almost 40%-75% of patients undergoing laparoscopic gynecologic surgery." | 5.15 | Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery. ( Bhagwat, S; D'souza, N; Swami, M, 2011) |
| "We investigated whether combined dexamethasone and ondansetron is more effective than ondansetron alone in preventing postoperative nausea and vomiting in patients with fentanyl-based intravenous patient-controlled analgesia." | 5.15 | The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. ( Kang, BC; Lee, JG; Park, EY; Park, YS; Shim, YH; Song, JW, 2011) |
| "This randomized, double-blind study evaluated the relative efficacy of palonosetron (a new, selective 5-hydroxytryptamine type 3 [5-HT(3)] receptor antagonist) and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynaecological laparoscopic surgery." | 5.15 | A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. ( Cho, EJ; Park, SK, 2011) |
| "Investigators from Bristol described a fentanyl- and diclofenac-based analgesic technique for tonsillectomy with low postoperative nausea and vomiting rates and low pain scores." | 5.15 | A randomised controlled trial of two analgesic techniques for paediatric tonsillectomy*. ( Bagshaw, O; Rawlinson, E; Skone, R; Thillaivasan, A; Walker, A, 2011) |
| "To compare the efficacy of ondansetron and granisetron in the prevention of postoperative nausea and vomiting (PONV) in high-risk patients." | 5.15 | [Preventive efficacy of ondansetron and granisetron for postoperative nausea and vomiting in high risk patients]. ( Quan, X; Ye, TH; Zhu, B, 2011) |
| "Patients identified as high risk for postoperative nausea and vomiting (PONV) are often treated prophylactically with intravenous (IV) ondansetron and an additional agent." | 5.15 | Prophylactic isopropyl alcohol inhalation and intravenous ondansetron versus ondansetron alone in the prevention of postoperative nausea and vomiting in high-risk patients. ( Bushey, B; Daniel, C; Fuller, TN; Pellegrini, JE; Radford, KD, 2011) |
| "The purpose of this study was to compare the effects of ondansetron combined with dexamethasone on Post-Operative Nausea and Vomiting (PONV) and pain with ondansetron alone in patients with laparoscopy assisted vaginal hysterectomy under general anesthesia." | 5.14 | [Effect of ondansetron combined with dexamethasone on postoperative nausea & vomiting and pain of patients with laparoscopic hysterectomy]. ( Nam, M; Yoon, H, 2009) |
| "To determine the efficacy of transdermal scopolamine in addition to ondansetron in decreasing the incidence of postoperative nausea and vomiting (PONV)." | 5.14 | Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. ( Dalby, P; Kaul, B; Ramesh, V; Sah, N; Shestak, K; Vallejo, MC, 2009) |
| " The purpose of this study was to evaluate the efficacy of ramosetron for the prevention of postoperative nausea and vomiting (PONV) with that of ondansetron or placebo in high-risk patients undergoing gynaecological surgery." | 5.14 | Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. ( Baek, YH; Kim, SC; Kim, SH; Kim, SI; Ok, SY, 2009) |
| "Frequently, patients identified as high risk for postoperative nausea and vomiting (PONV) are treated prophylactically with intravenous (IV) ondansetron and postoperatively with IV promethazine." | 5.14 | Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. ( Bennett, J; DeLoge, J; Kelly, J; Pellegrini, J, 2009) |
| " reduces the severity of pruritus and the use of rescue anti-pruritic medication, and improves satisfaction but does not reduce the overall incidence of pruritus in women who have received subarachnoid morphine 150 microg compared to ondansetron 8 mg i." | 5.14 | Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron. ( Carey, M; Choroszczak, P; Immani, S; Ojo, R; Tan, T, 2010) |
| "Prophylactic administration of either of either granisetron, ondansetron, midazolam combined with dexamethasone markedly decreases the incidence of PONV following strabismus surgery in pediatrics." | 5.14 | Combination therapy in the prevention of PONV after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone. ( Marouf, H; Riad, W, 2009) |
| "We compared the prophylactic effects of intravenously administered azasetron (10 mg) and ondansetron (8 mg) on postoperative nausea and vomiting (PONV) in patients undergoing gynecological laparoscopic surgery under general anesthesia." | 5.14 | Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery. ( Kim, AR; Kim, YH; Yun, MJ, 2010) |
| "Ondansetron is as effective as diphenhydramine in relieving pruritus caused by SA morphine in patients undergoing a cesarean delivery." | 5.14 | Ondansetron is as effective as diphenhydramine for treatment of morphine-induced pruritus after cesarean delivery. ( Adham, AM; Aouad, MT; Dagher, CM; Saasouh, WA; Siddik-Sayyid, SM; Yazbeck-Karam, VG; Zahreddine, BW, 2010) |
| "We compared the prophylactic anti-emetic efficacy of ramosetron, a newly developed 5-HT(3) antagonist, and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement." | 5.14 | Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. ( Choi, SJ; Gwak, MS; Hahm, TS; Ko, JS, 2010) |
| "In a prospective randomized double-blind study, we compared the effectiveness of dexamethasone 8 mg with either granisetron 1 mg or ondansetron 4 mg in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery." | 5.14 | Dexamethasone with either granisetron or ondansetron for postoperative nausea and vomiting in laparoscopic surgery. ( Baraka, AS; Dabbous, AS; El-Khatib, MF; Jabbour-Khoury, SI; Khouzam, NE; Moussa, AA; Nasr, VG; Zbeidy, RA, 2010) |
| "Compared with ondansetron alone, the casopitant and ondansetron combination results in superior emesis prevention during the first 24 h postoperatively in female patients with known risk factors for postoperative nausea and vomiting." | 5.14 | Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. ( Blackburn, L; Chung, F; Johnson, B; Kutsogiannis, DJ; Lane, SR; Levin, J; Pergolizzi, JV; Singla, NK; Singla, SK, 2010) |
| " Before induction of anesthesia, patients were randomly allocated to receive intravenously dexamethasone (8 mg) in group D, ondansetron (4 mg) in group O, metoclopramide (10 mg) in group M, and saline (2 mL) in group P." | 5.14 | A comparative study of the antiemetic efficacy of dexamethasone, ondansetron, and metoclopramide in patients undergoing gynecological surgery. ( Bilgin, TE; Birbicer, H; Doruk, N; Oral, U; Ozer, Z; Tok, E, 2010) |
| "To compare the clinical efficacy of acupressure with treatment induced by ondansetron and metoclopramide on reduction of the severity of postoperative nausea and vomiting (PONV) after strabismus surgery." | 5.14 | Acupressure using ondansetron versus metoclopramide on reduction of postoperative nausea and vomiting after strabismus surgery. ( Afkham, K; Arbabi, S; Darabi, ME; Ebrahim Soltani, A; Goudarzi, M; Mohammadinasab, H; Mohtaram, R; Momenzadeh, S, 2010) |
| "The purpose of this study was to determine if giving 50 mg of meclizine the night before and on the day of surgery would effectively reduce postoperative nausea and vomiting (PONV) for the entire 24 hours after surgery in patients identified as being at high risk for PONV Subjects were randomly assigned to receive either 50 mg of oral meclizine (experimental group) or a placebo (control group) the night before and the day of surgery." | 5.14 | Biphasic dosing regimen of meclizine for prevention of postoperative nausea and vomiting in a high-risk population. ( Bopp, EJ; Daniel, C; Estrada, TJ; Kilday, JM; Pellegrini, JE; Spradling, JC, 2010) |
| "To compare the efficacy of combination of dexamethasone plus ondansetron with dexamethasone alone for postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy." | 5.13 | Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone. ( Aftab, S; Bano, F; Haider, S; Zafar, S, 2008) |
| "During the first 12 hr following the procedures, patients experienced significantly less vomiting/retching and less disruption of activity while receiving ondansetron, and recorded significantly lower pain scores while receiving fentanyl." | 5.13 | Pediatric oncology sedation trial (POST): A double-blind randomized study. ( Barr, RD; Buckley, N; Korz, L; Lappan, J; Nagel, K; Willan, AR, 2008) |
| "To compare the effect of ramosetron with that of ondansetron on opioid-based IV patient-controlled analgesia (PCA) related postoperative nausea and vomiting (PONV) in highly susceptible patients after lumbar spine surgery." | 5.13 | Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. ( Choi, YS; Jeon, DH; Kwak, YL; Lee, JY; Shim, JK; Yoon, DH, 2008) |
| "To compare total intravenous anesthesia (TIVA) with ondansetron, and metoclopramide in preventing postoperative nausea and vomiting (PONV) in laparoscopic cholecystectomy patients." | 5.13 | Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy. ( Abd El-Hakeem, EE; Kaki, AM, 2008) |
| "To compare ondansetron with ondansetron plus prochlorperazine, added to a patient-controlled analgesia (PCA) solution for control of postoperative nausea and vomiting (PONV)." | 5.13 | Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery. ( Fluder, E; Jellish, WS; Owen, K; Sawicki, K; Sinacore, J, 2008) |
| "Haloperidol is effective for postoperative nausea and vomiting prophylaxis, but there are almost no data comparing it to 5-HT(3) antagonists." | 5.13 | Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. ( Bittner, EA; Grecu, L; Haspel, KL; Rosow, CE; Smith, SE, 2008) |
| "Haloperidol 1 mg and ondansetron 4 mg are equally safe and effective for postoperative nausea and vomiting prophylaxis." | 5.13 | Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. ( Bittner, EA; Grecu, L; Kher, J; Rosow, CE; Smith, SE, 2008) |
| "In an effort to determine the most effective timing of ondansetron administration to prevent postoperative nausea and vomiting (PONV), a prospective, randomized, double-blind study was performed." | 5.13 | Timing of ondansetron administration to prevent postoperative nausea and vomiting. ( Cruz, NI; Portilla, P; Vela, RE, 2008) |
| "To compare the efficacy of prophylactic ondansetron and tropisetron for postoperative nausea and vomiting (PONV)." | 5.12 | Comparison of ondansetron and tropisetron in preventing postoperative nausea and vomiting: A meta-analysis of randomized controlled trials. ( Chen, Y; Song, X; Wang, J; Wang, N; Wang, R, 2021) |
| "Neither ondansetron nor tropisetron prevent itching caused by intrathecal morphine with fentanyl." | 5.12 | Ondansetron and tropisetron do not prevent intraspinal morphine- and fentanyl-induced pruritus in elective cesarean delivery. ( Halonen, PM; Kainu, JP; Korttila, KT; Sarvela, PJ; Soikkeli, AI, 2006) |
| "Ondansetron is widely used for the prophylaxis of postoperative nausea and vomiting, while haloperidol is an antiemetic that lacks recent data on efficacy and adverse effects." | 5.12 | Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. ( Aouad, MT; Azar, MS; Baraka, AS; Hakki, MA; Nasr, VG; Siddik-Sayyid, SM; Taha, SK; Zoorob, DG, 2007) |
| "Prophylactic ondansetron or droperidol reduces the incidence of postoperative nausea and vomiting (PONV)." | 5.12 | The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. ( Apfel, CC; Chan, MT; Choi, KC; Chui, PT; Gan, TJ; Gin, T; Poon, AH; Short, TG; Yuen, PM, 2006) |
| "2 mg mL-1 of ondansetron added to morphine patient-controlled analgesia solution after a 4 mg loading dose on the incidence and severity of postoperative nausea and vomiting." | 5.12 | Antiemetic effect of ondansetron 0.2 mg mL-1 in PCA morphine solution. ( Boonmak, P; Boonmak, S; Bunsaengjaroen, P; Nonlhaopol, D; Poomsawat, S; Srichaipanha, S, 2007) |
| " This is the first study evaluating the efficacy and tolerability of the neurokinin-1 receptor antagonist, aprepitant, for the prevention of postoperative nausea and vomiting." | 5.12 | A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. ( Apfel, CC; Carides, AD; Evans, JK; Gan, TJ; Habib, AS; Horgan, KJ; Knighton, J; Kovac, A; Lawson, FC; Minkowitz, H; Philip, BK; Singla, N; Zhang, H, 2007) |
| " The aim of this study was to compare the prophylactic antiemetic efficacy of haloperidol vs ondansetron for the prevention of postoperative nausea and vomiting (PONV) after general anesthesia." | 5.12 | Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. ( Chu, CC; Lai, HY; Lee, Y; Wang, JJ; Wang, PK; Yang, YL, 2007) |
| " The incidence of pruritus and nausea was significantly lower in the epidural ondansetron group than in the intravenous ondansetron group at 24 and 48 h postoperatively." | 5.12 | Epidural ondansetron is more effective to prevent postoperative pruritus and nausea than intravenous ondansetron in elective cesarean delivery. ( Han, DW; Hong, SW; Kim, KJ; Kwon, JY; Lee, JW, 2007) |
| " We compared aprepitant with ondansetron for prevention of postoperative nausea and vomiting." | 5.12 | Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. ( Carides, AD; Chelly, JE; Diemunsch, P; Eberhart, L; Evans, JK; Gan, TJ; Girao, MJ; Irwin, MG; Lawson, FC; Philip, BK; Pueyo, J; Reiss, T, 2007) |
| "To compare the antiemetic efficacy of ondansetron with two different hypnotic drugs (propofol 15 mg, midazolam 1 and 2 mg) for the treatment of established postoperative nausea and vomiting (PONV)." | 5.11 | Comparative study of the antiemetic efficacy of ondansetron, propofol and midazolam in the early postoperative period. ( Guler, T; Gunes, Y; Isik, G; Unlugenc, H, 2004) |
| "5 mg of dolasetron were equally effective in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynecological procedures." | 5.11 | Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. ( Browning, BA; Fort, CA; Kemp, KD; Shimata, MF; Strube, MD, 2004) |
| "Ondansetron, dexamethasone, and droperidol each reduced the risk of postoperative nausea and vomiting by about 26 percent." | 5.11 | A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. ( Abdalla, M; Apfel, CC; Biedler, A; Danner, K; Jokela, R; Kerger, H; Korttila, K; Kredel, M; Pocock, SJ; Roewer, N; Sessler, DI; Trenkler, S; Turan, A; Vedder, I; Zernak, C, 2004) |
| "The present study was to evaluate the efficacy of ondansetron, 5-HT3 receptor antagonist, versus placebo in the prevention of postoperative nausea and vomiting (PONV) in a homogenous group of female patients undergoing breast reduction surgery under general anaesthesia." | 5.11 | Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study. ( Ambesh, SP; Sinha, PK, 2004) |
| "Fentanyl is commonly used for spinal analgesia during labour but it is associated with a high incidence of pruritus." | 5.11 | Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron. ( Evans, SF; Paech, MJ; Wells, J, 2004) |
| "The purpose of this study was to evaluate, in the pediatric ambulatory surgical population, the efficacy of: (i) oral transmucosal fentanyl citrate (OTFC), when given preoperatively, to reduce postoperative excitement associated with sevoflurane, and (ii) intravenous ondansetron to reduce postoperative nausea and vomiting (PONV) associated with OTFC." | 5.11 | The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients. ( Bachman, C; Binstock, W; Kahana, M; Lynch, JP; McDade, W; Rubin, R, 2004) |
| "In this study we evaluated the efficacy of electro-acupoint stimulation, ondansetron versus placebo for the prevention of postoperative nausea and vomiting (PONV)." | 5.11 | A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. ( Gan, TJ; Georgiade, G; Jiao, KR; Zenn, M, 2004) |
| "To determine the efficacy of a combination of ondansetron and dexamethasone in preventing postoperative nausea and vomiting after middle ear surgery compared with ondansetron alone." | 5.11 | Prevention of nausea and vomiting after middle ear surgery: combination of ondansetron and dexamethasone is the right choice. ( Bharadwaj, N; Chari, P; Kapoor, P; Panda, NB; Panda, NK, 2004) |
| "Ondansetron, dexamethasone, and droperidol each reduced the risk of postoperative nausea and vomiting by about 26%, propofol reduced the risk by 19%, and nitrogen by 12%." | 5.11 | [A factorial trial of six interventions for the prevention of postoperative nausea and vomiting]. ( Apfel, CC; Bacher, A; Biedler, A; Danner, K; Danzeisen, O; Eberhart, LH; Forst, H; Frings, G; Fritz, G; Goebel, A; Hergert, M; Hopf, HB; Kerger, H; Kranke, P; Lange, M; Mertzlufft, F; Motsch, J; Paura, A; Roewer, N; Schneider, E; Stoecklein, K; Wermelt, J; Zernak, C, 2005) |
| "To compare the risk-adapted approach with ondansetron against ondansetron plus dexamethasone to prevent postoperative nausea and vomiting (PONV) in a randomized clinical trial." | 5.11 | Prospective application of a simplified risk score to prevent postoperative nausea and vomiting. ( Apfel, CC; Biedler, A; Dethling, J; Eberhart, L; Rüsch, D, 2005) |
| "To compare the efficacy of stimulation of P6 acupoint with capsicum plaster in comparison with iv ondansetron for the prevention of postoperative nausea and vomiting (PONV)." | 5.11 | Prevention of PONV by acustimulation with capsicum plaster is comparable to ondansetron after middle ear surgery. ( Misra, MN; Mohamed, ZU; Pullani, AJ, 2005) |
| "Postoperative nausea and vomiting (PONV), a major complication in children, is responsive to IV and oral ondansetron." | 5.11 | Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy. ( Cohen, IT; Hummer, K; Joffe, D; Soluri, A, 2005) |
| " Overall nausea and vomiting were significantly lower in the ondansetron prophylaxis group than in the group without prophylaxis (52." | 5.11 | Postoperative nausea and vomiting in patients undergoing total abdominal hysterectomy under spinal anaesthesia: a randomized study of ondansetron prophylaxis. ( Baublys, A; Ivaskevicius, J; Kontrimaviciute, E, 2005) |
| "In this study we compared the efficacy of orally disintegrating tablets (ODT) and IV ondansetron for preventing spinal morphine-induced pruritus and postoperative nausea and vomiting (PONV) in healthy young male patients." | 5.11 | Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting, and pruritus in young males. ( Arslan, G; Candan, S; Pirat, A; Torgay, A; Tuncay, ŞF, 2005) |
| " We evaluated the ability of intraoperative IV ondansetron followed by postoperative ondansetron in an orally disintegrating tablet formulation to reduce the frequency and severity of postoperative nausea and vomiting in a prospective, randomized, placebo-controlled double-blind trial of 60 patients undergoing acoustic neuroma resection." | 5.11 | The efficacy of postoperative ondansetron (Zofran) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery. ( Hartsell, T; Kirsch, JR; Long, D, 2005) |
| "Pruritus is the most common side effect of intrathecal morphine for postoperative pain relief." | 5.11 | Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: a randomized, double-blinded, placebo-controlled study. ( Dimitriou, VK; Dragoumanis, CK; Iatrou, CA; Simopoulos, CE; Vogiatzaki, TD; Vretzakis, GI, 2005) |
| "This study evaluated the clinical efficacy and cost-effectiveness of prophylactic ondansetron versus early ondansetron treatment in the management of postoperative nausea and vomiting (PONV) in children undergoing strabismus repair using clinically meaningful outcomes and value-based principles." | 5.10 | Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes. ( Ilavajady, S; Jagan, D; Sadhasivam, S; Sennaraj, B; Shende, D, 2002) |
| "The ReliefBand compared favorably to ondansetron (4 mg intravenously) when used for prophylaxis against postoperative nausea and vomiting." | 5.10 | Comparative efficacy of acustimulation (ReliefBand) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting. ( Coleman, JE; Coloma, M; Hu, J; Ing, CH; Issioui, T; Jones, SB; Macaluso, AR; Markowitz, SD; Waddle, JP; White, PF, 2002) |
| "This study was designed to evaluate transcutaneous electrical acupoint stimulation (acustimulation) using the ReliefBand compared with ondansetron for the treatment of established postoperative nausea and vomiting (PONV) after outpatient laparoscopic surgery." | 5.10 | Comparison of acustimulation and ondansetron for the treatment of established postoperative nausea and vomiting. ( Berrisford, SB; Brown, PM; Coloma, M; Issioui, T; Jones, DB; Jones, SB; Lee, AQ; Markowitz, SD; Ogunnaike, BO; Wakefield, CA; White, PF, 2002) |
| "In this prospective, randomized, double-blinded study, we compared the prophylactic efficacy of nalbuphine and ondansetron for the prevention of intrathecal morphine-induced pruritus after cesarean delivery." | 5.10 | Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. ( Charuluxananan, S; Kyokong, O; Narasethakamol, A; Promlok, P; Somboonviboon, W, 2003) |
| "In a prospective, double-blinded, randomized trial, we evaluated the efficacy of IV (a) dexamethasone 8 mg, (b) ondansetron 8 mg, and (c) dexamethasone 8 mg plus ondansetron 4 mg for the prevention of postoperative nausea, vomiting (PONV), and pruritus in 130 (ASA physical status I to III) patients undergoing elective major orthopedic surgery after spinal anesthesia with hyperbaric 0." | 5.10 | A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery. ( Chellapuri, RS; Harmon, DC; Murphy, D; Owens, J; Shorten, GD; Szarvas, S, 2003) |
| "Ondansetron 4 mg or dexamethasone 4 mg are equally effective in the prevention of postoperative nausea and vomiting following breast surgery." | 5.10 | Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. ( Gupta, A; Liljegren, G; Lövqvist, A; Thörn, SE; Wattwil, L; Wattwil, M, 2003) |
| "To compare the antiemetic efficacy of ondansetron with two different hypnotic drugs (propofol 15 mg, midazolam 1 and 2 mg) for the treatment of established postoperative nausea and vomiting (PONV)." | 5.10 | Comparative study of the antiemetic efficacy of ondansetron, propofol and midazolam in the early postoperative period. ( Guler, T; Gunes, Y; Isik, G; Unlugenc, H, 2003) |
| "In a randomized, placebo-controlled, double-blind trial, we compared the efficacy of oral dolasetron and ondansetron in preventing postoperative nausea and vomiting in children after various surgical operations." | 5.10 | Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children. ( Karamanlioglu, B; Memis, D; Süt, N; Turan, A, 2003) |
| "We conclude that iv ondansetron 4 mg is effective in the prevention of nausea, vomiting, and pruritus following epidural morphine for postoperative pain control." | 5.10 | Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control. ( Cheng, KI; Chu, KS; Ho, ST; Liu, KS; Tzeng, JI; Wang, JJ, 2003) |
| "Ondansetron has a well documented antiemetic prophylactic effect, whereas in most studies of postoperative nausea and vomiting (PONV), metoclopramide is less efficacious." | 5.10 | Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. ( Quaynor, H; Raeder, JC, 2002) |
| "The purpose of this study was to compare the effects of a low-dose propofol infusion with a four-drug multimodal regimen for prophylaxis of postoperative nausea and vomiting (PONV)." | 5.10 | Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen - comparison with propofol or placebo. ( Hammas, B; Thörn, SE; Wattwil, M, 2002) |
| "Routine use of ondansetron does not reduce the incidence of postoperative nausea and vomiting after laparoscopic cholecystectomy." | 5.10 | Ondansetron in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study. ( Cheah, WK; Cheong, KF; Goh, P; Sng, C; So, JB, 2002) |
| "Ondansetron orally disintegrating tablet reduces postdischarge nausea and vomiting and improves patient satisfaction with postoperative nausea and vomiting management." | 5.10 | Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. ( Franiak, R; Gan, TJ; Reeves, J, 2002) |
| " Our hypothesis is that coinduction with clonidine reduces the incidence of PONV in adult patients undergoing breast cancer surgery." | 5.10 | Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. ( Bergendahl, HT; Eksborg, S; Lönnqvist, PA; Muhrbeck, O; Oddby-Muhrbeck, E, 2002) |
| " Intravenous ondansetron and tropisetron prevent postoperative nausea and vomiting (PONV) at least as efficiently as traditional antiemetics, droperidol and metoclopramide." | 5.10 | Oral ondansetron, tropisetron or metoclopramide to prevent postoperative nausea and vomiting: a comparison in high-risk patients undergoing thyroid or parathyroid surgery. ( Alahuhta, S; Jokela, R; Kangas-Saarela, T; Koivuranta, M; Purhonen, S, 2002) |
| "To assess the safety and efficacy of ondansetron for prevention of pruritus, nausea and vomiting after cesarean delivery with intrathecal sufentanil-morphine." | 5.10 | Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine. ( Chalhoub, V; Haddad, F; Hayek, G; Madi-Jebara, S; Yazigi, A, 2002) |
| "Efficacy and tolerability of ondansetron injection in prevention of postoperative nausea and vomiting were investigated in a prospective, randomised, double-blind, placebo controlled, three-armed clinical study in 148 patients undergoing laparoscopic cholecystectomy." | 5.10 | [Postoperative vomiting]. ( Karoliny, V; Murányi, M; Nagy, K; Pallós, J; Steiber, J; Szabó, Z; Vimláti, L, 2002) |
| "To compare the efficacy of ondansetron-dexamethasone combination with ondansetron alone for prevention of postoperative nausea and vomiting (PONV)." | 5.09 | Comparison of ondansetron with ondansetron and dexamethasone in prevention of PONV in diagnostic laparoscopy. ( Batra, YK; Bhardwaj, N; Dhaliwal, LK; Rajeeva, V, 1999) |
| " This study was carried out to evaluate the efficacy and safety of ondansetron for preventing postoperative nausea and vomiting in patients undergoing gastrointestinal tract surgery." | 5.09 | Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomized controlled trial. ( Kyokong, O; Pausawadi, S; Saratan, P; Somboonviboon, W; Visalyaputra, S; Vongvises, P, 1999) |
| "To evaluate the efficacy of a two-dose combination of droperidol and ondansetron as compared with single-dose droperidol alone, single-dose combined droperidol and ondansetron, and two-dose droperidol alone, for management of postoperative nausea and vomiting (PONV) among gynecologic laparoscopy outpatients." | 5.09 | Treating "rebound" emesis following outpatient gynecologic laparoscopy: the efficacy of a two-dose regimen of droperidol and ondansetron. ( Belo, SE; Warrick, PD, 1999) |
| "to assess the effectiveness of ondansetron in preventing postoperative nausea and vomiting after elective laparoscopic cholecystectomy, and the effect of this anesthetic on hospital stay." | 5.09 | Antiemetic efficacy of ondansetron in laparoscopic cholecystectomy. A randomized, double-blind, placebo-controlled study. ( Fernández Luengas, D; García Galán, F; Hernández Matías, A; López Herrero, J; Moreno Azcoita, M; Ortega Deballón, P; Ruiz de Adana, J; Tobalina Bonis, R, 1999) |
| "The purpose of this investigation was to evaluate the efficacy of ondansetron in controlling postoperative nausea and vomiting (PONV) when used prophylactically in patients undergoing routine dentoalveolar surgery performed under general anesthesia." | 5.09 | The effect of preoperative ondansetron on the incidence of postoperative nausea and vomiting in patients undergoing outpatient dentoalveolar surgery and general anesthesia. ( Hackett, C; Haug, RH; Wagley, C, 1999) |
| ") dosing of ondansetron 4 mg with placebo for the treatment of postoperative nausea and vomiting (PONV) in patients for whom prophylactic, preoperative ondansetron 4 mg i." | 5.09 | Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. ( Angel, JJ; Baughman, VL; Campbell, C; Creed, MR; Edmondson, D; Jense, HG; Kekoler, LJ; Kovac, AL; Mingus, M; O'Connor, TA; Pearman, MH; Shahvari, MB, 1999) |
| "We aimed to evaluate the antiemetic efficacy, safety, and clinical utility of prophylactic ondansetron administered at the end of the surgery for the prevention of postoperative nausea and vomiting (PONV) in a homogenous population of 54 women undergoing modified radical mastectomy (MRM)." | 5.09 | The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. ( Kannan, TR; Kathirvel, S; Mohan, V; Sadhasivam, S; Saxena, A; Trikha, A, 1999) |
| "To determine the incidence of postoperative nausea and vomiting when a combination of ondansetron and promethazine is given prophylactically, and to ascertain the effect of postoperative nausea and vomiting on recovery room duration and patient satisfaction." | 5.09 | Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery. ( Amhan, M; Aves, T; Chuang, AZ; Khalil, S; Lemak, NA; Philbrook, L; Rabb, M; Villanueva, G; Wells, L, 1999) |
| "We have compared the effectiveness of ondansetron (115 patients) and metoclopramide (101 patients) for prevention of postoperative nausea and vomiting in patients undergoing cardiac surgery involving cardiopulmonary bypass." | 5.09 | Antiemetic prophylaxis in cardiac surgery: comparison of metoclopramide and ondansetron. ( Harrison, D; Sherry, KM; Woodward, DK, 1999) |
| "This prospective, randomized, double-blinded study evaluated the effect of the timing of ondansetron administration on its antiemetic efficacy in children undergoing elective strabismus surgery." | 5.09 | Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery. ( Garg, S; Madan, R; Perumal, T; Sadashivam, S; Sadhasivam, S; Shende, D; Subramaniam, K, 2000) |
| "This prospective, randomized and double-blinded study was designed to evaluate the anti-emetic efficacy of a combination of ondansetron and metoclopramide in 100 ASA physical status I and II children of either sex and 1-15 years of age undergoing elective surgery for strabismus." | 5.09 | Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus. ( Kathirvel, S; Madan, R; Shende, D, 1999) |
| "In patients undergoing ambulatory laparoscopic cholecystectomy, ondansetron at induction was highly effective in decreasing postoperative nausea and vomiting and should become the standard." | 5.09 | Ondansetron versus placebo for prophylaxis of nausea and vomiting in patients undergoing ambulatory laparoscopic cholecystectomy. ( Howe, S; Lane, M; Liberman, MA, 2000) |
| "This study evaluated the antiemetic effectiveness, dose-response, and clinical usefulness of prophylactic ondansetron in the prevention of postoperative nausea and vomiting (PONV) in children undergoing strabismus repair." | 5.09 | Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study. ( Madan, R; Sadhasivam, S; Shende, D, 2000) |
| "To determine the efficacy of ondansetron and droperidol, alone and in combination, administered for prophylaxis of postoperative nausea and vomiting (PONV) in women undergoing general anesthesia for outpatient gynecological laparoscopy." | 5.09 | Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy. ( Belo, SE; Koutsoukos, G; Wu, O, 2000) |
| "Using a randomized, double-blind, placebo-controlled study design, CP-122,721 was initially compared with placebo and subsequently to ondansetron alone and in combination for prophylaxis against postoperative nausea and vomiting in 243 women undergoing abdominal hysterectomy." | 5.09 | Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. ( Black, LS; D'Angelo, R; Dalby, PL; Gesztesi, Z; MacLean, D; Scuderi, PE; Wender, RH; White, PF; Wright, W, 2000) |
| " Compared with either propofol or sevoflurane alone, sevoflurane with ondansetron resulted in a decreased incidence of postoperative nausea and vomiting." | 5.09 | Postoperative nausea and vomiting after sevoflurane with or without ondansetron compared with propofol in female patients undergoing breast surgery. ( Alahuhta, SM; Jokela, RM; Kangas-Saarela, TA; Koivuranta, MK; Ranta, PO; Valanne, JV, 2000) |
| "625 mg of IV droperidol given 30 min before emergence from general anesthesia reduces the incidence of immediate and delayed postoperative nausea and vomiting (PONV) in a general surgical adult patient population, and (2) compared the efficacy of droperidol, ondansetron, and promethazine for the rescue treatment of PONV." | 5.09 | Small-dose droperidol effectively reduces nausea in a general surgical adult patient population. ( Ascari, CM; Durieux, ME; Kloth, RL; Kreisler, NS; Rhyne, HA; Spiekermann, BF; Sullivan, LM, 2000) |
| "The prophylactic administration of dimenhydrinate (Dramamine) is as effective as the use of ondansetron (Zofran) in preventing postoperative nausea and vomiting (PONV) in patients undergoing elective laparoscopic cholecystectomy." | 5.09 | Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial inpatients undergoing laparoscopic cholecystectomy. ( Bottcher, ML; Boyd, WC; Kothari, SN; Lambert, PJ, 2000) |
| "Supplemental oxygen reduces the risk of postoperative nausea and vomiting (PONV) as well or better than 8 mg of ondansetron." | 5.09 | Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. ( Akça, O; Arkiliç, CF; Freitag, H; Goll, V; Greif, R; Krieger, G; Kurz, A; Lenhardt, R; Scheck, T; Sessler, DI; Zoeggeler, A, 2001) |
| " There was a statistically significant decrease in the chance of vomiting with increasing dose of ondansetron (P=0." | 5.09 | A randomized controlled trial of the antiemetic effect of three doses of ondansetron after strabismus surgery in children. ( Booker, PD; Bowhay, AR; May, HA; Rudnicka, AR, 2001) |
| "Neostigmine, used for reversal of neuromuscular block, has been implicated in the development of postoperative nausea and vomiting (PONV)." | 5.09 | Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. ( Berner, NS; Løvstad, RZ; Raeder, JC; Thagaard, KS, 2001) |
| "Droperidol 15 microg kg(-1) in combination with ondansetron 100 microg kg(-1), administered at the induction and end of the operative procedure respectively, is more effective than either drug given individually in reducing the incidence of PONV after strabismus surgery." | 5.09 | Combination of droperidol and ondansetron reduces PONV after pediatric strabismus surgery more than single drug therapy. ( Bharti, N; Kathirvel, S; Madan, R; Shende, D, 2001) |
| "This study evaluated the antiemetic efficacy, cost-effectiveness and clinical utility of prophylactic ondansetron and dexamethasone compared with placebo in the prevention of postoperative nausea and vomiting (PONV) in 135 children (2-15 yr, ASA I-II) undergoing strabismus repair." | 5.09 | Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. ( Jagan, D; Madan, R; Rajeshwari, S; Sadhasivam, S; Sennaraj, B; Shende, D; Subramaniam, B; Tamilselvan, P, 2001) |
| "There was a remarkably low incidence of postoperative vomiting of 5%; with the combination of dexamethasone plus a low-dose of ondansetron which more effectively decreased vomiting after strabismus surgery in children when compared with dexamethasone alone." | 5.09 | Prevention of vomiting after strabismus surgery in children: dexamethasone alone versus dexamethasone plus low-dose ondansetron. ( Splinter, WM, 2001) |
| " ondansetron, before induction of anaesthesia, on intraocular pressure (IOP) in patients undergoing cataract surgery was investigated." | 5.09 | Randomized prospective double-blind placebo-controlled trial of effect of intravenous ondansetron on intraocular pressure during ophthalmic surgery. ( Mostafa, SM; Robin, NM, 2001) |
| "To evaluate the prophylactic effect of ondansetron on postoperative nausea and vomiting (PONV) of cholecystectomy under abdominoscope." | 5.09 | [Clinical observation on ondansetron in preventing nausea and vomiting after cholecystectomy under abdominoscope]. ( Fu, D; Guo, Q; Li, Y, 1999) |
| "This investigation was conducted as a national multicenter study to evaluate effectiveness and safety of prophylactic and therapeutic ondansetron for postoperative nausea and vomiting (PONV) in major gynaecological surgery." | 5.08 | [Ondansetron. Prophylaxis and therapy of nausea and vomiting following major gynecologic procedures. Results of a national multicenter study]. ( Awwad, R; Biedler, A; Larsen, R; Silomon, M; Wilhelm, W, 1998) |
| "Limited data are available on the efficacy of ondansetron hydrochloride compared with prochlorperazine maleate for the treatment of postoperative nausea and vomiting (PONV)." | 5.08 | Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial. ( Chen, JJ; Frame, DG; White, TJ, 1998) |
| "While interventions such as crystalloids, colloids, ephedrine, phenylephrine, ondansetron, or lower leg compression can reduce the incidence of hypotension, none have been shown to eliminate the need to treat maternal hypotension in some women." | 5.05 | Techniques for preventing hypotension during spinal anaesthesia for caesarean section. ( Chemali, M; Chooi, C; Cox, JJ; Cyna, AM; Emmett, RS; Lumb, RS; Middleton, P; Simmons, SW, 2020) |
| "Background This meta-analysis was performed to evaluate the efficacy and safety of palonosetron and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic surgery with general anesthesia." | 4.98 | Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery. ( Bao, Z; Liu, Q; Zhou, C; Zhu, Y, 2018) |
| " ondansetron efficacy in preventing postoperative nausea and vomiting were as follows: Risk ratio [95% confidence interval] = 0." | 4.95 | Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis. ( Goto, T; Ka, K; Mihara, T; Yokoi, A, 2017) |
| "Palonosetron is a second-generation 5-HT3 receptor antagonist with proposed higher efficacy and sustained action for prophylaxis of postoperative nausea and vomiting (PONV)." | 4.93 | Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis. ( Arora, MK; Borle, A; Gouda, D; Goudra, B; Makkar, JK; Singh, PM; Sinha, A; Trikha, A, 2016) |
| "A comprehensive literature search was conducted to identify RCTs that investigated the efficacy and safety of intravenous dexamethasone or ondansetron on PONV in pediatric strabismus surgical patients." | 4.90 | Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: a meta-analysis of randomized controlled trials. ( Chen, CY; Cherng, YG; Shen, YD; Tam, KW; Wu, CH, 2014) |
| " In postoperative nausea and vomiting (PONV), two randomized controlled trials found treatment with haloperidol comparable to ondansetron." | 4.89 | Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. ( Bennett, MI; Blenkinsopp, A; McLean, SL, 2013) |
| "Ramosetron has been shown to have a very strong effect for preventing postoperative nausea and vomiting (PONV) in previous meta-analyses." | 4.89 | Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. ( Goto, T; Mihara, T; Morita, S; Tojo, K; Uchimoto, K, 2013) |
| "The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42." | 4.89 | Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013) |
| "The total incidence of postoperative nausea and vomiting within 24 hours after laparoscopic cholecystectomy was 31% (74 of 235) in the ondansetron group and 56% (127 of 225) in the metoclopramide group (OR=0." | 4.88 | Efficacy of ondansetron vs. metoclopramide in prophylaxis of postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Cheng, TY; Lin, YX; Wu, SJ; Xiong, XZ, 2012) |
| "To justify the use of ondansetron as a preventive treatment for postoperative nausea and vomiting (PONV) of adults and children in neurosurgery." | 4.86 | [Ondansetron: a meta-analysis on its efficacy to prevent postoperative nausea and vomiting after craniotomy in adults and children]. ( Dailler, F; Duflo, F; Frost, F, 2010) |
| "Postoperative nausea and vomiting (PONV) with morphine therapy develops in more than 60% of patients after surgery, markedly reducing patient QOL." | 4.81 | Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review. ( Hirayama, T; Ishii, F; Ogata, H; Yago, K, 2001) |
| "We performed a systematic review of published, randomized, controlled trials to determine the relative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting." | 4.80 | Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. ( Anderson, EA; Domino, KB; Polissar, NL; Posner, KL, 1999) |
| "The objective of this study was to compare, by means of meta-analysis, the postoperative antiemetic efficacy of ondansetron in patients with and without antecedents of postoperative nausea and vomiting." | 4.80 | Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. ( Canosa, L; Figueredo, E, 1999) |
| "The post-operative anti-emetic efficacy of 4 and 8 mg of ondansetron in adult patients with and without a previous history of motion sickness (PHMS) was assessed by meta-analysis." | 4.80 | Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. ( Canosa, L; Figueredo, E, 1999) |
| "To determine the efficacy and safety of ondansetron for the prevention and treatment of postoperative nausea and vomiting (PONV) in adults." | 4.80 | Systematic review of ondansetron for the prevention and treatment of postoperative nausea and vomiting in adults. ( Cox, F, 1999) |
| "The goal of this study was to determine whether CYP2D6 metabolizer status within the ondansetron-treated pediatric tonsillectomy population is associated with risk of postoperative nausea and vomiting (PONV) in the post-anesthesia care unit." | 4.31 | Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron. ( Black, K; Brenn, BR; Gaedigk, A; Van Driest, SL; Wanderer, JP, 2023) |
| " All patients were treated with a standardized postoperative protocol consisting of scheduled ondansetron, along with promethazine and scopolamine for breakthrough nausea and vomiting episodes." | 4.12 | Predictors of Postoperative Nausea and Vomiting After Endoscopic Skull Base Surgery. ( Abiri, A; Birkenbeuel, JL; Bitner, BF; Boladian, LA; Brown, NJ; Chen, JW; Golshani, K; Goshtasbi, K; Hsu, FPK; Hsu, Z; Kuan, EC; Lee, A; Nguyen, ES; Warner, DC, 2022) |
| " When used, the enhanced recovery protocol was associated with a lesser mean amount of ondansetron to treat postoperative nausea and vomiting (5." | 4.02 | A specific enhanced recovery protocol decreases opioid use after thyroid and parathyroid surgery. ( Boisen, ML; Carty, SE; Esper, SA; Holder-Murray, JM; McCoy, KL; Nicholson, KJ; Recker, A; Yip, L, 2021) |
| "We convened a multidisciplinary team to develop a postoperative nausea and vomiting prophylaxis guideline which included administration of dexamethasone, ondansetron, and a low-dose propofol infusion in addition to a femoral and sciatic nerve block and routine ketorolac administration for pain control." | 3.96 | Reducing postoperative nausea and vomiting in pediatric patients undergoing anterior cruciate ligament reconstruction: A quality report. ( Browne, P; Galvez, J; Ganley, T; Gurnaney, HG; Jantzen, E; Keren, R; Kerr, J; Kraemer, FW; Muhly, WT; Wells, L, 2020) |
| " Our anesthetic protocol for strabismus surgery included postoperative nausea and vomiting prevention using dexamethasone and ondansetron." | 3.91 | Prospective evaluation of anesthetic protocols during pediatric ophthalmic surgery. ( Couret, C; Ducloyer, JB; Le Meur, G; Lebranchu, P; Lejus-Bourdeau, C; Magne, C; Weber, M, 2019) |
| "Objective To evaluate the application of adding ondansetron in morphine intravenous analgesia pump for prevention of postoperative nausea and vomiting(PONV)in women." | 3.88 | [Adding Ondansetron in Morphine Intravenous Analgesia Pump for Prevention of Postoperative Nausea and Vomiting in Women]. ( Bai, B; Huang, YG; Pei, LJ; Sang, NE; Zhang, XH; Zhang, YL, 2018) |
| "To determine the association of ABCB1 polymorphism G2677T with anti-emetic efficacy in patients treated with ondansetron for preventing postoperative nausea and vomiting." | 3.81 | Association of Anti-Emetic Efficacy of Ondansetron with G2677T Polymorphism in a Drug Transporter Gene ABCB1 in Pakistani Population. ( Farhat, K; Iqbal, J; Ismail, M; Mansoor, Q; Pasha, AK; Waheed, A, 2015) |
| "We asked whether a single dose of preoperative aprepitant (40 mg orally) reduced postoperative nausea and vomiting after THA or TKA." | 3.76 | Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting? ( DiIorio, TM; Hewitt, AM; Parvizi, J; Sharkey, PF, 2010) |
| "We investigated whether the 2677G>T/A and 3435C>T polymorphisms of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) affect the efficacy of ondansetron to prevent postoperative nausea and vomiting." | 3.76 | Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting. ( Choi, EM; Choi, KW; Choi, SH; Lee, MG; Lee, SH, 2010) |
| "To provide further evidence of cardiovascular adverse effects of ondansetron, including new-onset atrial fibrillation, ST segment elevation, and chest pain subsequent to ondansetron administration, and to review cardiovascular adverse events related to several 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonists." | 3.75 | Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. ( Havrilla, PL; Kane-Gill, SL; Reis, SE; Seybert, AL; Verrico, MM, 2009) |
| "116 consecutive patients scheduled for breast cancer surgery were prospectively scored according to pain, PONV and sedation after being introduced to a combined evidence-based, empiric multimodal opioid-sparing prevention and treatment regime consisting of Paracetamol, Celecoxib, Dextromethorphan, Gabapetin, Dexamethason and Ondansetron." | 3.74 | [Multimodal treatment of pain and nausea in breast cancer surgery]. ( Callesen, T; Gärtner, R; Kehlet, H; Kroman, N, 2008) |
| "Some patients treated with ondansetron for postoperative nausea and vomiting do not respond to therapy." | 3.73 | The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? ( Andrews, D; Birnbach, DJ; Candiotti, KA; Kamat, A; Koch, WH; Lubarsky, DA; Nhuch, F; Nikoloff, M; Wu, L, 2005) |
| "To compare the cost-effectiveness of 2 antiemetic agents, ondansetron and prochlorperazine, for the prevention of postoperative nausea and vomiting (PONV) in patients undergoing total hip replacement or total knee replacement procedures." | 3.73 | Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting. ( Chang, P; Chen, J; Frame, D; Okamoto, M, 2005) |
| "In this study, a cost-consequence analysis (CCA) is used to estimate the economic benefit of ondansetron and dimenhydrinate as antiemetics administered prophylactically in children undergoing strabismus surgery." | 3.73 | Economic evaluation of ondansetron vs dimenhydrinate for prevention of postoperative vomiting in children undergoing strabismus surgery. ( Alanezi, K; Coyte, PC; Lasry, A; Piwko, C; Ungar, WJ, 2005) |
| " She received 4 mg of ondansetron intravenously for postoperative nausea and vomiting prophylaxis at the end of the procedure and an additional 4 mg in the recovery room for nausea." | 3.72 | Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. ( Kasinath, NS; Malak, O; Tetzlaff, J, 2003) |
| "We treated a patient who developed transient multifocal encephalopathy with extrapyramidal symptoms (oromandibular dystonia, oculogyric crisis, and limb dystonia) in temporal proximity to ondansetron administration on emergence from general anesthesia." | 3.72 | Ondansetron-induced multifocal encephalopathy. ( Goodman, BP; Ritter, MJ; Sprung, J; Wijdicks, EF, 2003) |
| " This paper describes in detail the protocol for the conduct of clinical trials based on this new method of analysis, which is illustrated in a retrospective analysis of data from a clinical trial comparing the anti-emetic drugs ondansetron and droperidol in the treatment of postoperative nausea and vomiting." | 3.71 | Using imprecise probabilities to address the questions of inference and decision in randomized clinical trials. ( Burton, PR; Gurrin, LC; Sly, PD, 2002) |
| "Nevertheless, PONV has not been completely eliminated, and the clinicians are trying to reduce the incidence of PONV yet." | 3.30 | Effects of ondansetron, metoclopramide and granisetron on perioperative nausea and vomiting in patients undergone bariatric surgery: a randomized clinical trial. ( Ebrahimian, M; Ghayebi, N; Kialashaki, M; Mirhashemi, SH; Oshidari, B; Shadidi-Asil, R; Zamani, A, 2023) |
| "Acupuncture combined with ondansetron as a multimodal prophylaxis approach is more effective than ondansetron alone in preventing postoperative nausea in high-risk patients." | 3.30 | Acupuncture combined with ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic gynaecological surgery: A randomised controlled trial. ( Cao, W; Li, H; Liu, C; Xiong, Z; Xu, M; Yan, S; Yang, J; Zhu, Z; Zou, X, 2023) |
| "Olanzapine is an antipsychotic drug that is used to prevent nausea and vomiting in palliative care and to treat chemotherapy-induced nausea and vomiting." | 3.30 | Olanzapine as an add-on, pre-operative anti-emetic drug for postoperative nausea or vomiting: a randomised controlled trial. ( Grigio, TR; Martins, JVB; Slullitel, A; Sousa, AM; Timmerman, H; Wolff, AP, 2023) |
| "Ondansetron was beneficial for PON prophylaxis in patients under the age of 50, whereas preoperative intravenous fluid loading was considered a risk factor for PON in this population." | 3.11 | A randomized controlled trial comparing incidences of postoperative nausea and vomiting after laparoscopic cholecystectomy for preoperative intravenous fluid loading, ondansetron, and control groups in a regional hospital setting in a developing country. ( Charoensawan, S; Peanpanich, P; Wongyingsinn, M, 2022) |
| "PONV was assessed in recovery and 24 hours after surgery in the ward." | 3.01 | Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial. ( Aghabagheri, M; Khajavi, MR; Najjari, K; Pourfakhr, P; Talebpour, M; Zabihi Mahmoudabadi, H, 2021) |
| "The incidence of postoperative nausea in women was more than men (p=0." | 2.87 | Comparison of Ondansetron versus Clonidine efficacy for prevention of postoperative pain, nausea and vomiting after orthognathic surgeries: A triple blind randomized controlled trial. ( Eshghpour, M; Hashemipour, MS; Hosseini-Abrishami, M; Mianbandi, V; Samieirad, S; Shadkam, E; Sharifian-Attar, A, 2018) |
| "However, postoperative nausea and vomiting (PONV) is a major concern." | 2.84 | Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial. ( Chaiwuttisak, A; Pinsornsak, P; Ruetiwarangkoon, C; Teeyaphudit, M, 2017) |
| "Haloperidol is an antipsychotic." | 2.84 | Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial. ( Aouad, MT; Barakat, HB; Korjian, S; Siddik-Sayyid, SM; Yazbeck-Karam, VG, 2017) |
| "Postoperative Nausea and Vomiting is one of the most common problems after implementation of general anesthesia." | 2.84 | Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. ( Aydın, B; Bilgen, S; Kaspar, EC; Kizilcik, N; Koner, O; Menda, F; Türe, H, 2017) |
| "The primary outcome was the incidence of postoperative nausea and vomiting (PONV) during the first postoperative day." | 2.84 | Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis. ( Gögenur, I; Kirkegaard, A; Kleif, J; Vilandt, J, 2017) |
| "In obese patients, the incidence of postoperative nausea and vomiting (PONV) following sleeve gastrectomy under titration of total intravenous anaesthesia (TIVA) and the relevance of risk factors to indicate prophylaxis is unknown." | 2.82 | Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind place ( Bataille, A; Charmeau, A; Chazot, T; Diemunsch, P; Fischler, M; Le Guen, M; Léger, P; Lemedioni, P; Letourneulx, JF; Liu, N, 2016) |
| "Fifty-eight patients consented to the pharmacokinetic analysis and were assigned randomly to receive 0." | 2.82 | Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients. ( Choi, BM; Jeong, SW; Lee, EK; Lee, YH; Lim, YJ; Min, KT; Noh, GJ; Seo, JH, 2016) |
| "The incidence of PONV and postoperative vomiting was significantly lower (P> ." | 2.82 | Comparison of dexamethasone or intravenous fluids or combination of both on postoperative nausea, vomiting and pain in pediatric strabismus surgery. ( F Riad, MA; M Ali, MO; Sayed, JA, 2016) |
| "Postoperative nausea was evaluated with a Numerical Rating Scale, 0 to10, and the frequency of vomiting was recorded for 48 hours." | 2.80 | The efficacy of P6 acupressure with sea-band in reducing postoperative nausea and vomiting in patients undergoing craniotomy: a randomized, double-blinded, placebo-controlled study. ( Bergenheim, T; Karlsson, A; Koskinen, LO; Lindgren, L; Nilsson, I; Nilsson, U, 2015) |
| "Drugs used for postoperative nausea and vomiting prophylaxis are believed to provoke torsadogenic changes in cardiac repolarization." | 2.80 | Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study. ( Owczuk, R; Tracz, K, 2015) |
| "Ondansetron is a 5-HT3 receptor antagonist which is generally used for the prophylactic management of nausea and vomiting; however, studies have found that ondansetron might decrease the incidence of PDPH." | 2.80 | Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study. ( Fattahi, Z; Hadavi, SM; Sahmeddini, MA, 2015) |
| "Postoperative nausea and vomiting is a major cause of patient dissatisfaction towards surgery." | 2.79 | Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. ( Goudra, BG; Ochroch, EA; Singh, PM; Sinha, AC; Williams, NW, 2014) |
| "The incidence of postoperative nausea and vomiting (PONV) is 30-50% after surgery." | 2.79 | The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: a prospective, randomized, double-blinded study. ( Hamaguchi, E; Kakuta, N; Kume, K; Soga, T; Tanaka, K; Tsutsumi, R; Tsutsumi, YM, 2014) |
| "Ramosetron at 0." | 2.79 | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. ( Baik, HJ; Do, SH; Han, JI; Hong, DM; Kim, HZ; Lee, JE; Lim, YJ; Min, KT; Park, HP; Ryu, JH, 2014) |
| "Many patients may experience postoperative nausea and vomiting (PONV) following laparoscopic sleeve gastrectomy (LSG)." | 2.78 | The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. ( Benevides, ML; de Aguilar-Nascimento, JE; Oliveira, SS, 2013) |
| "The incidence of postoperative nausea and vomiting (PONV) is 50 to 79% after neurosurgery." | 2.78 | P6 acupoint stimulation for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: study protocol for a randomized controlled trial. ( Feng, RZ; Li, N; Lv, JQ, 2013) |
| "Ramosetron was more effective during the first 24-h period after surgery than ondansetron in children using fentanyl patient-controlled analgesia after general anesthesia." | 2.78 | Comparison of the efficacy of ramosetron and ondansetron in the prophylaxis of postoperative vomiting in children receiving fentanyl by patient-controlled analgesia after orthopedic surgery: a randomized controlled trial. ( Byon, HJ; Jang, YE; Kim, HS; Kim, JT; Park, YH, 2013) |
| " The participants were randomized into three prophylactic treatment groups: dexamethasone (n = 43), ondansetron in combination with dexamethasone (n = 44), and placebo (n = 42)." | 2.77 | Dexamethasone versus ondansetron in combination with dexamethasone for the prophylaxis of postoperative vomiting in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial. ( Borges, PS; de Orange, FA; Flores, M; Marques, J, 2012) |
| "The common prophylactic treatment for postoperative nausea and vomiting is a triple therapy of droperidol, promethazine and dexamethasone." | 2.77 | Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial. ( Antor, A; Bergese, S; Fernandez, S; Uribe, A; Viloria, A, 2012) |
| "To compare the incidence of postoperative nausea and vomiting (PONV) and postoperative pain in thyroidectomy patients undergoing general anaesthesia, with or without bilateral superficial cervical plexus block (BSCPB)." | 2.77 | Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy. ( Cai, HD; Lin, CZ; Lin, XZ; Yu, CX, 2012) |
| "Aprepitant is a neurokin-1 receptor antagonist with a long duration of action and no sedative side effect." | 2.76 | A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. ( Borel, CO; Gan, TJ; Habib, AS; Keifer, JC; White, WD, 2011) |
| "Ondansetron 4 mg was equally effective, but its action lasted only 6 h, whereas tropisetron 5 mg was found ineffective." | 2.76 | Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents. ( Askitopoulou, H; Chatzimichali, A; Metaxari, M; Papaioannou, A; Petrou, A; Pharmakalidou, E, 2011) |
| "Cervical hematoma is hardly a predictable complication of thyroid surgery." | 2.75 | Incidence and circumstances of cervical hematoma complicating thyroidectomy and its relationship to postoperative vomiting. ( Amore Bonapasta, S; Bononi, M; De Cesare, A; Meucci, M; Miccini, M; Scarpini, M; Tocchi, A; Vari, A, 2010) |
| "Of 200 consecutive breast cancer patients, 191 received the full package." | 2.75 | Multimodal prevention of pain, nausea and vomiting after breast cancer surgery. ( Callesen, T; Gärtner, R; Kehlet, H; Kroman, N, 2010) |
| "Ramosetron was found safe and more effective antiemetic than ondansetron in patients undergoing lap chole." | 2.75 | Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy. ( Akhtar, S; Ansari, MM; Haleem, S; Khan, FA; Siddiqui, OA; Varshney, R, 2010) |
| " We investigated the analgesic effect of pregabalin and dexamethasone in combination with paracetamol after abdominal hysterectomy." | 2.74 | Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. ( Dahl, JB; Dierking, G; Fomsgaard, JS; Hilsted, KL; Lech, K; Lose, G; Mathiesen, O; Rasmussen, ML, 2009) |
| "Data for postoperative vomiting were grouped into the following time periods: 0-4 and 4-24 h." | 2.73 | Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy. ( Alici, HA; Altas, E; Atalay, C; Cesur, M; Erdem, AF; Kursad, H; Yoruk, O; Yuksek, MS, 2008) |
| "However, postoperative nausea and vomiting was significantly lower in groups II and III (p < 0." | 2.73 | Postoperative intravenous patient-controlled analgesia in thyroid surgery: comparison of fentanyl and ondansetron regimens with and without the nonsteriodal anti-inflammatory drug ketorolac. ( Chang, DJ; Kim, EM; Kim, KJ; Kim, SY; Nam, KH; Nam, SH, 2008) |
| "Ketamine was associated with all reported nausea and vomiting incidents because propofol and midazolam are rarely associated with such events." | 2.73 | Retrospective outcomes evaluation of 100 parenteral moderate and deep sedations conducted in a general practice dental residency. ( Cruz-Gonzalez, W; Hakim, MI; Messieha, Z, 2008) |
| "The incidence of postoperative nausea and vomiting was significantly smaller in both groups than predicted according to the patients' underlying risks (midazolam group: p = 0." | 2.73 | Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial. ( Chen, A; Lai, HY; Lee, Y; Wang, JJ; Yang, YL, 2007) |
| "The occurrence of postoperative nausea and vomiting/retching, need for rescue antiemetics, and the complete response rates (i." | 2.73 | Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms. ( Coleman, JE; Kapu, R; Ogunnaike, B; Shah, M; Sloninsky, A; Song, D; Tang, J; Webb, T; Wender, RH; White, PF, 2007) |
| "No difference in rescue antiemetic treatment or postoperative nausea and vomiting at specific time intervals (0-6 and 6-24 h postoperative period) was seen among the three groups." | 2.73 | Scheduled prophylactic ondansetron administration did not improve its antiemetic efficacy after intracranial tumour resection surgery in children. ( Bhatia, A; Bithal, PK; Dash, HH; Dash, M; Pandia, MP; Subramaniam, B; Subramaniam, K, 2007) |
| "Patients at high risk of postoperative nausea and vomiting often receive more than one prophylactic antiemetic drug." | 2.73 | Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting. ( Bennett, EJ; Dodd, PH; Doherty, DA; Lain, J; Paech, MJ; Rucklidge, MW, 2007) |
| "Unlike patients with chemotherapy-induced nausea and vomiting, perioperative patients who failed ondansetron prophylaxis did not have a significant response to cross-over dosing with granisetron." | 2.73 | Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study. ( Arheart, KL; Birnbach, DJ; Candiotti, KA; Deepika, K; Kamat, A; Lubarsky, DA; Nhuch, F, 2007) |
| "The exact incidence of postoperative nausea and vomiting (PONV) in patients on steroids undergoing neurosurgical procedures is not known." | 2.73 | Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors. ( Chandrashekharappa, KN; Mukherjee, KK; Nakra, D; Wig, J; Yaddanapudi, LN, 2007) |
| "Observations of postoperative nausea and vomiting score and need for antiemetics at other time intervals (2 to 6, 6 to 12, and 12 to 24 h) were not significantly different among the three groups." | 2.73 | Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study. ( Arora, R; Bhatnagar, S; Gupta, D; Mishra, S; Singh, M; Srikanti, M, 2007) |
| "A relatively high incidence of postoperative nausea and vomiting (PONV) occurs in patients undergoing a laparoscopic cholecystectomy." | 2.73 | Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy. ( Ezberci, M; Oksuz, H; Zencirci, B, 2007) |
| "Ondansetron was used as an active control." | 2.72 | Supplemental 80% oxygen does not attenuate post-operative nausea and vomiting after breast surgery. ( Hirvonen, E; Hynynen, M; Niskanen, M; Purhonen, S; Wüstefeld, M, 2006) |
| "The frequency of postoperative nausea and vomiting (PONV), number needed to treat to prevent PONV, and the costs of the anesthetic drugs to prevent PONV in one additional patient were evaluated." | 2.72 | Efficacy and costs of 3 anesthetic regimens in the prevention of postoperative nausea and vomiting. ( Hynynen, M; Koski, EM; Niskanen, M; Purhonen, S, 2006) |
| "Ondansetron was effective in reducing the incidence of nausea and vomiting in patients receiving intrathecal morphine for Caesarean section." | 2.72 | Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. ( Celich, MF; Peixoto Filho, AJ; Peixoto, AJ; Zardo, L, 2006) |
| " Factorial design was a powerful tool, allowing simultaneous determination of dose-response relationships for three drugs and identifying a previously unreported negative interaction between OND and MET." | 2.72 | A factorial study of ondansetron, metoclopramide, and dexamethasone for emesis prophylaxis after adenotonsillectomy in children. ( Beckman, EC; Gunter, JB; McAuliffe, JJ; Spaeth, JP; Varughese, AM; Wittkugel, EP, 2006) |
| "Short term efficacy of dexamethasone to treat PONV was similar to ondansetron, but inferior to droperidol." | 2.72 | [Controlled trial of dexamethasone compared with droperidol and ondansetron for the treatment of postoperative nausea and vomiting]. ( Ibacache, ME; Mertz, VF; Muñoz, HR, 2006) |
| "However, the occurrence of postoperative nausea and vomiting (PONV) can delay patient discharge." | 2.71 | Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial? ( Chen, X; Kariger, R; Ma, H; Naruse, R; Sloninsky, A; Tang, J; Webb, T; Wender, RH; White, PF; Zaentz, A, 2003) |
| "We conclude that the risk of postoperative nausea and vomiting remained high in this setting despite 5-HT3 receptor antagonist prophylaxis and that the choice between these agents should be based on the lowest available acquisition cost." | 2.71 | The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron. ( Banks, SL; Gurrin, LC; Orlikowski, CE; Paech, MJ; Pavy, TJ; Rucklidge, MW, 2003) |
| "Based on this study, it seems postoperative nausea can be resolved quicker using 70% inhaled isopropyl alcohol compared with intravenous ondansetron in women undergoing outpatient gynecologic laparoscopic procedures." | 2.71 | Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. ( Pellegrini, JE; Riley, GP; Rinehart, RS; Vacchiano, CA; Winston, AW, 2003) |
| "Rates of previous postoperative nausea and vomiting and motion sickness were comparable across the groups." | 2.71 | A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children. ( O'Brien, CM; Titley, G; Whitehurst, P, 2003) |
| "Treatment with ondansetron was necessary in seven low-risk and 37 high-risk patients with a complete response rate of 71% (low-risk) and 43% (high-risk)." | 2.71 | A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. ( Apfel, CC; Biedler, A; Dethling, J; Kunitz, O; Müller, A; Wermelt, J; Wilhelm, W, 2004) |
| "A complete response (as no postoperative nausea and vomiting) was achieved in 60% of patients given ondansetron, 63% of the patients given dexamethasone, 78% of patients given ondansetron with dexamethasone and 37% of patients received placebo." | 2.71 | Comparison of ondansetron, dexamethasone, ondansetron plus dexamethasone and placebo in the prevention of nausea and vomiting after laparoscopic tubal ligation. ( Biswas, BN; Mandal, SK; Rudra, A, 2003) |
| "The management of postoperative nausea and vomiting (PONV) remains a persistent problem." | 2.71 | Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. ( Davis, J; McLeskey, CH; Meyer, TA; Rajab, MH; Roberson, CR, 2005) |
| "Median postoperative nausea scores were significantly reduced in the peri- and postoperative (versus preoperative) treatment groups." | 2.71 | Optimal timing of acustimulation for antiemetic prophylaxis as an adjunct to ondansetron in patients undergoing plastic surgery. ( Coleman, JE; Cox, L; Hamza, MA; Jaffer, O; Macaluso, AR; Recart, A; Rohrich, R; Song, D; White, PF, 2005) |
| "Ondansetron treatment also resulted in fewer patients requiring rescue medication or assumed to have had rescue upon early discontinuation from the study during the postoperative period (ondansetron, 5%; placebo, 10%) and less emesis (0 of 6) after rescue medication when compared with placebo (7 of 21)." | 2.71 | A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia. ( Anschuetz, GC; Ansermino, JM; Blackburn, LM; Bolos, ME; Brooks, PB; Cohen, IT; Coté, CJ; Davis, PJ; Hannallah, RS; Khalil, SN; Roth, AG; Russo, MW; Simhi, E, 2005) |
| "Data on postoperative nausea and vomiting were collected at 0, 2, 6, and 24 h." | 2.71 | A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. ( Coop, A; Gan, TJ; Philip, BK, 2005) |
| "Postoperative nausea and vomiting are observed in increased frequency after laparoscopic surgery." | 2.70 | Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study. ( Argiriadou, H; Georgiou, M; Papagiannopoulou, P; Papaziogas, B; Papaziogas, T; Parlapani, A; Pavlidis, T, 2002) |
| "The incidence of postoperative nausea and vomiting was 33% for group C, 44% for group O and 41% for group D." | 2.70 | The addition of antiemetics to the morphine solution in patient controlled analgesia syringes used by children after an appendicectomy does not reduce the incidence of postoperative nausea and vomiting. ( Dickson, U; Fisher, S; Morton, N; Munro, FJ, 2002) |
| " The aim of this randomized double blind, dose-ranging study was to determine the minimum single effective dose of dexamethasone combined with ondansetron for the prevention of PONV in patients undergoing laparoscopic cholecystectomy." | 2.70 | Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. ( Atef, A; Elhakim, M; Mahmoud, K; Nafie, M, 2002) |
| "With the use of volatile anesthetics, postoperative nausea and vomiting (PONV) are common, with an incidence of emesis as frequent as 60%." | 2.70 | Postoperative nausea and vomiting in children and adolescents undergoing radiofrequency catheter ablation: a randomized comparison of propofol- and isoflurane-based anesthetics. ( Erb, TO; Gan, TJ; Hall, JM; Ing, RJ; Kanter, RJ; Kern, FH; Schulman, SR, 2002) |
| "Tramadol has weak opioid properties, and an analgesic effect that is mediated mainly by inhibition of the reuptake of norepinephrine and serotonin (5-hydroxytryptamine [5-HT]) and facilitation of 5-HT release (1,2) at the spinal cord." | 2.70 | The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. ( De Witte, JL; Deloof, T; Schoenmaekers, B; Sessler, DI, 2001) |
| "Metoclopramide is a more cost-effective treatment." | 2.70 | Metoclopramide versus ondansetron in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy. ( Abrameit, W; Bass, CS; Roberson, R; Smith, RW; Wilson, EB, 2001) |
| "The frequency of intraoperative and postoperative vomiting were similar between Group O and Group M, but significantly higher in Group P (p < 0." | 2.70 | Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. ( Moore, CH; Pan, PH, 2001) |
| "Ondansetron was compared with placebo for nausea and vomiting prophylaxis after fentanyl/isoflurane/relaxant anesthesia and infratentorial craniotomy." | 2.70 | A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. ( Borel, CO; El-Moalem, HE; Fabling, JM; Gan, TJ; Warner, DS, 2002) |
| "mL(-1)." | 2.70 | Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. ( Arcioni, R; della Rocca, M; Gasparetto, A; Pietropaoli, P; Romano, R; Romanò, S, 2002) |
| "Ondansetron (Zofran) has proven benefit in preventing postoperative nausea and vomiting if given before general anesthesia in a variety of surgical procedures." | 2.70 | The prevention of emesis in plastic surgery: a randomized, prospective study. ( Chao, JD; Few, JW; Fine, NA; Marcus, JR; Mustoe, TA, 2002) |
| "The incidence of postoperative emesis was 55% and 10% in placebo and ondansetron group respectively." | 2.69 | Effects of ondansetron on postoperative emesis in Chinese children. ( Chao, A; Chen, CL; Chen, LK; Cherng, YG; Fan, SZ; Huang, CH; Liu, CC, 1998) |
| "The ondansetron regimen was more expensive (at local prices) by a factor of 27, and our results suggested no clinical advantage over droperidol." | 2.69 | High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia. ( Bellamy, M; Dean, S; Dresner, M; Lumb, A, 1998) |
| "Although PONV is unpleasant, the data indicate little difference in outcomes when routine prophylactic medications are administered versus simply treating PONV should symptoms occur." | 2.69 | Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. ( Harris, L; James, RL; Mims, GR; Scuderi, PE, 1999) |
| "Postoperative vomiting is a common occurrence that can delay recovery and result in cerebrospinal fluid leak and fistula formation in these patients." | 2.69 | Prophylactic use of ondansetron for emesis after craniofacial operations in children. ( Celik, N; Gürler, T; Sakarya, M; Songür, E; Totan, S, 1999) |
| "The anti-emetic efficacy of prophylactic ondansetron and tropisetron in combination with a low dose of droperidol in patients with high probability for post-operative nausea and vomiting undergoing gynaecological laparoscopy was compared." | 2.69 | Comparison of ondansetron and tropisetron combined with droperidol for the prevention of emesis in women with a history of post-operative nausea and vomiting. ( Ala-Kokko, TI; Jokela, R; Koivuranta, M; Ranta, P, 1999) |
| "The incidence of postoperative nausea, emesis, pain and sedation scores, and rescue antiemetic use were recorded at 0, 0." | 2.69 | A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. ( Borel, CO; El-Moalem, HE; Fabling, JM; Gan, TJ; Warner, DS, 2000) |
| "PONV was analysed by a linear nausea/vomiting score, incidence of nausea and vomiting, and the need for antiemetic rescue." | 2.69 | Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial. ( Barros, MA; Celich, MF; Leães, LF; Peixoto Filho, AJ; Peixoto, AJ, 2000) |
| "Metoclopramide was ineffective." | 2.69 | A comparison of commonly used anti-emetics for the prevention of emetic sequelae after a major gynaecological surgery. ( Abdullah, N; Sharma, S, 2000) |
| "Ondansetron has been approved for the treatment and prevention of postoperative emesis." | 2.69 | Failure of prevention against postoperative vomiting by ondansetron or prochlorperazine in patients undergoing gynecological laparoscopy. ( Buerkle, H; Hsu, TY; Lee, TC; Lee, TH; Lin, CR; Mao, CC; Yang, LC, 2000) |
| "A systematic review and meta-analysis of published randomized controlled trials was performed to update the present evidence about the safety and efficacy of dexamethasone combined with other antiemetics versus single antiemetics for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy." | 2.53 | Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis. ( Abushouk, AI; Ahmed, H; Al Nahrawi, S; Attia, A; Awad, K; Elsherbeny, MY; Mustafa, SM, 2016) |
| "Postoperative nausea and vomiting is a common side effect of general anesthesia." | 2.52 | Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials. ( Cao, G; Gao, C; Li, B; Lv, F; Wang, F; Wang, H; Wu, G; Xu, L, 2015) |
| "Palonosetron was superior to ondansetron in the reduction of early PON [RR, 0." | 2.52 | Efficacy of palonosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. ( Liu, G; Ma, R; Wu, A; Xiong, C; Xue, J, 2015) |
| "PONV has a multifactor etiology, but there are ways to reduce its occurrence." | 2.44 | The effects of stimulation of acupressure point p6 on postoperative nausea and vomiting: a review of literature. ( Guinn, C; Nunley, C; Wakim, J, 2008) |
| " Dose-response relationships show that higher doses of ibuprofen may be particularly effective." | 2.40 | Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review. ( McQuay, HJ; Moore, RA, 1998) |
| "Fosaprepitant is a relevant alternative in preventing and treating PONV in patients who underwent bariatric/metabolic surgical procedures." | 1.91 | Impact of Emend on Perioperative Bariatric Surgery Antiemetic Utilization, Patient Satisfaction, and Costs. ( Aghazarian, GS; Ghanem, M; Jawad, MA; Lastrapes, L; Lind, R; Motola, D; Perry, M; Singletary, N; Teixeira, AF, 2023) |
| "Postoperative nausea and vomiting is a patient- centered outcome measure and a main driver of unplanned admissions." | 1.91 | Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study. ( Andreae, MH; Jiang, SY; Lui, B; Ma, X; Nachamie, AS; Pryor, KO; Tangel, VE; Turnbull, ZA; White, RS, 2023) |
| "PONV was experienced by 74." | 1.91 | Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study). ( Abuyousif, YA; Aldossary, HM; Attia, M; El Hefnawy, E; El Nakeeb, A; Elmorshedi, M; Mohammed, MN; Rashad, AE; Salem, A; Zaid, A, 2023) |
| "Postoperative nausea and vomiting are frequent complications after laparoscopic cholecystectomy." | 1.72 | Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy under General Anaesthesia in a Tertiary Care Centre: A Descriptive Cross-sectional Study. ( Acharya, S; Bajracharya, GR; Shrestha, N; Thapa, C, 2022) |
| "Pain and postoperative nausea and vomiting are among the most unpleasant sensations experienced after surgery." | 1.62 | The impact of multimodal therapies on the comfort and safety of patients in the immediate post-anaesthetic period following gynaecological procedures - part I. ( Biskup, A; Merks, P; Plagens-Rotman, K; Polocka-Molinska, M, 2021) |
| "Even ketamine has an unpleasant taste." | 1.62 | Preanesthetic nebulized ketamine vs preanesthetic oral ketamine for sedation and postoperative pain management in children for elective surgery: A retrospective analysis for effectiveness and safety. ( Chen, C; Cheng, X; Fu, F; Lin, L, 2021) |
| "The factors contributing to postoperative nausea and vomiting in children have been identified, but there have been no reported studies that have studied pediatric postdischarge nausea and vomiting." | 1.51 | An exploratory study of the relationship between postoperative nausea and vomiting and postdischarge nausea and vomiting in children undergoing ambulatory surgery. ( Chandrakantan, A; Jacob, ZC; Jasiewicz, R; Reinsel, RA; Seidman, PA, 2019) |
| "PONV is a common and peculiar problem in bariatric surgery patients." | 1.48 | Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery. ( Bamgbade, OA; Khaw, RR; Oluwole, O, 2018) |
| "Among the 910 patients who underwent inguinal hernia repair, PONV occurred in 68 patients (7." | 1.48 | Postoperative nausea and vomiting (PONV) in outpatient repair of inguinal hernia. ( Amatucci, C; Illuminati, G; Palumbo, P; Pulli, VT; Tellan, G; Usai, S; Vietri, F, 2018) |
| "Ondansetron 0." | 1.42 | Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting. ( Choi, EM; Choi, SH; Kim, EH; Kim, MS; Lee, JR, 2015) |
| "A previous history of postoperative nausea and vomiting (PONV; OR 3." | 1.39 | Incidence and predictors of postdischarge nausea and vomiting in a 7-day population. ( Apfel, CC; Hall, LA; Holtman, J; Hooper, V; Jalota, L; Lennie, TA; Moser, DK; Odom-Forren, J, 2013) |
| "All patients scheduled for breast cancer surgery at Danderyd Hospital, Stockholm, Sweden during 1 year (March 2003-March 2004) were asked to participate in this prospective, observational study." | 1.39 | Is there an association between PONV and chemotherapy-induced nausea and vomiting? ( Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S, 2013) |
| "To describe a case of ventricular tachycardia after co-administration of ondansetron and dimenhydrinate to a child with occult congenital QT prolongation." | 1.36 | Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome. ( Froese, A; McKechnie, K, 2010) |
| "Palonosetron is a 5-HT(3)-receptor antagonist (5-HT(3)-RA) that has been shown to be superior to other 5-HT(3)-RAs in phase III clinical trials for the prevention of acute, delayed, and overall chemotherapy-induced nausea and vomiting." | 1.35 | Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. ( Alt, J; Cantoreggi, S; Massuda, EB; Rojas, C; Rubenstein, E; Sebastiani, S; Slusher, B; Snyder, SH; Stathis, M; Thomas, AG; Zhang, J, 2008) |
| "Data on the risk factors for postoperative vomiting, whether the patient vomited and details of the patient's vomitus were collected prospectively on consecutive patients and compared with a gold standard." | 1.35 | A significant reduction in paediatric post-tonsillectomy vomiting through audit. ( Bennett, AM; Emery, PJ, 2008) |
| "Promethazine was significantly more effective than ondansetron for treating PONV after failed ondansetron prophylaxis." | 1.34 | A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. ( Gan, TJ; Habib, AS; Reuveni, J; Taguchi, A; White, WD, 2007) |
| "To characterize the evolution of postoperative nausea and vomiting (PONV) prophylactic drug use." | 1.34 | Changing patterns of postoperative nausea and vomiting prophylaxis drug use in an academic anesthesia practice. ( Bodian, CA; Doshi, A; Hossain, S; Krol, M; Reich, DL; Wax, D, 2007) |
| "When used in treatment of postoperative nausea and vomiting, a situation where prolongation of the QTc interval seems to occur, the safety of 5-hydroxytryptamine type 3 antagonists may not be superior to that of low-dose droperidol." | 1.33 | Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. ( Albaladejo, P; Charbit, B; Funck-Brentano, C; Legrand, M; Marty, J; Samain, E, 2005) |
| "PONV was found in 27 of 47 patients completing the study." | 1.33 | Blood-borne factors possibly associated with post-operative nausea and vomiting: an explorative study in women after breast cancer surgery. ( Bjellerup, P; Eksborg, S; Helander, A; Lindahl, S; Lönnqvist, P; Oddby-Muhrbeck, E, 2005) |
| "Morphine alone was associated with a significant increase in plasma AVP concentrations from baseline at 45, 60, and 90 min (P < 0." | 1.33 | Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets. ( Wilkens, EP; Yates, BJ, 2005) |
| " Dose-response curves were also obtained with tramadol combined with ondansetron or droperidol at 1:1 fixed ratios." | 1.33 | Interaction between tramadol and two anti-emetics on nociception and gastrointestinal transit in mice. ( Dürsteler, C; Fernandez, V; Mases, A; Pol, O; Puig, MM, 2006) |
| "The onset of dystonia coincided temporally with the removal of a transdermal scopolamine patch used as adjunctive antiemetic therapy." | 1.33 | Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch. ( Roberge, RJ, 2006) |
| "The incidence of postoperative nausea (PON) and postoperative vomiting (POV) following the introduction of the protocol was 36% and 34%, respectively." | 1.31 | Impact of an antiemetic protocol on postoperative nausea and vomiting in children. ( Anderson, BJ; Drake, R; Persson, MA; Thompson, JM, 2001) |
| "Because practitioners have taken widely differing approaches to the selection and dosing of agents in this class, this retrospective study assessed the relative efficacy of i." | 1.31 | Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting. ( Walker, JB, 2001) |
| "incidence of postoperative nausea and vomiting without prophylaxis) of between 10 and 90%." | 1.30 | Cost-effectiveness of ondansetron for postoperative nausea and vomiting. ( McQuay, HJ; Moore, RA; Phillips, C; Reynolds, DJ; Tramèr, MR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 42 (9.27) | 18.2507 |
| 2000's | 209 (46.14) | 29.6817 |
| 2010's | 164 (36.20) | 24.3611 |
| 2020's | 38 (8.39) | 2.80 |
| Authors | Studies |
|---|---|
| Kienbaum, P | 1 |
| Schaefer, MS | 1 |
| Weibel, S | 1 |
| Schlesinger, T | 1 |
| Meybohm, P | 1 |
| Eberhart, LH | 4 |
| Kranke, P | 5 |
| Birkenbeuel, JL | 1 |
| Warner, DC | 1 |
| Abiri, A | 1 |
| Brown, NJ | 1 |
| Nguyen, ES | 1 |
| Lee, A | 2 |
| Goshtasbi, K | 1 |
| Boladian, LA | 1 |
| Hsu, Z | 1 |
| Bitner, BF | 1 |
| Golshani, K | 1 |
| Chen, JW | 1 |
| Hsu, FPK | 1 |
| Kuan, EC | 1 |
| Nuttall, GA | 1 |
| Voogd, SC | 1 |
| Danke, H | 1 |
| Warner, PA | 1 |
| Oyen, LJ | 1 |
| Marienau, MS | 1 |
| Ackerman, MJ | 1 |
| Bilgen, S | 2 |
| Erdoğan Ari, D | 1 |
| Özveri, E | 1 |
| Putnam, EM | 1 |
| Hong, RA | 1 |
| Park, JM | 1 |
| Li, Y | 4 |
| Leis, A | 1 |
| Malviya, S | 1 |
| Wongyingsinn, M | 1 |
| Peanpanich, P | 1 |
| Charoensawan, S | 1 |
| Black, K | 1 |
| Brenn, BR | 1 |
| Gaedigk, A | 2 |
| Wanderer, JP | 1 |
| Van Driest, SL | 1 |
| Abdulhussain, AS | 3 |
| Thapa, C | 1 |
| Bajracharya, GR | 1 |
| Acharya, S | 1 |
| Shrestha, N | 1 |
| Shama, AAA | 1 |
| Elsayed, AA | 1 |
| Albraithen, AA | 1 |
| Arafa, SK | 1 |
| Ebrahimian, M | 1 |
| Mirhashemi, SH | 1 |
| Oshidari, B | 1 |
| Zamani, A | 1 |
| Shadidi-Asil, R | 1 |
| Kialashaki, M | 1 |
| Ghayebi, N | 1 |
| Aghazarian, GS | 1 |
| Lind, R | 1 |
| Motola, D | 1 |
| Perry, M | 1 |
| Singletary, N | 1 |
| Lastrapes, L | 1 |
| Ghanem, M | 1 |
| Jawad, MA | 1 |
| Teixeira, AF | 1 |
| Theodosopoulou, P | 2 |
| Rekatsina, M | 1 |
| Staikou, C | 2 |
| Chen, Y | 3 |
| Liu, S | 1 |
| Liang, J | 1 |
| Zhu, H | 1 |
| Zhao, G | 1 |
| Song, G | 1 |
| Liu, J | 1 |
| White, RS | 1 |
| Andreae, MH | 1 |
| Lui, B | 1 |
| Ma, X | 1 |
| Tangel, VE | 1 |
| Turnbull, ZA | 1 |
| Jiang, SY | 1 |
| Nachamie, AS | 1 |
| Pryor, KO | 1 |
| Yan, S | 1 |
| Xu, M | 1 |
| Zou, X | 1 |
| Xiong, Z | 1 |
| Li, H | 1 |
| Yang, J | 1 |
| Cao, W | 1 |
| Zhu, Z | 1 |
| Liu, C | 1 |
| Grigio, TR | 1 |
| Timmerman, H | 1 |
| Martins, JVB | 1 |
| Slullitel, A | 1 |
| Wolff, AP | 1 |
| Sousa, AM | 1 |
| Fassoulaki, A | 1 |
| Liu, Y | 2 |
| Chen, X | 2 |
| Wang, X | 1 |
| Zhong, H | 1 |
| He, H | 1 |
| Liao, Y | 1 |
| Pan, Z | 1 |
| Hu, W | 1 |
| Liu, W | 1 |
| Zheng, F | 1 |
| Rashad, AE | 1 |
| El Hefnawy, E | 1 |
| Elmorshedi, M | 1 |
| Abuyousif, YA | 1 |
| Salem, A | 1 |
| Attia, M | 1 |
| El Nakeeb, A | 1 |
| Zaid, A | 1 |
| Aldossary, HM | 1 |
| Mohammed, MN | 1 |
| Campos, GO | 1 |
| de Jesus Martins, M | 1 |
| Jesus, GN | 1 |
| de Oliveira, PRR | 1 |
| Lessa, CN | 1 |
| de Oliveira Junior, JCMF | 1 |
| de Castro Alves, LJS | 1 |
| Alves, RL | 1 |
| Módolo, NSP | 1 |
| Barney, EZ | 1 |
| Fuller, ME | 1 |
| Habib, AS | 8 |
| Deng, R | 1 |
| Zhou, J | 1 |
| Ouyang, A | 1 |
| Uribe, AA | 1 |
| Stoicea, N | 1 |
| Echeverria-Villalobos, M | 1 |
| Todeschini, AB | 1 |
| Esparza Gutierrez, A | 1 |
| Folea, AR | 1 |
| Bergese, SD | 1 |
| Muhly, WT | 1 |
| Ganley, T | 1 |
| Jantzen, E | 1 |
| Browne, P | 1 |
| Kerr, J | 1 |
| Gurnaney, HG | 1 |
| Kraemer, FW | 1 |
| Galvez, J | 1 |
| Keren, R | 1 |
| Wells, L | 2 |
| Safaeian, R | 1 |
| Hassani, V | 1 |
| Asghari, A | 1 |
| Mohseni, M | 1 |
| Ashraf, H | 1 |
| Koleini, ZS | 1 |
| Nejadi, JR | 1 |
| Shamseh, M | 1 |
| Ronasi, N | 1 |
| Birjandi, M | 1 |
| Karimi, A | 1 |
| Chooi, C | 1 |
| Cox, JJ | 1 |
| Lumb, RS | 1 |
| Middleton, P | 1 |
| Chemali, M | 1 |
| Emmett, RS | 1 |
| Simmons, SW | 1 |
| Cyna, AM | 1 |
| Yip, L | 1 |
| Carty, SE | 1 |
| Holder-Murray, JM | 1 |
| Recker, A | 1 |
| Nicholson, KJ | 1 |
| Boisen, ML | 1 |
| Esper, SA | 1 |
| McCoy, KL | 1 |
| Vasquez-Camargo, A | 1 |
| Gamble, J | 1 |
| Fedoruk, KA | 1 |
| Lim, HJJ | 1 |
| Mondal, PK | 1 |
| Martinez, J | 1 |
| Miller, GG | 1 |
| Wang, EHZ | 1 |
| Sunderland, S | 1 |
| Edwards, NY | 1 |
| Chima, NS | 1 |
| Yarnold, CH | 1 |
| Schwarz, SKW | 1 |
| Coley, MA | 1 |
| Lee, SU | 1 |
| Lee, HJ | 1 |
| Kim, YS | 1 |
| Biskup, A | 1 |
| Plagens-Rotman, K | 1 |
| Polocka-Molinska, M | 1 |
| Merks, P | 1 |
| Chen, C | 1 |
| Cheng, X | 1 |
| Lin, L | 2 |
| Fu, F | 1 |
| Prakash, K | 1 |
| Meshram, T | 1 |
| Jain, P | 1 |
| Moore, CC | 1 |
| Bledsoe, LTR | 1 |
| Bonds, CR | 1 |
| Keller, M | 1 |
| King, CH | 1 |
| Abdelaziz, DH | 1 |
| Boraii, S | 1 |
| Cheema, E | 1 |
| Elnaem, MH | 1 |
| Omar, T | 1 |
| Abdelraouf, A | 1 |
| Mansour, NO | 1 |
| Wang, R | 1 |
| Song, X | 1 |
| Wang, N | 1 |
| Wang, J | 1 |
| Pourfakhr, P | 1 |
| Aghabagheri, M | 1 |
| Zabihi Mahmoudabadi, H | 1 |
| Najjari, K | 1 |
| Talebpour, M | 1 |
| Khajavi, MR | 1 |
| Schoen, NB | 1 |
| Jermakowicz, WJ | 1 |
| Luca, CC | 1 |
| Jagid, JR | 1 |
| Flubacher, P | 1 |
| Fournier, N | 1 |
| Cherpillod, J | 1 |
| Waridel, F | 1 |
| Nydegger, M | 1 |
| Albrecht, E | 1 |
| Cortés-Flores, AO | 1 |
| Jiménez-Tornero, J | 1 |
| Morgan-Villela, G | 1 |
| Delgado-Gómez, M | 1 |
| Zuloaga-Fernández Del Valle, CJ | 1 |
| García-Rentería, J | 1 |
| Rendón-Félix, J | 1 |
| Fuentes-Orozco, C | 1 |
| Macías-Amezcua, MD | 1 |
| Ambriz-González, G | 1 |
| Alvarez-Villaseñor, AS | 1 |
| Urias-Valdez, D | 1 |
| Chavez-Tostado, M | 1 |
| Contreras-Hernández, GI | 1 |
| González-Ojeda, A | 1 |
| Bourdaud, N | 1 |
| François, C | 1 |
| Jacqmarcq, O | 1 |
| Guye, ML | 1 |
| Jean, J | 1 |
| Studer, C | 1 |
| Engrand-Donal, C | 1 |
| Devys, JM | 1 |
| Boutin, F | 1 |
| Guyot, E | 1 |
| Bouazza, N | 1 |
| Treluyer, JM | 1 |
| Orliaguet, GA | 1 |
| Isazadehfar, K | 1 |
| Entezariasl, M | 1 |
| Shahbazzadegan, B | 1 |
| Nourani, Z | 1 |
| Shafaee, Y | 1 |
| Koyuncu, O | 1 |
| Leung, S | 1 |
| You, J | 2 |
| Oksar, M | 1 |
| Turhanoglu, S | 1 |
| Akkurt, C | 1 |
| Dolapcioglu, K | 1 |
| Sahin, H | 1 |
| Sessler, DI | 5 |
| Turan, A | 4 |
| Bruderer, U | 1 |
| Fisler, A | 1 |
| Steurer, MP | 1 |
| Steurer, M | 1 |
| Dullenkopf, A | 1 |
| Therneau, IW | 1 |
| Martin, EE | 1 |
| Sprung, J | 3 |
| Kellogg, TA | 1 |
| Schroeder, DR | 1 |
| Weingarten, TN | 1 |
| Liu, Q | 1 |
| Zhou, C | 1 |
| Bao, Z | 1 |
| Zhu, Y | 1 |
| Yokoi, A | 1 |
| Mihara, T | 3 |
| Ka, K | 1 |
| Goto, T | 3 |
| Bamgbade, OA | 1 |
| Oluwole, O | 1 |
| Khaw, RR | 1 |
| Dewinter, G | 2 |
| Staelens, W | 1 |
| Veef, E | 1 |
| Teunkens, A | 2 |
| Van de Velde, M | 2 |
| Rex, S | 2 |
| Murakami, C | 1 |
| Kakuta, N | 4 |
| Kume, K | 4 |
| Sakai, Y | 1 |
| Kasai, A | 1 |
| Oyama, T | 1 |
| Tanaka, K | 4 |
| Tsutsumi, YM | 4 |
| Bercovici, N | 1 |
| Russomanno, K | 1 |
| Santoro, F | 1 |
| Scola, C | 1 |
| Murphy, M | 1 |
| Elaba, Z | 1 |
| Palumbo, P | 1 |
| Usai, S | 1 |
| Amatucci, C | 1 |
| Pulli, VT | 1 |
| Illuminati, G | 1 |
| Vietri, F | 1 |
| Tellan, G | 1 |
| Chiu, C | 1 |
| Aleshi, P | 1 |
| Esserman, LJ | 1 |
| Inglis-Arkell, C | 1 |
| Yap, E | 1 |
| Whitlock, EL | 1 |
| Harbell, MW | 1 |
| Charton, A | 1 |
| Greib, N | 1 |
| Ruimy, A | 1 |
| Faitot, V | 1 |
| Noudem, Y | 1 |
| Joshi, GP | 1 |
| Meyer, N | 1 |
| Diemunsch, P | 5 |
| Farhat, K | 2 |
| Waheed, A | 2 |
| Pasha, AK | 2 |
| Ismail, M | 2 |
| Bai, B | 1 |
| Pei, LJ | 1 |
| Zhang, YL | 1 |
| Sang, NE | 1 |
| Zhang, XH | 1 |
| Huang, YG | 1 |
| Niewiński, PA | 1 |
| Wojciechowski, R | 1 |
| Śliwiński, M | 1 |
| Hurkacz, ME | 1 |
| Głowacka, K | 1 |
| Orzechowska-Juzwenko, K | 1 |
| Wiela-Hojeńska, AK | 1 |
| Munsterman, C | 1 |
| Strauss, P | 1 |
| Ducloyer, JB | 1 |
| Couret, C | 1 |
| Magne, C | 1 |
| Lejus-Bourdeau, C | 1 |
| Weber, M | 1 |
| Le Meur, G | 1 |
| Lebranchu, P | 1 |
| Samieirad, S | 1 |
| Sharifian-Attar, A | 1 |
| Eshghpour, M | 1 |
| Mianbandi, V | 1 |
| Shadkam, E | 1 |
| Hosseini-Abrishami, M | 1 |
| Hashemipour, MS | 1 |
| Martin, CS | 1 |
| Deverman, SE | 1 |
| Norvell, DC | 1 |
| Cusick, JC | 1 |
| Kendrick, A | 1 |
| Koh, J | 1 |
| Gabel, E | 1 |
| Shin, J | 1 |
| Hofer, I | 1 |
| Grogan, T | 1 |
| Ziv, K | 1 |
| Hong, J | 1 |
| Dhillon, A | 1 |
| Moore, J | 1 |
| Mahajan, A | 1 |
| Cannesson, M | 1 |
| Carvalho Braga, EL | 1 |
| Figueiredo, NV | 1 |
| Barrucand, L | 1 |
| Cavalcanti, IL | 1 |
| Hossain, MM | 1 |
| Begum, M | 1 |
| Hossain, M | 1 |
| Chowdhury, MG | 1 |
| Begum, R | 1 |
| Ahamed, S | 1 |
| Shuvo, FR | 1 |
| Chandrakantan, A | 1 |
| Reinsel, RA | 1 |
| Jasiewicz, R | 1 |
| Jacob, ZC | 1 |
| Seidman, PA | 1 |
| Ienca, R | 1 |
| Giardiello, C | 1 |
| Scozzarro, A | 1 |
| di Cola, RS | 1 |
| Di Lorenzo, N | 1 |
| Juneja, G | 1 |
| Lopez, G | 1 |
| Badiuddin, F | 1 |
| Klyukin, MI | 1 |
| Kulikov, AS | 1 |
| Lubnin, AY | 1 |
| Darvall, J | 1 |
| von Ungern-Sternberg, BS | 1 |
| Braat, S | 1 |
| Story, D | 1 |
| Davidson, A | 1 |
| Allen, M | 1 |
| Tran-Duy, A | 1 |
| Middleton, D | 1 |
| Leslie, K | 2 |
| Aroke, EN | 1 |
| Hicks, TL | 1 |
| Sridharan, K | 1 |
| Sivaramakrishnan, G | 1 |
| Zhang, D | 1 |
| Shen, Z | 1 |
| Zhu, X | 1 |
| Tang, QF | 1 |
| Benevides, ML | 1 |
| Oliveira, SS | 1 |
| de Aguilar-Nascimento, JE | 1 |
| Su, X | 1 |
| Geng, ZY | 1 |
| Zheng, YL | 1 |
| McLean, SL | 1 |
| Blenkinsopp, A | 1 |
| Bennett, MI | 1 |
| Lv, JQ | 1 |
| Feng, RZ | 1 |
| Li, N | 1 |
| Tojo, K | 1 |
| Uchimoto, K | 1 |
| Morita, S | 1 |
| Odom-Forren, J | 1 |
| Jalota, L | 1 |
| Moser, DK | 1 |
| Lennie, TA | 1 |
| Hall, LA | 1 |
| Holtman, J | 1 |
| Hooper, V | 1 |
| Apfel, CC | 10 |
| Sinha, AC | 2 |
| Singh, PM | 2 |
| Williams, NW | 1 |
| Ochroch, EA | 1 |
| Goudra, BG | 1 |
| Chen, ZY | 1 |
| Wang, HH | 1 |
| Zhou, Y | 1 |
| Yan, JQ | 1 |
| Huang, YL | 1 |
| Guo, QL | 1 |
| Christofaki, M | 1 |
| Papaioannou, A | 2 |
| Shen, YD | 1 |
| Chen, CY | 1 |
| Wu, CH | 1 |
| Cherng, YG | 2 |
| Tam, KW | 1 |
| Veiga-Gil, L | 1 |
| López-Olaondo, L | 2 |
| Pueyo, J | 2 |
| Callejas, R | 1 |
| Duque, P | 1 |
| Carrascosa, F | 2 |
| Ahsan, K | 1 |
| Abbas, N | 1 |
| Naqvi, SM | 1 |
| Murtaza, G | 1 |
| Tariq, S | 1 |
| Kung, AT | 1 |
| Yang, X | 1 |
| Vasudevan, A | 1 |
| Pratt, S | 1 |
| Hess, P | 1 |
| Nilsson, I | 1 |
| Karlsson, A | 1 |
| Lindgren, L | 1 |
| Bergenheim, T | 1 |
| Koskinen, LO | 1 |
| Nilsson, U | 1 |
| Soga, T | 2 |
| Hamaguchi, E | 3 |
| Tsutsumi, R | 3 |
| Ryu, JH | 1 |
| Lee, JE | 1 |
| Lim, YJ | 2 |
| Hong, DM | 1 |
| Park, HP | 1 |
| Han, JI | 1 |
| Baik, HJ | 1 |
| Kim, HZ | 1 |
| Min, KT | 2 |
| Do, SH | 2 |
| Candiotti, KA | 3 |
| Ahmed, SR | 1 |
| Cox, D | 1 |
| Gan, TJ | 18 |
| Ramirez, L | 1 |
| Cros, J | 1 |
| Marin, B | 1 |
| Boulogne, P | 1 |
| Bergeron, A | 1 |
| de Lafont, GE | 1 |
| Renon-Carron, F | 1 |
| de Vinzelles, MA | 1 |
| Guigonis, V | 1 |
| Nathan, N | 2 |
| Beaulieu, P | 1 |
| Rehill, RH | 1 |
| Tracz, K | 1 |
| Owczuk, R | 1 |
| Imeh, A | 1 |
| Olaniyi, O | 1 |
| Simeon, O | 1 |
| Omotola, O | 1 |
| Kim, SH | 2 |
| Lee, SM | 2 |
| Kim, YK | 1 |
| Park, SY | 1 |
| Lee, JH | 2 |
| Cho, SH | 1 |
| Chai, WS | 1 |
| Jin, HC | 1 |
| Thompson, JP | 1 |
| Dalby, PL | 2 |
| Novikova, E | 1 |
| Johnson, BM | 1 |
| Russ, SF | 1 |
| Noble, R | 1 |
| Brigandi, RA | 1 |
| Stevens, AJ | 1 |
| Woodman, RJ | 1 |
| Owen, H | 1 |
| Merli, GJ | 1 |
| Weitz, HH | 1 |
| Kawanishi, R | 1 |
| Fukuta, K | 1 |
| Fattahi, Z | 1 |
| Hadavi, SM | 1 |
| Sahmeddini, MA | 1 |
| Agámez Medina, GL | 1 |
| González-Arévalo, A | 1 |
| Gómez-Arnau, JI | 1 |
| García del Valle, S | 1 |
| Rubio, JA | 1 |
| Esteban, E | 1 |
| Pérez, E | 1 |
| Motamed, C | 1 |
| Bourgain, JL | 1 |
| Brookes, CD | 1 |
| Turvey, TA | 1 |
| Phillips, C | 2 |
| Kopp, V | 1 |
| Anderson, JA | 1 |
| Gao, C | 1 |
| Li, B | 1 |
| Xu, L | 1 |
| Lv, F | 1 |
| Cao, G | 1 |
| Wang, H | 1 |
| Wang, F | 1 |
| Wu, G | 1 |
| Koju, RB | 1 |
| Gurung, BS | 1 |
| Dongol, Y | 1 |
| Liu, M | 1 |
| Zhang, H | 2 |
| Du, BX | 1 |
| Xu, FY | 1 |
| Zou, Z | 1 |
| Sui, B | 1 |
| Shi, XY | 1 |
| Vermeulen, K | 1 |
| Devroe, S | 1 |
| Van Hemelrijck, J | 1 |
| Meuleman, C | 1 |
| Vergote, I | 1 |
| Fieuws, S | 1 |
| Iqbal, J | 1 |
| Mansoor, Q | 1 |
| Mita, N | 1 |
| Kim, MS | 1 |
| Lee, JR | 1 |
| Choi, EM | 2 |
| Kim, EH | 2 |
| Choi, SH | 2 |
| Wang, XX | 1 |
| Zhou, Q | 1 |
| Pan, DB | 1 |
| Deng, HW | 1 |
| Zhou, AG | 1 |
| Huang, FR | 1 |
| Guo, HJ | 1 |
| Li, ZH | 1 |
| Liu, D | 1 |
| He, ZJ | 1 |
| Fan, ZY | 1 |
| Xiong, C | 1 |
| Liu, G | 1 |
| Ma, R | 1 |
| Xue, J | 1 |
| Wu, A | 1 |
| Cho, JS | 1 |
| Kim, EJ | 2 |
| Kim, SJ | 1 |
| Kim, JM | 1 |
| Byun, JI | 1 |
| Nam, EJ | 1 |
| Koo, BN | 1 |
| Ham, SY | 1 |
| Shim, YH | 2 |
| Son, MJ | 1 |
| Park, WS | 1 |
| Lee, JS | 1 |
| Brettner, F | 1 |
| Janitza, S | 1 |
| Prüll, K | 1 |
| Weninger, E | 1 |
| Mansmann, U | 1 |
| Küchenhoff, H | 1 |
| Jovanovic, A | 1 |
| Pollwein, B | 1 |
| Chappell, D | 1 |
| Zwissler, B | 1 |
| von Dossow, V | 1 |
| Bataille, A | 1 |
| Letourneulx, JF | 1 |
| Charmeau, A | 1 |
| Lemedioni, P | 1 |
| Léger, P | 1 |
| Chazot, T | 1 |
| Le Guen, M | 1 |
| Fischler, M | 1 |
| Liu, N | 1 |
| Lee, YH | 1 |
| Seo, JH | 1 |
| Jeong, SW | 1 |
| Lee, EK | 1 |
| Choi, BM | 1 |
| Noh, GJ | 1 |
| Wolf, R | 1 |
| Morinello, E | 1 |
| Kestler, G | 1 |
| Käsmann-Kellner, B | 1 |
| Bischoff, M | 1 |
| Hager, T | 1 |
| Schöpe, J | 1 |
| Joo, J | 2 |
| Park, S | 1 |
| Park, HJ | 1 |
| Shin, SY | 1 |
| Tien, M | 1 |
| Dhakal, I | 1 |
| White, WD | 4 |
| Olufolabi, AJ | 1 |
| Fink, R | 1 |
| Mishriky, BM | 1 |
| Lacassie, HJ | 1 |
| Sayed, JA | 1 |
| F Riad, MA | 1 |
| M Ali, MO | 1 |
| Borle, A | 1 |
| Gouda, D | 1 |
| Makkar, JK | 1 |
| Arora, MK | 1 |
| Trikha, A | 2 |
| Sinha, A | 2 |
| Goudra, B | 1 |
| Awad, K | 1 |
| Ahmed, H | 1 |
| Abushouk, AI | 1 |
| Al Nahrawi, S | 1 |
| Elsherbeny, MY | 1 |
| Mustafa, SM | 1 |
| Attia, A | 1 |
| Pinsornsak, P | 1 |
| Teeyaphudit, M | 1 |
| Ruetiwarangkoon, C | 1 |
| Chaiwuttisak, A | 1 |
| Moeen, SM | 1 |
| Yazbeck-Karam, VG | 2 |
| Siddik-Sayyid, SM | 3 |
| Barakat, HB | 1 |
| Korjian, S | 1 |
| Aouad, MT | 3 |
| Bell, GC | 1 |
| Caudle, KE | 1 |
| Whirl-Carrillo, M | 1 |
| Gordon, RJ | 1 |
| Hikino, K | 1 |
| Prows, CA | 1 |
| Agundez, J | 1 |
| Sadhasivam, S | 6 |
| Klein, TE | 1 |
| Schwab, M | 1 |
| Darvall, JN | 1 |
| Handscombe, M | 1 |
| Kizilcik, N | 1 |
| Menda, F | 1 |
| Türe, H | 1 |
| Aydın, B | 1 |
| Kaspar, EC | 1 |
| Koner, O | 1 |
| Kleif, J | 1 |
| Kirkegaard, A | 1 |
| Vilandt, J | 1 |
| Gögenur, I | 1 |
| Gärtner, R | 3 |
| Callesen, T | 3 |
| Kroman, N | 3 |
| Kehlet, H | 3 |
| Bano, F | 1 |
| Zafar, S | 1 |
| Aftab, S | 1 |
| Haider, S | 1 |
| Pan, PH | 2 |
| Lee, SC | 1 |
| Harris, LC | 1 |
| Rojas, C | 1 |
| Stathis, M | 1 |
| Thomas, AG | 1 |
| Massuda, EB | 2 |
| Alt, J | 1 |
| Zhang, J | 1 |
| Rubenstein, E | 2 |
| Sebastiani, S | 1 |
| Cantoreggi, S | 1 |
| Snyder, SH | 1 |
| Slusher, B | 1 |
| Apiliogullari, S | 1 |
| Duman, A | 1 |
| Nagel, K | 1 |
| Willan, AR | 1 |
| Lappan, J | 1 |
| Korz, L | 1 |
| Buckley, N | 1 |
| Barr, RD | 1 |
| Nunley, C | 1 |
| Wakim, J | 1 |
| Guinn, C | 1 |
| Choi, YS | 1 |
| Shim, JK | 1 |
| Yoon, DH | 1 |
| Jeon, DH | 1 |
| Lee, JY | 1 |
| Kwak, YL | 1 |
| Erdem, AF | 1 |
| Yoruk, O | 1 |
| Alici, HA | 1 |
| Cesur, M | 1 |
| Atalay, C | 1 |
| Altas, E | 1 |
| Kursad, H | 1 |
| Yuksek, MS | 1 |
| Kaki, AM | 1 |
| Abd El-Hakeem, EE | 1 |
| Kumar, N | 1 |
| Hu, WT | 1 |
| Kim, SY | 1 |
| Kim, EM | 1 |
| Nam, KH | 1 |
| Chang, DJ | 1 |
| Nam, SH | 1 |
| Kim, KJ | 2 |
| Mathiesen, O | 1 |
| Rasmussen, ML | 1 |
| Dierking, G | 1 |
| Lech, K | 1 |
| Hilsted, KL | 1 |
| Fomsgaard, JS | 1 |
| Lose, G | 1 |
| Dahl, JB | 1 |
| Jellish, WS | 2 |
| Owen, K | 1 |
| Fluder, E | 2 |
| Sawicki, K | 2 |
| Sinacore, J | 1 |
| Messieha, Z | 1 |
| Cruz-Gonzalez, W | 1 |
| Hakim, MI | 1 |
| Jokela, RM | 2 |
| Cakmakkaya, OS | 2 |
| Danzeisen, O | 2 |
| Korttila, KT | 2 |
| Malhotra, A | 2 |
| Paura, A | 2 |
| Radke, OC | 1 |
| Soikkeli, A | 1 |
| Roewer, N | 3 |
| Dagtekin, O | 1 |
| Wiese, P | 1 |
| Wolter, K | 1 |
| Hermann, MM | 1 |
| Pietruck, C | 1 |
| Kampe, S | 1 |
| Havrilla, PL | 1 |
| Kane-Gill, SL | 1 |
| Verrico, MM | 1 |
| Seybert, AL | 1 |
| Reis, SE | 1 |
| Nam, M | 1 |
| Yoon, H | 1 |
| Feng, PH | 1 |
| Chu, KS | 2 |
| Lu, IC | 1 |
| Shieh, JP | 1 |
| Tzeng, JI | 2 |
| Ho, ST | 2 |
| Wang, JJ | 4 |
| Chu, CC | 2 |
| Kovac, AL | 2 |
| Jones, RK | 1 |
| Cohen, SA | 1 |
| Battikha, JP | 1 |
| Deutsch, JS | 1 |
| Pergolizzi, JV | 3 |
| Glass, PS | 2 |
| Neufeld, SM | 2 |
| Newburn-Cook, CV | 2 |
| Grover, VK | 1 |
| Mathew, PJ | 1 |
| Hegde, H | 1 |
| Perry, JD | 1 |
| Sah, N | 2 |
| Ramesh, V | 1 |
| Kaul, B | 1 |
| Dalby, P | 1 |
| Shestak, K | 1 |
| Vallejo, MC | 2 |
| Alghanem, SM | 1 |
| Massad, IM | 1 |
| Rashed, EM | 1 |
| Abu-Ali, HM | 1 |
| Daradkeh, SS | 1 |
| Jain, V | 1 |
| Mitra, JK | 1 |
| Rath, GP | 1 |
| Prabhakar, H | 1 |
| Bithal, PK | 2 |
| Dash, HH | 2 |
| Frings, G | 2 |
| Stader, A | 1 |
| Biedler, A | 6 |
| Kolodzie, K | 1 |
| Kim, SI | 1 |
| Kim, SC | 1 |
| Baek, YH | 1 |
| Ok, SY | 1 |
| Ryu, J | 1 |
| So, YM | 1 |
| Hwang, J | 1 |
| Pellegrini, J | 1 |
| DeLoge, J | 1 |
| Bennett, J | 1 |
| Kelly, J | 1 |
| Tan, T | 1 |
| Ojo, R | 1 |
| Immani, S | 1 |
| Choroszczak, P | 1 |
| Carey, M | 1 |
| Riad, W | 1 |
| Marouf, H | 1 |
| Bononi, M | 1 |
| Amore Bonapasta, S | 1 |
| Vari, A | 1 |
| Scarpini, M | 1 |
| De Cesare, A | 1 |
| Miccini, M | 1 |
| Meucci, M | 1 |
| Tocchi, A | 1 |
| Sharma, R | 1 |
| Panda, A | 1 |
| Mraovic, B | 1 |
| Simurina, T | 1 |
| Yun, MJ | 1 |
| Kim, YH | 1 |
| Kim, AR | 1 |
| Frost, F | 1 |
| Dailler, F | 1 |
| Duflo, F | 1 |
| Schwartz, A | 1 |
| McKechnie, K | 1 |
| Froese, A | 1 |
| Zahreddine, BW | 1 |
| Adham, AM | 1 |
| Dagher, CM | 1 |
| Saasouh, WA | 1 |
| Hahm, TS | 1 |
| Ko, JS | 2 |
| Choi, SJ | 1 |
| Gwak, MS | 1 |
| Dabbous, AS | 1 |
| Jabbour-Khoury, SI | 1 |
| Nasr, VG | 2 |
| Moussa, AA | 1 |
| Zbeidy, RA | 1 |
| Khouzam, NE | 1 |
| El-Khatib, MF | 1 |
| Baraka, AS | 2 |
| DiIorio, TM | 1 |
| Sharkey, PF | 1 |
| Hewitt, AM | 1 |
| Parvizi, J | 1 |
| Rauers, NI | 1 |
| Stüber, F | 3 |
| Lee, EH | 2 |
| Musshoff, F | 2 |
| Fimmers, R | 1 |
| Barann, M | 1 |
| Stamer, UM | 3 |
| Huh, BK | 1 |
| Jung, S | 1 |
| White, W | 1 |
| Jeon, Y | 1 |
| Singla, NK | 1 |
| Singla, SK | 1 |
| Chung, F | 1 |
| Kutsogiannis, DJ | 1 |
| Blackburn, L | 1 |
| Lane, SR | 1 |
| Levin, J | 2 |
| Johnson, B | 1 |
| Rabbani, MZ | 1 |
| Khan, MN | 1 |
| Qureshi, R | 1 |
| Zubair, M | 1 |
| Pervez, MB | 1 |
| Bilgin, TE | 1 |
| Birbicer, H | 1 |
| Ozer, Z | 1 |
| Doruk, N | 1 |
| Tok, E | 1 |
| Oral, U | 1 |
| Ebrahim Soltani, A | 1 |
| Mohammadinasab, H | 1 |
| Goudarzi, M | 1 |
| Arbabi, S | 1 |
| Mohtaram, R | 1 |
| Afkham, K | 1 |
| Momenzadeh, S | 1 |
| Darabi, ME | 1 |
| Fujii, Y | 1 |
| Choi, DK | 1 |
| Chin, JH | 1 |
| Lim, OB | 1 |
| Chung, CH | 1 |
| Ro, YJ | 1 |
| Choi, IC | 1 |
| Singh, V | 1 |
| Prakash, N | 1 |
| Talesh, KT | 1 |
| Motamedi, MH | 1 |
| Kahnamouii, S | 1 |
| Lee, MG | 1 |
| Lee, SH | 1 |
| Choi, KW | 1 |
| Mehta, D | 1 |
| Sanatani, S | 1 |
| Whyte, SD | 1 |
| Williams, BA | 2 |
| Orebaugh, SL | 1 |
| Kentor, ML | 1 |
| Bopp, EJ | 1 |
| Estrada, TJ | 1 |
| Kilday, JM | 1 |
| Spradling, JC | 1 |
| Daniel, C | 2 |
| Pellegrini, JE | 4 |
| Madea, B | 1 |
| Keifer, JC | 1 |
| Borel, CO | 3 |
| Ekinci, O | 1 |
| Malat, I | 1 |
| Işıtmangil, G | 1 |
| Aydın, N | 1 |
| Anixter, MB | 1 |
| Alvarez, JC | 1 |
| Charbit, B | 2 |
| Grassin-Delyle, S | 1 |
| Demolis, JL | 1 |
| Funck-Brentano, C | 2 |
| Abe, E | 1 |
| Altorjay, A | 1 |
| Melson, T | 1 |
| Chinachoit, T | 1 |
| Kett, A | 1 |
| Aqua, K | 1 |
| Blackburn, LM | 2 |
| Lane, S | 1 |
| D'souza, N | 1 |
| Swami, M | 1 |
| Bhagwat, S | 1 |
| Song, JW | 1 |
| Park, EY | 1 |
| Lee, JG | 1 |
| Park, YS | 1 |
| Kang, BC | 1 |
| Metaxari, M | 1 |
| Petrou, A | 1 |
| Chatzimichali, A | 1 |
| Pharmakalidou, E | 1 |
| Askitopoulou, H | 1 |
| Belani, K | 1 |
| Stowman, AM | 1 |
| Bothun, ED | 1 |
| Belani, KG | 1 |
| Park, SK | 1 |
| Cho, EJ | 1 |
| El-Deeb, AM | 1 |
| Ahmady, MS | 1 |
| Robb, PJ | 1 |
| Ewah, BN | 1 |
| Johnston, KD | 1 |
| Quinlan, J | 1 |
| Gelbrich, G | 1 |
| Wallenborn, J | 1 |
| Rawlinson, E | 1 |
| Walker, A | 1 |
| Skone, R | 1 |
| Thillaivasan, A | 1 |
| Bagshaw, O | 1 |
| Quan, X | 2 |
| Zhu, B | 2 |
| Ye, TH | 2 |
| Binhas, M | 1 |
| Hawajri, N | 1 |
| Maison, P | 1 |
| Brucker, R | 1 |
| Marty, J | 2 |
| Mercier, F | 1 |
| Keita, H | 1 |
| Phelps, AL | 1 |
| Ibinson, JW | 1 |
| Barnes, LR | 1 |
| Milord, PJ | 1 |
| Romeo, RC | 1 |
| Lane, B | 1 |
| Cannella, K | 1 |
| Bowen, C | 1 |
| Copelan, D | 1 |
| Nteff, G | 1 |
| Barnes, K | 1 |
| Poudevigne, M | 1 |
| Lawson, J | 1 |
| Ormel, G | 1 |
| Romundstad, L | 1 |
| Lambert-Jensen, P | 1 |
| Stubhaug, A | 1 |
| Basu, A | 1 |
| Saha, D | 1 |
| Hembrom, BP | 1 |
| Roy, A | 1 |
| Naaz, A | 1 |
| Falzon, D | 1 |
| Jefferson, P | 1 |
| Ball, DR | 1 |
| Moon, YE | 1 |
| Kim, JE | 1 |
| Lee, Y | 4 |
| Wu, SJ | 2 |
| Xiong, XZ | 2 |
| Cheng, TY | 1 |
| Lin, YX | 2 |
| Cheng, NS | 2 |
| Wang, PK | 2 |
| Tsay, PJ | 1 |
| Huang, CC | 1 |
| Lai, HY | 3 |
| Lin, PC | 1 |
| Huang, SJ | 1 |
| Jukar-Rao, S | 1 |
| Radford, KD | 1 |
| Fuller, TN | 1 |
| Bushey, B | 1 |
| White, PF | 10 |
| Zhao, M | 1 |
| Tang, J | 4 |
| Wender, RH | 5 |
| Yumul, R | 1 |
| Sloninsky, AV | 1 |
| Naruse, R | 3 |
| Kariger, R | 3 |
| Cunneen, S | 2 |
| de Orange, FA | 1 |
| Marques, J | 1 |
| Flores, M | 1 |
| Borges, PS | 1 |
| Shen, YJ | 1 |
| Yin, YQ | 1 |
| Zhang, YJ | 1 |
| Zhu, Q | 1 |
| Zhang, JH | 1 |
| Zhao, W | 1 |
| Li, CH | 1 |
| Bergese, S | 1 |
| Viloria, A | 1 |
| Uribe, A | 1 |
| Antor, A | 1 |
| Fernandez, S | 1 |
| Stiff, PJ | 1 |
| Fox-Geiman, MP | 1 |
| Kiley, K | 1 |
| Rychlik, K | 1 |
| Parthasarathy, M | 1 |
| Fletcher-Gonzalez, D | 1 |
| Porter, N | 1 |
| Go, A | 1 |
| Smith, SE | 3 |
| Rodriguez, TE | 1 |
| Ansari, MM | 1 |
| Siddiqui, OA | 1 |
| Haleem, S | 1 |
| Varshney, R | 1 |
| Akhtar, S | 1 |
| Khan, FA | 1 |
| Cai, HD | 1 |
| Lin, CZ | 1 |
| Yu, CX | 1 |
| Lin, XZ | 1 |
| Puttaswamy, RK | 1 |
| Valap, S | 1 |
| Pierson, R | 1 |
| Das, B | 1 |
| Hodges, M | 1 |
| Hodgson, R | 1 |
| Chaudhari, S | 1 |
| Botros, S | 1 |
| Moore, P | 1 |
| Oddby-Muhrbeck, E | 3 |
| Öbrink, E | 1 |
| Eksborg, S | 3 |
| Rotstein, S | 1 |
| Lönnqvist, PA | 2 |
| Park, YH | 1 |
| Jang, YE | 1 |
| Byon, HJ | 1 |
| Kim, JT | 1 |
| Kim, HS | 1 |
| Size, MH | 1 |
| Rubin, JS | 1 |
| Patel, A | 1 |
| Argiriadou, H | 1 |
| Papaziogas, B | 1 |
| Pavlidis, T | 1 |
| Parlapani, A | 1 |
| Georgiou, M | 1 |
| Papagiannopoulou, P | 1 |
| Papaziogas, T | 1 |
| Cox, F | 2 |
| Munro, FJ | 1 |
| Fisher, S | 1 |
| Dickson, U | 1 |
| Morton, N | 1 |
| Burdett, HJ | 1 |
| Carr, AS | 2 |
| Sukhani, R | 1 |
| Pappas, AL | 1 |
| Lurie, J | 1 |
| Hotaling, AJ | 1 |
| Park, A | 1 |
| Sennaraj, B | 2 |
| Shende, D | 6 |
| Ilavajady, S | 1 |
| Jagan, D | 2 |
| Issioui, T | 2 |
| Hu, J | 1 |
| Jones, SB | 2 |
| Coleman, JE | 3 |
| Waddle, JP | 1 |
| Markowitz, SD | 2 |
| Coloma, M | 2 |
| Macaluso, AR | 2 |
| Ing, CH | 1 |
| Elhakim, M | 1 |
| Nafie, M | 1 |
| Mahmoud, K | 1 |
| Atef, A | 1 |
| Erb, TO | 1 |
| Hall, JM | 1 |
| Ing, RJ | 1 |
| Kanter, RJ | 1 |
| Kern, FH | 1 |
| Schulman, SR | 1 |
| Ogunnaike, BO | 1 |
| Brown, PM | 1 |
| Lee, AQ | 1 |
| Berrisford, SB | 1 |
| Wakefield, CA | 1 |
| Jones, DB | 1 |
| Awad, IT | 1 |
| Murphy, D | 2 |
| Stack, D | 1 |
| Swanton, BJ | 1 |
| Meeke, RI | 1 |
| Shorten, GD | 2 |
| Ma, H | 1 |
| Sloninsky, A | 3 |
| Webb, T | 2 |
| Zaentz, A | 1 |
| Miller, DR | 1 |
| Kasinath, NS | 1 |
| Malak, O | 1 |
| Tetzlaff, J | 1 |
| Thagaard, KS | 2 |
| Steine, S | 1 |
| Raeder, J | 1 |
| Paech, MJ | 3 |
| Rucklidge, MW | 2 |
| Banks, SL | 1 |
| Gurrin, LC | 2 |
| Orlikowski, CE | 1 |
| Pavy, TJ | 1 |
| Charuluxananan, S | 2 |
| Kyokong, O | 3 |
| Somboonviboon, W | 3 |
| Narasethakamol, A | 2 |
| Promlok, P | 2 |
| Winston, AW | 1 |
| Rinehart, RS | 1 |
| Riley, GP | 1 |
| Vacchiano, CA | 1 |
| Szarvas, S | 1 |
| Chellapuri, RS | 1 |
| Harmon, DC | 1 |
| Owens, J | 1 |
| Wattwil, M | 2 |
| Thörn, SE | 2 |
| Lövqvist, A | 1 |
| Wattwil, L | 1 |
| Gupta, A | 1 |
| Liljegren, G | 1 |
| Olutoye, O | 1 |
| Jantzen, EC | 1 |
| Alexis, R | 1 |
| Rajchert, D | 1 |
| Schreiner, MS | 1 |
| Watcha, MF | 2 |
| O'Brien, CM | 1 |
| Titley, G | 1 |
| Whitehurst, P | 1 |
| Unlugenc, H | 2 |
| Guler, T | 2 |
| Gunes, Y | 2 |
| Isik, G | 2 |
| Ritter, MJ | 1 |
| Goodman, BP | 1 |
| Wijdicks, EF | 1 |
| Pueyo, FJ | 1 |
| Sanchez-Ledesma, MJ | 1 |
| Ortega, A | 1 |
| Karamanlioglu, B | 1 |
| Memis, D | 1 |
| Süt, N | 1 |
| Oldman, M | 1 |
| Youngs, P | 1 |
| Johnson, A | 1 |
| Ku, CM | 1 |
| Ong, BC | 1 |
| Cheng, KI | 1 |
| Liu, KS | 1 |
| Vaidya, JS | 1 |
| Wermelt, J | 2 |
| Kunitz, O | 1 |
| Müller, A | 1 |
| Wilhelm, W | 2 |
| Dethling, J | 2 |
| Browning, BA | 1 |
| Fort, CA | 1 |
| Kemp, KD | 1 |
| Shimata, MF | 1 |
| Strube, MD | 1 |
| Waresak, M | 1 |
| Korttila, K | 1 |
| Abdalla, M | 1 |
| Kerger, H | 2 |
| Vedder, I | 1 |
| Zernak, C | 2 |
| Danner, K | 2 |
| Jokela, R | 3 |
| Pocock, SJ | 1 |
| Trenkler, S | 1 |
| Kredel, M | 1 |
| Biswas, BN | 1 |
| Rudra, A | 1 |
| Mandal, SK | 1 |
| Sinha, PK | 2 |
| Ambesh, SP | 2 |
| Odin, I | 1 |
| Merle, JC | 1 |
| Feiss, P | 1 |
| Sanjay, OP | 1 |
| Tauro, DI | 1 |
| Eubanks, S | 1 |
| Pappas, TN | 1 |
| Celiker, V | 1 |
| Celebi, N | 1 |
| Canbay, O | 1 |
| Başgül, E | 1 |
| Aypar, U | 1 |
| Wells, J | 1 |
| Evans, SF | 1 |
| Binstock, W | 1 |
| Rubin, R | 1 |
| Bachman, C | 1 |
| Kahana, M | 1 |
| McDade, W | 1 |
| Lynch, JP | 1 |
| Jiao, KR | 1 |
| Zenn, M | 1 |
| Georgiade, G | 1 |
| Yalçýn, S | 1 |
| Yalçýn, B | 1 |
| Büyükçelik, A | 1 |
| Panda, NB | 1 |
| Bharadwaj, N | 1 |
| Kapoor, P | 1 |
| Chari, P | 1 |
| Panda, NK | 1 |
| Meyer, TA | 1 |
| Roberson, CR | 1 |
| Rajab, MH | 1 |
| Davis, J | 1 |
| McLeskey, CH | 1 |
| Hamza, MA | 2 |
| Recart, A | 1 |
| Cox, L | 1 |
| Jaffer, O | 1 |
| Song, D | 2 |
| Rohrich, R | 1 |
| Birnbach, DJ | 2 |
| Lubarsky, DA | 3 |
| Nhuch, F | 2 |
| Kamat, A | 2 |
| Koch, WH | 1 |
| Nikoloff, M | 1 |
| Wu, L | 1 |
| Andrews, D | 1 |
| Bacher, A | 1 |
| Forst, H | 1 |
| Fritz, G | 1 |
| Hergert, M | 1 |
| Goebel, A | 1 |
| Hopf, HB | 1 |
| Lange, M | 1 |
| Mertzlufft, F | 1 |
| Motsch, J | 1 |
| Schneider, E | 1 |
| Stoecklein, K | 1 |
| Chang, P | 1 |
| Okamoto, M | 1 |
| Chen, J | 1 |
| Frame, D | 1 |
| Rüsch, D | 1 |
| Eberhart, L | 2 |
| Misra, MN | 1 |
| Pullani, AJ | 1 |
| Mohamed, ZU | 1 |
| Albaladejo, P | 1 |
| Legrand, M | 1 |
| Samain, E | 1 |
| Cohen, IT | 2 |
| Joffe, D | 1 |
| Hummer, K | 1 |
| Soluri, A | 1 |
| Kabalak, AA | 1 |
| Akcay, M | 1 |
| Akcay, F | 1 |
| Gogus, N | 1 |
| Khalil, SN | 1 |
| Roth, AG | 1 |
| Simhi, E | 1 |
| Ansermino, JM | 1 |
| Bolos, ME | 1 |
| Coté, CJ | 1 |
| Hannallah, RS | 1 |
| Davis, PJ | 1 |
| Brooks, PB | 1 |
| Russo, MW | 1 |
| Anschuetz, GC | 1 |
| Kontrimaviciute, E | 1 |
| Baublys, A | 1 |
| Ivaskevicius, J | 1 |
| Piwko, C | 1 |
| Lasry, A | 1 |
| Alanezi, K | 1 |
| Coyte, PC | 1 |
| Ungar, WJ | 1 |
| Cherian, A | 1 |
| Maguire, M | 1 |
| Helander, A | 1 |
| Bjellerup, P | 1 |
| Lindahl, S | 1 |
| Lönnqvist, P | 1 |
| Wilkens, EP | 1 |
| Yates, BJ | 1 |
| Coop, A | 1 |
| Philip, BK | 3 |
| Pirat, A | 1 |
| Tuncay, ŞF | 1 |
| Torgay, A | 1 |
| Candan, S | 1 |
| Arslan, G | 1 |
| Hartsell, T | 1 |
| Long, D | 1 |
| Kirsch, JR | 1 |
| Iatrou, CA | 1 |
| Dragoumanis, CK | 1 |
| Vogiatzaki, TD | 1 |
| Vretzakis, GI | 1 |
| Simopoulos, CE | 1 |
| Dimitriou, VK | 1 |
| Dürsteler, C | 2 |
| Mases, A | 2 |
| Fernandez, V | 1 |
| Pol, O | 1 |
| Puig, MM | 2 |
| Sarvela, PJ | 1 |
| Halonen, PM | 1 |
| Soikkeli, AI | 1 |
| Kainu, JP | 1 |
| Purhonen, S | 3 |
| Niskanen, M | 2 |
| Wüstefeld, M | 1 |
| Hirvonen, E | 1 |
| Hynynen, M | 2 |
| Koski, EM | 1 |
| Board, T | 1 |
| Board, R | 1 |
| Jones, S | 1 |
| Strobl, R | 1 |
| Crosby, D | 1 |
| Burkard, JF | 1 |
| Maye, J | 1 |
| Ogunnaike, B | 2 |
| Lo, M | 1 |
| Khalili, T | 1 |
| Roberge, RJ | 1 |
| Isik, B | 1 |
| Cekmen, N | 1 |
| Arslan, M | 1 |
| Ozsoylar, O | 1 |
| Kordan, AZ | 1 |
| Akcabay, M | 1 |
| Peixoto, AJ | 2 |
| Celich, MF | 2 |
| Zardo, L | 1 |
| Peixoto Filho, AJ | 2 |
| Mychaskiw, G | 1 |
| Badr, AE | 1 |
| Calimaran, AM | 1 |
| Neustein, SM | 1 |
| Leonetti, JP | 1 |
| Anderson, D | 1 |
| Origitano, TC | 1 |
| Taha, SK | 1 |
| Azar, MS | 1 |
| Hakki, MA | 1 |
| Zoorob, DG | 1 |
| Birmingham, SD | 1 |
| Mecklenburg, BW | 1 |
| Lujan, E | 1 |
| Dacanay, RG | 1 |
| Boyle, PK | 1 |
| Green, R | 1 |
| Gunter, JB | 1 |
| McAuliffe, JJ | 1 |
| Beckman, EC | 1 |
| Wittkugel, EP | 1 |
| Spaeth, JP | 1 |
| Varughese, AM | 1 |
| Chan, MT | 1 |
| Choi, KC | 1 |
| Gin, T | 2 |
| Chui, PT | 1 |
| Short, TG | 1 |
| Yuen, PM | 1 |
| Poon, AH | 1 |
| Muñoz, HR | 1 |
| Ibacache, ME | 1 |
| Mertz, VF | 1 |
| Yang, YL | 2 |
| Chen, A | 1 |
| Kapu, R | 1 |
| Shah, M | 1 |
| Subramaniam, K | 2 |
| Pandia, MP | 1 |
| Dash, M | 1 |
| Bhatia, A | 1 |
| Subramaniam, B | 2 |
| Cavaretta, M | 1 |
| Noviasky, J | 1 |
| Reuveni, J | 1 |
| Taguchi, A | 1 |
| Lain, J | 1 |
| Dodd, PH | 1 |
| Bennett, EJ | 1 |
| Doherty, DA | 1 |
| Boonmak, P | 1 |
| Boonmak, S | 1 |
| Bunsaengjaroen, P | 1 |
| Srichaipanha, S | 1 |
| Poomsawat, S | 1 |
| Nonlhaopol, D | 1 |
| Kovac, A | 1 |
| Singla, N | 1 |
| Minkowitz, H | 1 |
| Knighton, J | 1 |
| Carides, AD | 2 |
| Horgan, KJ | 1 |
| Evans, JK | 2 |
| Lawson, FC | 2 |
| Timms, G | 1 |
| Deepika, K | 1 |
| Arheart, KL | 1 |
| Han, DW | 1 |
| Hong, SW | 1 |
| Kwon, JY | 1 |
| Lee, JW | 1 |
| Girao, MJ | 1 |
| Irwin, MG | 1 |
| Chelly, JE | 1 |
| Reiss, T | 2 |
| Antonetti, M | 1 |
| Kirton, O | 1 |
| Bui, P | 1 |
| Ademi, A | 1 |
| Staff, I | 1 |
| Hudson-Civetta, JA | 1 |
| Lilly, R | 1 |
| Bolton, CM | 1 |
| Myles, PS | 1 |
| Carlin, JB | 1 |
| Nolan, T | 1 |
| Harnett, MJ | 1 |
| O'Rourke, N | 1 |
| Walsh, M | 1 |
| Carabuena, JM | 1 |
| Segal, S | 1 |
| Wax, D | 1 |
| Doshi, A | 1 |
| Hossain, S | 1 |
| Bodian, CA | 1 |
| Krol, M | 1 |
| Reich, DL | 1 |
| Wig, J | 1 |
| Chandrashekharappa, KN | 1 |
| Yaddanapudi, LN | 1 |
| Nakra, D | 1 |
| Mukherjee, KK | 1 |
| Kim, CS | 1 |
| Choi, DH | 1 |
| Erhan, Y | 1 |
| Erhan, E | 1 |
| Aydede, H | 1 |
| Yumus, O | 1 |
| Yentur, A | 1 |
| Carides, A | 1 |
| Lines, C | 1 |
| McKeon, B | 1 |
| Bhatnagar, S | 1 |
| Gupta, D | 1 |
| Mishra, S | 1 |
| Srikanti, M | 1 |
| Singh, M | 1 |
| Arora, R | 1 |
| Oksuz, H | 1 |
| Zencirci, B | 1 |
| Ezberci, M | 1 |
| Ramakrishna, H | 1 |
| Trentman, TL | 1 |
| Hall, BA | 1 |
| Rosow, CE | 2 |
| Haspel, KL | 1 |
| Grecu, L | 2 |
| Bittner, EA | 2 |
| Kher, J | 1 |
| Bennett, AM | 1 |
| Emery, PJ | 1 |
| Wasowicz-Kemps, DK | 1 |
| Slootmaker, SM | 1 |
| Kemps, HM | 1 |
| Borel-Rinkes, IH | 1 |
| Biesma, DH | 1 |
| van Ramshorst, B | 1 |
| Cruz, NI | 1 |
| Portilla, P | 1 |
| Vela, RE | 1 |
| Sakellaris, G | 1 |
| Georgogianaki, P | 1 |
| Astyrakaki, E | 1 |
| Michalakis, M | 1 |
| Dede, O | 1 |
| Alegakis, A | 1 |
| Makatounaki, K | 1 |
| Charissis, G | 1 |
| Sandhu, T | 1 |
| Tanvatcharaphan, P | 1 |
| Cheunjongkolkul, V | 1 |
| Silomon, M | 1 |
| Awwad, R | 1 |
| Larsen, R | 1 |
| Hadji, F | 1 |
| Eastwood, D | 1 |
| Fear, S | 1 |
| Corfield, HJ | 1 |
| Chen, JJ | 1 |
| Frame, DG | 1 |
| White, TJ | 1 |
| Duncan, M | 1 |
| Donnelly, M | 1 |
| Chen, LK | 1 |
| Fan, SZ | 1 |
| Huang, CH | 1 |
| Chao, A | 1 |
| Chen, CL | 1 |
| Liu, CC | 1 |
| Dresner, M | 1 |
| Dean, S | 1 |
| Lumb, A | 1 |
| Bellamy, M | 1 |
| Scholz, J | 1 |
| Hennes, HJ | 1 |
| Steinfath, M | 1 |
| Färber, L | 1 |
| Schweiger, C | 1 |
| Dick, W | 1 |
| Schulte am Esch, J | 1 |
| Tripathi, M | 1 |
| Fisher, DM | 1 |
| Scuderi, PE | 2 |
| James, RL | 1 |
| Harris, L | 1 |
| Mims, GR | 1 |
| Phillips, J | 1 |
| Rajeeva, V | 1 |
| Bhardwaj, N | 1 |
| Batra, YK | 1 |
| Dhaliwal, LK | 1 |
| Visalyaputra, S | 1 |
| Pausawadi, S | 1 |
| Saratan, P | 1 |
| Vongvises, P | 1 |
| McQuay, HJ | 2 |
| Moore, RA | 2 |
| Barst, SM | 1 |
| Leiderman, JU | 1 |
| Markowitz, A | 1 |
| Rosen, AM | 1 |
| Abramson, AL | 1 |
| Bienkowski, RS | 1 |
| Domino, KB | 1 |
| Anderson, EA | 1 |
| Polissar, NL | 1 |
| Posner, KL | 1 |
| Tramèr, MR | 1 |
| Reynolds, DJ | 1 |
| Helmy, SA | 1 |
| Broome, IJ | 1 |
| Robb, HM | 1 |
| Raj, N | 1 |
| Girgis, Y | 1 |
| Wardall, GJ | 1 |
| Arregui, LM | 1 |
| Leonato, MS | 1 |
| Vigil, MD | 1 |
| Pérez de Cossío, JM | 1 |
| Cardona, A | 1 |
| Martínez de la Casa, JM | 1 |
| Warrick, PD | 1 |
| Belo, SE | 2 |
| Gürler, T | 1 |
| Celik, N | 1 |
| Totan, S | 1 |
| Songür, E | 1 |
| Sakarya, M | 1 |
| Figueredo, E | 3 |
| Canosa, L | 2 |
| Koivuranta, M | 2 |
| Ala-Kokko, TI | 1 |
| Ranta, P | 1 |
| Ruiz de Adana, J | 1 |
| Tobalina Bonis, R | 1 |
| García Galán, F | 1 |
| Hernández Matías, A | 1 |
| Fernández Luengas, D | 1 |
| Ortega Deballón, P | 1 |
| López Herrero, J | 1 |
| Moreno Azcoita, M | 1 |
| Wagley, C | 1 |
| Hackett, C | 1 |
| Haug, RH | 1 |
| Tsui, SL | 1 |
| Ng, KF | 1 |
| Wong, LC | 1 |
| Tang, GW | 1 |
| Pun, TC | 1 |
| Yang, JC | 1 |
| Courtman, SP | 1 |
| Rawlings, E | 1 |
| O'Connor, TA | 1 |
| Pearman, MH | 1 |
| Kekoler, LJ | 1 |
| Edmondson, D | 1 |
| Baughman, VL | 1 |
| Angel, JJ | 1 |
| Campbell, C | 1 |
| Jense, HG | 1 |
| Mingus, M | 1 |
| Shahvari, MB | 1 |
| Creed, MR | 2 |
| Soriano Bru, JL | 1 |
| García-Aguado, R | 1 |
| Vivó Benlloch, M | 1 |
| Zaragoza Fernández, C | 1 |
| Papadimitriou, L | 1 |
| Pourgezi, T | 1 |
| Petropoulos, G | 1 |
| Vassiliou, J | 1 |
| Papadimitriou, J | 1 |
| Saxena, A | 1 |
| Kathirvel, S | 3 |
| Kannan, TR | 1 |
| Mohan, V | 1 |
| Khalil, S | 1 |
| Philbrook, L | 1 |
| Rabb, M | 1 |
| Aves, T | 1 |
| Villanueva, G | 1 |
| Amhan, M | 1 |
| Chuang, AZ | 2 |
| Lemak, NA | 1 |
| Cholwill, JM | 1 |
| Wright, W | 2 |
| Hobbs, GJ | 2 |
| Curran, J | 1 |
| Bugedo, G | 1 |
| Gonzalez, J | 1 |
| Asenjo, C | 1 |
| De la Cuadra, JC | 1 |
| Gajardo, A | 1 |
| Castillo, L | 1 |
| Muñoz, H | 1 |
| Dagnino, J | 1 |
| Woodward, DK | 1 |
| Sherry, KM | 1 |
| Harrison, D | 1 |
| Madan, R | 5 |
| Perumal, T | 1 |
| Garg, S | 1 |
| Sadashivam, S | 1 |
| Swiatkowski, J | 1 |
| Goral, A | 1 |
| Dzieciuch, JA | 1 |
| Przesmycki, K | 1 |
| Liberman, MA | 1 |
| Howe, S | 1 |
| Lane, M | 1 |
| Hill, RP | 1 |
| Phillips-Bute, B | 1 |
| Fortney, JT | 1 |
| Reihnér, E | 1 |
| Grunditz, R | 1 |
| Giesecke, K | 1 |
| Gustafsson, LL | 1 |
| Manullang, TR | 1 |
| Viscomi, CM | 1 |
| Pace, NL | 1 |
| Zarate, E | 1 |
| Klein, KW | 1 |
| Sa Rego, M | 1 |
| Stewart, DG | 1 |
| Wu, O | 1 |
| Koutsoukos, G | 1 |
| Fabling, JM | 2 |
| El-Moalem, HE | 2 |
| Warner, DS | 2 |
| Abouleish, EI | 1 |
| Rashid, S | 1 |
| Haque, S | 1 |
| Giezentanner, A | 1 |
| Joynton, P | 1 |
| Gesztesi, Z | 1 |
| D'Angelo, R | 1 |
| Black, LS | 1 |
| MacLean, D | 1 |
| Kangas-Saarela, TA | 1 |
| Valanne, JV | 1 |
| Koivuranta, MK | 1 |
| Ranta, PO | 1 |
| Alahuhta, SM | 1 |
| Kreisler, NS | 1 |
| Spiekermann, BF | 1 |
| Ascari, CM | 1 |
| Rhyne, HA | 1 |
| Kloth, RL | 1 |
| Sullivan, LM | 1 |
| Durieux, ME | 1 |
| Leães, LF | 1 |
| Barros, MA | 1 |
| Sharma, S | 1 |
| Abdullah, N | 1 |
| Kothari, SN | 1 |
| Boyd, WC | 1 |
| Bottcher, ML | 1 |
| Lambert, PJ | 1 |
| Ahmed, AB | 1 |
| Curran, JP | 1 |
| Drake, R | 1 |
| Anderson, BJ | 1 |
| Persson, MA | 1 |
| Thompson, JM | 1 |
| Goll, V | 1 |
| Akça, O | 1 |
| Greif, R | 1 |
| Freitag, H | 1 |
| Arkiliç, CF | 1 |
| Scheck, T | 1 |
| Zoeggeler, A | 1 |
| Kurz, A | 1 |
| Krieger, G | 1 |
| Lenhardt, R | 1 |
| Millo, J | 1 |
| Siddons, M | 1 |
| Innes, R | 1 |
| Laurie, PS | 1 |
| Hirayama, T | 1 |
| Ishii, F | 1 |
| Yago, K | 1 |
| Ogata, H | 1 |
| Bowhay, AR | 1 |
| May, HA | 1 |
| Rudnicka, AR | 1 |
| Booker, PD | 1 |
| White, LA | 1 |
| Vanarase, M | 1 |
| Brockbank, K | 1 |
| Barrett, RF | 1 |
| Løvstad, RZ | 1 |
| Berner, NS | 1 |
| Raeder, JC | 2 |
| De Witte, JL | 1 |
| Schoenmaekers, B | 1 |
| Deloof, T | 1 |
| Lee, TH | 1 |
| Lin, CR | 1 |
| Lee, TC | 1 |
| Buerkle, H | 1 |
| Hsu, TY | 1 |
| Mao, CC | 1 |
| Yang, LC | 1 |
| Bharti, N | 1 |
| Wilson, EB | 1 |
| Bass, CS | 1 |
| Abrameit, W | 1 |
| Roberson, R | 1 |
| Smith, RW | 1 |
| Walker, JB | 1 |
| Harmon, D | 1 |
| Gardiner, J | 1 |
| Cherian, VT | 1 |
| Smith, I | 1 |
| Tamilselvan, P | 1 |
| Rajeshwari, S | 1 |
| Somri, M | 1 |
| Vaida, SJ | 1 |
| Sabo, E | 1 |
| Yassain, G | 1 |
| Gankin, I | 1 |
| Gaitini, LA | 1 |
| Moore, CH | 1 |
| Splinter, WM | 1 |
| Grimsehl, K | 1 |
| Whiteside, JB | 1 |
| Mackenzie, N | 1 |
| Sanai, L | 1 |
| Thomas, R | 1 |
| Jones, N | 1 |
| Robin, NM | 1 |
| Mostafa, SM | 1 |
| Quaynor, H | 1 |
| Hammas, B | 1 |
| So, JB | 1 |
| Cheong, KF | 1 |
| Sng, C | 1 |
| Cheah, WK | 1 |
| Goh, P | 1 |
| Franiak, R | 1 |
| Reeves, J | 1 |
| Bergendahl, HT | 1 |
| Muhrbeck, O | 1 |
| Roberts, RG | 1 |
| Jones, RM | 1 |
| Kangas-Saarela, T | 1 |
| Alahuhta, S | 1 |
| Yazigi, A | 1 |
| Chalhoub, V | 1 |
| Madi-Jebara, S | 1 |
| Haddad, F | 1 |
| Hayek, G | 1 |
| Arcioni, R | 1 |
| della Rocca, M | 1 |
| Romanò, S | 1 |
| Romano, R | 1 |
| Pietropaoli, P | 1 |
| Gasparetto, A | 1 |
| Marcus, JR | 1 |
| Few, JW | 1 |
| Chao, JD | 1 |
| Fine, NA | 1 |
| Mustoe, TA | 1 |
| Vimláti, L | 1 |
| Pallós, J | 1 |
| Nagy, K | 1 |
| Murányi, M | 1 |
| Szabó, Z | 1 |
| Karoliny, V | 1 |
| Steiber, J | 1 |
| Sly, PD | 1 |
| Burton, PR | 1 |
| Guo, Q | 1 |
| Fu, D | 1 |
| Neufeld, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Ondansetron on the Efficacy of Tramadol[NCT04745273] | Phase 4 | 60 participants (Actual) | Interventional | 2020-09-02 | Completed | ||
| Comparison of Preoperative Intravenous Fluid Loading and Ondansetron in Reduction of Incidence Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Study[NCT03141645] | 171 participants (Actual) | Interventional | 2017-06-20 | Completed | |||
| Evaluation of the Efficacy of 6% Hydroxyethyl Starch (HES, 130/0.4) in Normal Saline Compared to Ringer's Lactate Solution for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section[NCT00694343] | Phase 4 | 167 participants (Actual) | Interventional | 2008-06-30 | Completed | ||
| The Time Required to Remain Sitting After Spinal Anesthesia for 50% of Patients to Not Experience Hypotension[NCT01561274] | Phase 2 | 50 participants (Actual) | Interventional | 2012-03-31 | Completed | ||
| The Oxygenation of the Brain During Caesarean Section. A Comparison of Ephedrine Versus Phenylephrine[NCT01509521] | Phase 4 | 24 participants (Anticipated) | Interventional | 2012-02-29 | Completed | ||
| Electrical Acupoint Stimulation Alleviates Hypotension After Spinal Anesthesia in Parturients: a Prospective Randomized Controlled Clinical Trial[NCT05724095] | 90 participants (Actual) | Interventional | 2023-02-20 | Completed | |||
| Intravenous Dextrose Versus Ondansetron for Prevention of Postoperative Vomiting in Children: a Randomized Non-inferiority Trial[NCT01912807] | 300 participants (Actual) | Interventional | 2013-12-31 | Completed | |||
| A Double-blinded, Randomized Control Trial of Prophylactic Ondansetron in a Post-operative Cardiac Surgery Population for Post-operative Nausea and Vomiting[NCT02966041] | 186 participants (Actual) | Interventional | 2018-03-06 | Completed | |||
| Triple Combination of Fosaprepitant, Dexamethasone and Palonosetron Versus Combination of Dexamethasone and Palonosetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gastrointestinal Surgery[NCT04853147] | Phase 3 | 1,154 participants (Actual) | Interventional | 2021-04-27 | Completed | ||
| Postoperative Vomiting in Children: Evaluation of the Addition of Droperidol to Conventional Bi-prophylaxis[NCT01739985] | 322 participants (Actual) | Interventional | 2010-12-31 | Completed | |||
| Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery: a Randomized Clinical Trial[NCT05087615] | Phase 3 | 130 participants (Actual) | Interventional | 2021-03-01 | Completed | ||
| Effect of Remimazolam on Incidence of Postoperative Nausea and Vomiting Following General Anesthesia in High-risk Patients: a Multicenter, Double-blinded, Placebo-controlled Randomized Trial[NCT04861337] | Phase 4 | 552 participants (Actual) | Interventional | 2021-05-19 | Completed | ||
| The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Thoracicsurgery Patients: A Single-center, Randomized, Double-Blinded Clinical Study[NCT05881486] | 234 participants (Anticipated) | Interventional | 2023-06-30 | Not yet recruiting | |||
| Etude de l'Effet du dropéridol et de l'Ondansetron Sur l'Incidence de l'Akathisie Post opératoire en Chirurgie Ambulatoire[NCT01942343] | Phase 3 | 300 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Is Intra-operative Acupuncture at P6 Plus IV Antiemetics More Effective Than IV Antiemetic Therapy Alone in Preventing Postoperative Vomiting in Pediatric Patients Following Tonsillectomy With or Without Adenoidectomy?[NCT01417741] | 164 participants (Actual) | Interventional | 2011-08-31 | Completed | |||
| A Multi-Center, Open-Label, 2-Arm, Randomized, Stratified, Parallel, Pilot Study to Assess Palonosetron vs. Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)[NCT00967499] | Phase 2 | 239 participants (Actual) | Interventional | 2009-07-13 | Completed | ||
| Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position[NCT03232125] | 54 participants (Actual) | Interventional | 2017-08-01 | Completed | |||
| A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 36 mg) Dose of the Neurokinin-1 Receptor Antagonist, Vestip[NCT01507194] | Phase 2 | 131 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| The Efficacy of Neostigmine as an Adjuvant to Bupivacaine for Intrathecal Block in Reducing the Incidence and Severity of Post-Dural Puncture Headache for Parturients Scheduled for Elective Caesarean Section[NCT03587441] | Phase 4 | 240 participants (Actual) | Interventional | 2018-08-04 | Completed | ||
| Role of Dexamethasone or Ondansetron in the Quality of Recovery After Intrathecal Morphine Administration in Patients Undergoing Lower Limb Surgery.[NCT03035942] | Phase 4 | 135 participants (Actual) | Interventional | 2017-01-02 | Completed | ||
| Effect of Intravenous Granisetron on Incidence and Severity of Intrathecal Morphine Induced Pruritus in Elective Cesarean Section[NCT03483870] | Phase 2 | 80 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
| Ultrasound Guided Quadratus Lumborum Block Versus Erector Spinae Plane Block For Postoperative Analgesia In Patient Undergoing Laparoscopic Hysterectomy: A Randomized Double Blinded Study[NCT05465525] | 81 participants (Actual) | Interventional | 2022-07-25 | Completed | |||
| Ultrasound Guided Quadratus Lumborum Block Versus Erector Spinae Plane Block For Postoperative Analgesia In Patient Undergoing Abdominal Hysterectomy: A Randomized Double Blinded Study[NCT05675657] | 81 participants (Actual) | Interventional | 2023-01-15 | Completed | |||
| The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting[NCT01897337] | Phase 4 | 125 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
| Should we Associate Dexamethasone and Ondansetron to Closed-loop Anesthesia to Reduce the Incidence of Postoperative Nausea and Vomiting After Bariatric Surgery?[NCT01876290] | Phase 4 | 122 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| Sublingual Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting in Elective Gynaecological Patients at the University Hospital of the West Indies (UHWI)[NCT06137027] | Early Phase 1 | 120 participants (Anticipated) | Interventional | 2023-09-21 | Recruiting | ||
| The Putative Role of the Pavlovian Reflex as a Non-pharmacological Preoperative Intervention in the Prevention of Postoperative Nausea and Vomiting[NCT04719910] | 70 participants (Actual) | Interventional | 2021-09-01 | Completed | |||
| Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis[NCT02415335] | Phase 2 | 119 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy[NCT00878228] | Phase 4 | 98 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| Studying the Effectiveness of Triple Therapy With Palonosetron, Dexamethasone and Promethazine for Prevention of Post Operative Nausea and Vomiting in High Risk Patients Undergoing Neurological Surgery and General Anesthesia[NCT02635828] | Phase 4 | 40 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy[NCT02541019] | Phase 4 | 80 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
| The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study[NCT01106547] | Phase 4 | 55 participants (Anticipated) | Interventional | 2009-08-31 | Completed | ||
| Preoperative Use of Pregabalin and Analgesia Levels After Laparoscopic Cholecystectomy[NCT01321801] | 50 participants (Actual) | Interventional | 2009-11-30 | Completed | |||
| The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery[NCT02139241] | 114 participants (Actual) | Interventional | 2013-06-30 | Completed | |||
| A Randomized Controlled Trial: Role of EFTs (Emotional Freedom Techniques) in Reducing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy.[NCT02169856] | 50 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Evaluation of an Enhanced Recovery Pathway for Endoscopy Patients Receiving Moderate Sedation[NCT04983498] | Phase 4 | 0 participants (Actual) | Interventional | 2021-09-01 | Withdrawn (stopped due to Investigator left organization before study initiated.) | ||
| Inhalation Intervention for Nausea in the Emergency Department[NCT02092441] | 80 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)[NCT03125811] | Early Phase 1 | 121 participants (Actual) | Interventional | 2017-07-17 | Completed | ||
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondan[NCT00108095] | Phase 2 | 701 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| Combined General Anesthesia Plus Paravertebral Block Versus General Anesthesia Plus Opioid Analgesia for Breast Cancer Surgery: A Prospective Randomized Trial[NCT01904266] | 60 participants (Actual) | Interventional | 2013-05-31 | Completed | |||
| Multimodal Pain Treatment for Breast Cancer Surgery - a Prospective Cohort Study[NCT04875559] | 236 participants (Actual) | Observational [Patient Registry] | 2021-04-19 | Completed | |||
| A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy[NCT00734929] | Phase 4 | 115 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| Therapeutic Drug Monitoring of Corticosteroids/β2-agonists in Hair in Asthmatic Patients: an Open-label Feasibility Study[NCT03691961] | 24 participants (Actual) | Interventional | 2018-09-20 | Active, not recruiting | |||
| A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50mg Oral Dosing With the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention of Postoperative Nausea and Vomiting in Female Subjects [NCT00326248] | Phase 3 | 482 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| The Use of P6 Acupressure for the Reduction of Intraoperative and Postoperative Nausea and Vomiting in Women Undergoing Cesarean Delivery: a Randomized Trial[NCT04799587] | 200 participants (Actual) | Interventional | 2021-05-26 | Completed | |||
| Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients[NCT03130218] | 204 participants (Actual) | Interventional | 2017-06-08 | Completed | |||
| Optimization of Post-Operative Therapy for Nausea or Vomiting[NCT03075163] | Phase 4 | 300 participants (Actual) | Interventional | 2016-10-18 | Terminated (stopped due to recruitment futility) | ||
| Randomized Phase 3 Study of Aprepitant Versus Placebo in Chinese Advanced Non-small Cell Lung Cancer Who Received Highly Emetogenic Chemotherapy[NCT02161991] | Phase 3 | 244 participants (Actual) | Interventional | 2014-02-01 | Completed | ||
| Aprepitant- and Olanzapine- Containing Regimens for Prevention of Acute and Delayed Nausea and Vomiting Associated With High Dose Melphalan and BEAM in Autologous Stem Cell Transplant Patients[NCT02939287] | Phase 3 | 429 participants (Actual) | Interventional | 2017-09-23 | Completed | ||
| ENDOblock: Do Bilateral Superficial Cervical Blocks With Local Wound Infiltration Decrease Postoperative Pain After Thyroid Surgery[NCT05805423] | 74 participants (Anticipated) | Interventional | 2023-04-17 | Recruiting | |||
| Bilateral Superficial Cervical Plexus Block Combined With Intravenous Sedation Versus General Anesthesia in Selected Patients for Thyroid/Parathyroid Surgery ; a Prospective Randomized Control Trial[NCT04051099] | 52 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | |||
| Effect of Superficial Cervical Plexus Block on Incidence and Severity of Post Operative Nausea and Vomiting in Tympanomastoid Operations in Adults, Randomized Controlled Study[NCT05504551] | 90 participants (Actual) | Interventional | 2022-08-31 | Completed | |||
| Is Intra-operative Acupuncture Point P6 Stimulation as Effective as Traditional Pharmacotherapy in Reducing Nausea and Vomiting During Cesarean Section With Regional Anesthesia?[NCT02959840] | Phase 4 | 180 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| Quality of Recovery Following Administration of Transverse Abdominus Plane (TAP) Catheter as Compared to Intrathecal Morphine After Cesarean Delivery Under Spinal Anesthesia: a Prospective, Randomized Trial[NCT01593280] | 80 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | |||
| A Randomized Controlled Trial of Cesamet(R) (Nabilone) for the Prevention of Postoperative Nausea and Vomiting in Elective Surgery[NCT02115529] | Phase 2 | 331 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
| Granisetron vs Granisetron and Dexamethasone on the Reduction of Postoperative Nausea and Vomiting After Caesarean Section With Intrathecal Morphine: A Randomized Controlled Trial[NCT04570592] | Phase 2 | 126 participants (Anticipated) | Interventional | 2020-10-01 | Recruiting | ||
| A Prospective Evaluation of an Anesthesia Protocol to Reduce Post-operative and Post-discharge Nausea and Vomiting in a High Risk Orthognathic Surgery Population[NCT01592708] | 233 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
| Antagonism Research Between Antiemetics Agents (Droperidol, Dexametasone, Ondansetron) and Acetaminophen in Thyroidectomy's Post-operative Analgesia.[NCT01679093] | Phase 3 | 66 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: Effects on Postoperative Recovery and Cancer Recurrence[NCT01204242] | Phase 2 | 78 participants (Actual) | Interventional | 2009-08-01 | Completed | ||
| The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery Patients: A Prospective, Randomized, Blinded Clinical Trial[NCT00941005] | 122 participants (Actual) | Interventional | 2008-01-31 | Completed | |||
| Metabolites of Tramadol in the Postoperative Surgical Patients Admitted in the ICU[NCT04004481] | 50 participants (Actual) | Observational | 2019-01-25 | Completed | |||
| Electrical Acupoint Stimulation for Postoperative Recovery After Knee Arthroplasty. A Randomized, Double-blind, Clinical Trial.[NCT03249701] | 90 participants (Anticipated) | Interventional | 2018-05-01 | Not yet recruiting | |||
| IRB-HSR# 14583: Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients[NCT01414777] | Phase 2/Phase 3 | 68 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| The Effects of Scalp Block on Haemodynamic Response and Postoperative Pain in[NCT02852382] | Phase 2 | 45 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
| Postoperative Pain and Headache After Craniotomy[NCT03908944] | Phase 2 | 0 participants (Actual) | Interventional | 2019-01-02 | Withdrawn (stopped due to PI- Dr. Jellish passed away. The study was terminated with the IRB) | ||
| A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomitin[NCT00090155] | Phase 3 | 805 participants (Actual) | Interventional | 2003-09-26 | Completed | ||
| Comparison of Aprepitant PO and Ondansetron IV for Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Orthognathic Surgery and General Anesthesia.[NCT00699894] | 0 participants (Actual) | Interventional | 2008-06-30 | Withdrawn (stopped due to Logistical difficulties running the study) | |||
| A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomitin[NCT00090246] | Phase 3 | 922 participants (Actual) | Interventional | 2004-05-13 | Completed | ||
| Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection[NCT03134612] | Phase 2 | 104 participants (Actual) | Interventional | 2016-07-31 | Completed | ||
| A Phase III, Randomized, Open-label, Active-controlled, Two-arm, Parallel-design, Interventional Clinical Trial Evaluating the Efficacy and Safety of Ondansetron 8 mg IV/ IM Injection Compared to Metoclopramide 10 mg in the Management of Nausea and Vomiti[NCT05876585] | Phase 3 | 126 participants (Anticipated) | Interventional | 2023-06-30 | Not yet recruiting | ||
| The Effect of Antibiotic Prophylaxis Timing on Intraoperative Nausea and Vomiting in Patients Undergoing Cesarean Section Under Regional Anesthesia.[NCT04697277] | Phase 4 | 120 participants (Anticipated) | Interventional | 2015-08-20 | Recruiting | ||
| Randomized Double Control Study to Assess the Efficacy of Administering 1 ml of Glycopyrrolate With the Spinal Dose in Minimizing Nausea and Vomiting in Patients Undergoing Cesarean Section Under Spinal Anesthesia[NCT02872935] | Phase 4 | 22 participants (Actual) | Interventional | 2015-05-15 | Terminated | ||
| Comparison of Sugammadex Versus Neostigmine in Women at High Risk of Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery: A Randomized Controlled Trial[NCT02666014] | Phase 3 | 184 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measuring the blood glucose level is important to ensure that administration of IV Dextrose at the dose to be used in our protocol, did not cause hyperglycemia in the participants. This measurement was done while patients were still under general anesthetic during the procedure. (NCT01912807)
Timeframe: Intraoperatively
| Intervention | mmol/L (Median) |
|---|---|
| Dextrose (D5NS) - Intervention Group | 6.3 |
| Ondansetron - Control Group | 5.5 |
Data was recorder for number of patients with delays in discharge from PACU due to POV (NCT01912807)
Timeframe: Within 24 hours after the procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Dextrose (D5NS) - Intervention Group | 2 |
| Ondansetron - Control Group | 0 |
"Parents were informed during the consent process that postoperative 24 hour follow up was going to be done over the phone by the researcher.~The number of participants (parents / caregivers) who answered the call was recorded, and from those the number of patients who presented the secondary outcome." (NCT01912807)
Timeframe: 2 to 24 hr after procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Dextrose (D5NS) - Intervention Group | 15 |
| Ondansetron - Control Group | 9 |
"In the Post Anesthetic Care Unit (PACU) the proper data (intraoperative and recovery period) was recorded at immediate postoperative period, at 2 hours after the procedure and prior to discharge.~Parents were informed during the consent process that postoperative 24 hour follow up was going to be done over the phone by researcher." (NCT01912807)
Timeframe: 0 to 2 hr after the procedure (in PACU)
| Intervention | Participants (Count of Participants) |
|---|---|
| Dextrose (D5NS) - Intervention Group | 11 |
| Ondansetron - Control Group | 5 |
Post operative Nausea and vomiting in phase 1 and 11 recovery (Measured as a percentage of participants who experienced this outcome) Post op Nausea and vomiting on post op day one ( measured as a percentage of participants who experienced this outcome) as reported on a telephone survey (NCT01417741)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Immediate Post Op | Post Op Day 1 | |
| Acupuncture Plus Standard Therapy | 6 | 31 |
| Standard Therapy Only | 26 | 37 |
(NCT00967499)
Timeframe: Up to 72 hours postdose
| Intervention | percentage of participants (Number) |
|---|---|
| Palonosetron | 70.8 |
| Ondansetron | 52.0 |
(NCT00967499)
Timeframe: Up to 72 hours postdose
| Intervention | percentage of participants (Number) |
|---|---|
| Palonosetron | 37.5 |
| Ondansetron | 44.0 |
Complete control was defined as participants with no emetic episode, no rescue medication, and no more than 3 on the nausea numeric rating scale (NRS) severity score. The 11-point NRS scale (ranging from 0-10), where 0 means no nausea, 2 or 3 was mild nausea, around 5 was moderate nausea, 7 and higher was severe nausea and 10 means the worst possible nausea. Higher scores were considered as worse outcome. (NCT00967499)
Timeframe: Up to 72 hours postdose
| Intervention | percentage of participants (Number) |
|---|---|
| Palonosetron | 25.0 |
| Ondansetron | 18.0 |
Complete response was defined as participants with no emetic episode and no use of rescue medication. An emetic episodic is defined as any number of retches (unproductive emesis) in a single 5-minute period; 1 or a sequence of vomits in a close succession not relieved by a period of relaxation of at least 2 minutes; or retching of less than (<) 5 minutes duration combined with a single vomit. (NCT00967499)
Timeframe: Up to 72 hours postdose
| Intervention | percentage of participants (Number) |
|---|---|
| Palonosetron | 31.3 |
| Ondansetron | 26.0 |
Severity of nausea was assessed at specific time points using an 11-point NRS scale (ranging from 0-10) for evaluation of nausea severity. On the 0-10 rating scale, 0 means no nausea, 2 or 3 was mild nausea, around 5 was moderate nausea, 7 and higher was severe nausea and 10 means the worst possible nausea. Higher scores were considered as worse outcome. (NCT00967499)
Timeframe: Baseline up to 72 hours postdose
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Baseline | Change at 72 hours postdose | |
| Ondansetron | 5.9 | -5.6 |
| Palonosetron | 5.7 | -5.1 |
"Modified Osoba nausea and emesis module questionnaire was used to assess the impact of nausea and emesis on functional interference at 24, 48 and 72 hours postdose. The modified Osoba questionnaire included specific questions regarding the interference of nausea and emesis in daily activities (appetite, sleep, physical activities, social life, and enjoyment of life) with respective choices. The raw score of the modified Osoba questionnaire was the arithmetic mean of the non-missing item scores, using 1 for the answer not at all, 2 for the answer a little, 3 for the answer quite a bit, and 4 for the answer very much. Raw score range from 5-20 and the total score was computed by linearly transformed the raw score to final score range as 0 to 100 by calculating ([RS-1]/range)*100, with RS being the raw score and range being 3 in this case of answers scored from 1 to 4. Lower scores indicate better quality of life." (NCT00967499)
Timeframe: 24, 48 and 72 hours postdose
| Intervention | score on a scale (Mean) | ||
|---|---|---|---|
| 24 Hours Postdose | 48 Hours Postdose | 72 Hours Postdose | |
| Ondansetron | 12.1 | 7.0 | 6.2 |
| Palonosetron | 11.3 | 6.5 | 6.7 |
The occurrence of PONV will be registered during the PACU (NCT03035942)
Timeframe: 4h
| Intervention | Participants (Count of Participants) |
|---|---|
| O Group | 3 |
| D Group | 9 |
| S Group | 9 |
The occurrence of localized or generalized itching (patients who answered yes or no) (NCT03035942)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| O Group | 4 |
| D Group | 7 |
| S Group | 8 |
Pain were assessed every 15 minutes during postanesthesia care unit, where zero meant no pain and 10 the worst imaginable pain (higher values represent worse outcome). Twenty four hours after surgery, patients were asked to describe the highest pain score (NRS) during ward stay. (NCT03035942)
Timeframe: 24 hours
| Intervention | Score on a scale (NRS) (Median) |
|---|---|
| D Group | 0 |
| O Group | 5 |
| S Group | 2 |
Quality of Recovery Questionnaire (QoR-40). Minimum score 40 (very poor quality of recovery) and maximun score 200 (excellent quality of recovery). Higher scores mean better outcome (NCT03035942)
Timeframe: Twenty four hours after surgery by a blinded investigator
| Intervention | Score on a scale (Median) |
|---|---|
| O Group | 184 |
| D Group | 187 |
| S Group | 185 |
Percentage of participants whose quality of life was impacted by nausea and vomiting (NCT00878228)
Timeframe: Postdischarge Day 1
| Intervention | percentage of participants (Number) |
|---|---|
| Study Group | 18 |
| Control Group | 30 |
Percentage of participants with nausea (NCT00878228)
Timeframe: Postdischarge Day 1
| Intervention | percentage of participants (Number) |
|---|---|
| Study Group | 46 |
| Control Group | 54 |
Percentage of participants reporting moderate or severe nausea in the first 24 hours (NCT00878228)
Timeframe: Postdischarge Day 1
| Intervention | percentage of participants (Number) |
|---|---|
| Study Group | 23 |
| Control Group | 32 |
The incidence of significant QTc prolongation was measured by comparing baseline EKG, 24 hours and 120 hours after surgery (NCT02635828)
Timeframe: 24 and 120 hours/discharge after end of surgery
| Intervention | participants (Number) |
|---|---|
| Triple Therapy PONV Prohylaxis | 0 |
The incidence of PONV (NCT02635828)
Timeframe: 24 hours after end of surgery
| Intervention | participants (Number) |
|---|---|
| Triple Therapy PONV Prohylaxis | 12 |
"Primary outcome is nausea and vomiting measured on a scale from 0 (no nausea) to 10 (worst nausea imaginable) Verbal Numerical Response Scale (VNRS) at 10 minutes post intervention." (NCT02092441)
Timeframe: 10 minutes post intervention
| Intervention | VNRS (Median) |
|---|---|
| Alcohol Prep Pad Group | 3 |
| Normal Saline Prep Pad | 6 |
"Patient satisfaction of smelling prep pad to alleviate nausea on a scale from 1 (completely unsatisfied) to 5 (completely satisfied)" (NCT02092441)
Timeframe: 10 minutes post intervention
| Intervention | 5 point Likert Scale (Median) |
|---|---|
| Alcohol Prep Pad Group | 4 |
| Normal Saline Prep Pad | 2 |
"Scale ranges from 0 (no pain) to 10 (worst pain imaginable)" (NCT02092441)
Timeframe: 10 minutes post intervention
| Intervention | VNRS (Median) |
|---|---|
| Alcohol Prep Pad Group | 6 |
| Normal Saline Prep Pad | 6 |
Participants rated their satisfaction with antiemetic management on a 5 points scale: very satisfied, somewhat satisfied, neither satisfied nor dissatisfied, somewhat dissatisfied, very dissatisfied) (NCT00734929)
Timeframe: 48 hour
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 36 |
| Ondansetron | 32 |
Any vomiting or retching (NCT00734929)
Timeframe: 48 h
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 8 |
| Ondansetron | 20 |
Any vomiting or retching (NCT00734929)
Timeframe: 24 h
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 7 |
| Ondansetron | 19 |
(NCT00734929)
Timeframe: Post OP (0 - 2 hours)
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 3 |
| Ondansetron | 11 |
(NCT00734929)
Timeframe: 48 hours
| Intervention | vomiting episodes (Mean) |
|---|---|
| Aprepitant | 0 |
| Ondansetron | 0 |
(NCT00734929)
Timeframe: 48 h
| Intervention | hours (Median) |
|---|---|
| Aprepitant + Dexamethasone | 13.5 |
| Ondansetron + Dexamethasone | 2 |
(NCT00734929)
Timeframe: 24 h
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 31 |
| Ondansetron | 30 |
(NCT00734929)
Timeframe: 48 hour
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 33 |
| Ondansetron | 32 |
(NCT00734929)
Timeframe: Post OP (0 - 2 hours)
| Intervention | participants (Number) |
|---|---|
| Aprepitant | 20 |
| Ondansetron | 24 |
Participants verbally rated their nausea on a scale of 0-10. 0 = No nausea, 10 = worst nausea imaginable (NCT00734929)
Timeframe: Post OP hours 0-2, 24 h, 48 h
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| 0-2 hours post op | 24 hours post op | 48 hours post op | |
| Aprepitant | 0.4 | 0.8 | 0.9 |
| Ondansetron | 0.6 | 1.3 | 1.1 |
operative procedure (NCT00734929)
Timeframe: Post operative procedure (OP) hours (0-2, 24, 48)
| Intervention | participants (Number) | ||
|---|---|---|---|
| 0-2 hours Post OP | 24 Hours Post Op | 48 Hours Post Op | |
| Aprepitant | 27 | 33 | 35 |
| Ondansetron | 27 | 30 | 32 |
complete response rate: defined as no Postoperative nausea and vomiting (PONV) and no need for rescue antiemetics. (NCT00734929)
Timeframe: 24 hours Post OP, 48 hours Post OP
| Intervention | participants (Number) | |
|---|---|---|
| 24 Hours Post OP | 48 Hours Post OP | |
| Aprepitant | 14 | 11 |
| Ondansetron | 21 | 19 |
"Difference in the nausea score before and after treatment. Nausea is scored on a scale from 1 to 10 with 1 being no nausea and 10 being severe nausea with impending vomiting.~A greater difference is indicative of a better outcome" (NCT03075163)
Timeframe: Time to discharge from post anesthetic care unit
| Intervention | score on a scale (Mean) |
|---|---|
| Acupressure | 1.88 |
| Ondansetron | 1.25 |
The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea at any point during the surgical procedure in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 44 |
| Metoclopramide, Ondansetron | 14 |
| Acupressure Point P6 Stimulator | 22 |
Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage I. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 33 |
| Metoclopramide, Ondansetron | 7 |
| Acupressure Point P6 Stimulator | 14 |
Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage II. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 12 |
| Metoclopramide, Ondansetron | 6 |
| Acupressure Point P6 Stimulator | 5 |
Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage III. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 16 |
| Metoclopramide, Ondansetron | 8 |
| Acupressure Point P6 Stimulator | 14 |
Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage IV. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 3 |
| Metoclopramide, Ondansetron | 4 |
| Acupressure Point P6 Stimulator | 0 |
Patients are asked their overall anesthetic care satisfaction (0 = Not Satisfied, 10 = Extremely Satisfied). Data are expressed as number of parturients who gave a score of 8 or higher. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 53 |
| Metoclopramide, Ondansetron | 58 |
| Acupressure Point P6 Stimulator | 56 |
Patients are asked their anti-emetic treatment satisfaction (0 = Not Satisfied, 10 = Extremely Satisfied). Data are expressed as number of parturients who gave a score of 8 or higher. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 49 |
| Metoclopramide, Ondansetron | 58 |
| Acupressure Point P6 Stimulator | 55 |
The investigators will perform objective assessments of whether or not the patients have vomited during the procedure. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 27 |
| Metoclopramide, Ondansetron | 10 |
| Acupressure Point P6 Stimulator | 8 |
The investigators will perform objective assessments of whether or not the patients have vomited during stage I. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 20 |
| Metoclopramide, Ondansetron | 5 |
| Acupressure Point P6 Stimulator | 4 |
The investigators will perform objective assessments of whether or not the patients have vomited during stage II. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 10 |
| Metoclopramide, Ondansetron | 1 |
| Acupressure Point P6 Stimulator | 3 |
The investigators will perform objective assessments of whether or not the patients have vomited during stage III. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 9 |
| Metoclopramide, Ondansetron | 4 |
| Acupressure Point P6 Stimulator | 6 |
The investigators will perform objective assessments of whether or not the patients have vomited during stage IV. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 0 |
| Metoclopramide, Ondansetron | 2 |
| Acupressure Point P6 Stimulator | 0 |
Anesthesia start time determined from anesthesia portion of the medical record. Time at which discharge order was placed will serve as time of discharge. (NCT01592708)
Timeframe: Anesthesia start time to placement of hospital discharge order - average 26 - 28 hours
| Intervention | hours (Median) |
|---|---|
| Intervention Cohort | 26.4 |
| Comparison Cohort | 28.2 |
To be assessed based on patient diary completed daily for 1 week following discharge to home from the hospital (NCT01592708)
Timeframe: 1 week from discharge from hospital
| Intervention | percentage of subjects with PDN (Number) |
|---|---|
| Intervention Cohort | 72 |
| Comparison Cohort | 60 |
(NCT01592708)
Timeframe: 1 week post discharge
| Intervention | percentage of subjects with PDV (Number) |
|---|---|
| Intervention Cohort | 22 |
| Comparison Cohort | 29 |
End of surgery time determined by anesthesia portion of the medical record. PONV to be assessed by review of surgeons' and nurses' notes in the medical record as well as through review of patient diaries. Vomiting constitutes a safety issue and, as such, associated adverse events will be noted. (NCT01592708)
Timeframe: End of surgery to discharge from hospital
| Intervention | percentage of subjects with PON (Number) |
|---|---|
| Intervention Cohort | 24 |
| Comparison Cohort | 70 |
(NCT01592708)
Timeframe: End of surgery to discharge from hospital
| Intervention | percentage of subjects with POV (Number) |
|---|---|
| Intervention Cohort | 11 |
| Comparison Cohort | 28 |
(NCT00941005)
Timeframe: 24 hours
| Intervention | incidence of emetic events (Mean) |
|---|---|
| Electroacustimulation | 0 |
| Control | 0 |
Phone survey of post-op pain medication usage was administered on postoperative day 1. (NCT00941005)
Timeframe: 24 hours post-op
| Intervention | Participants (Count of Participants) |
|---|---|
| Electroacustimulation | NA |
| Control | NA |
(NCT00941005)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Electroacustimulation | NA |
| Control | NA |
Phone survey of nausea/vomiting symptoms was administered on postoperative day 1. The survey consists of 8 questions, including: 1) a query about whether or not participant has experienced nausea since returning home; 2) rate nausea severity on a scale of 1-10 (where 10 is the most severe); 3) a query about satisfaction of nausea control; 4) a question asking if they would use the same post-op nausea treatment again; 5) a query about what activities the participant has been unable to do since surgery; 6) whether or not the participant has taken prescription medicine for treatment of nausea since returning home; 7) whether or not participant has taken prescription medicine for treatment of pain since returning home; and 8) if yes for 6-7, which medications. (NCT00941005)
Timeframe: 24 hours post-op
| Intervention | score on a scale (Mean) |
|---|---|
| Electroacustimulation | NA |
| Control | NA |
(NCT00941005)
Timeframe: 24 hours
| Intervention | minutes (Mean) |
|---|---|
| Electroacustimulation | NA |
| Control | NA |
Nausea is scored on a scale of 1-10 where 1 is least nauseated and 10 is severely nauseated. Nausea scores will be collected 30, 60, and 120 minutes after surgery. (NCT00941005)
Timeframe: 24 hours
| Intervention | participants (Number) | ||
|---|---|---|---|
| 30 min post-op | 60 min post-op | 120 min post-op | |
| Control | NA | NA | NA |
| Electroacustimulation | NA | NA | NA |
Participants will evaluate their postoperative pain score on a scale of 1-10 where 1 is the least pain and 10 is the most severe pain. Pain scores will be evaluated at 30, 60, and 120 minutes postop. (NCT00941005)
Timeframe: 24 hours
| Intervention | score on a scale (Mean) | ||
|---|---|---|---|
| 30 min post-op | 60 min post-op | 120 min post-op | |
| Control | NA | NA | NA |
| Electroacustimulation | NA | NA | NA |
Length of stay in ICU will be recorded and correlated with standard laboratory values and tramadol and metabolites concentration. (NCT04004481)
Timeframe: Up to 6 months
| Intervention | days (Median) |
|---|---|
| Low Plasma Cholinesterase Activity | 1.5 |
| Normal Plasma Cholinesterase Activity | 1 |
Nausea and/or vomiting during treatment with tramadol in ICU will be recorded. (NCT04004481)
Timeframe: Nausea and vomiting was assessed during first 30 minutes after tramadol administration
| Intervention | Participants (Count of Participants) |
|---|---|
| PONV in EM | 12 |
| PONV in IM | 4 |
Respiratory depression after tramadol is considered to be any drop in saturation below 90% or drop in respiratory rate below 10/min. (NCT04004481)
Timeframe: Respiratory depression was observed up to 30 minutes after tramadol administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Number of Patients With Postoperative Respiratory Depression | 0 |
In unconsciousness patents, the analgesic effect of tramadol will be tested by Critical Care Pain Observation Tool (CPOT). Highest score on a scale is 8 (worst pain) and lowest is 0 (no pain). The CPOT value of less than 2 will be considered as adequate analgesia. (NCT04004481)
Timeframe: Pain was assessed before and 30 minutes after each tramadol dose, up to 24 hours.
| Intervention | score on a scale (Median) | ||||
|---|---|---|---|---|---|
| 1st assessment point | 2nd assessment point | 3rd assessment point | 4th assessment point | 5th assessment point | |
| Median CPOT Score After Tramadol Administration | 0 | 0 | 0 | 0 | 0 |
| Median CPOT Score Before Tramadol Administration | 0 | 0 | 0 | 0 | 0 |
The analgesic effect of tramadol will be measured in awake patients with Numeric Rating Scale (NRS, 0 - without pain, 10 - the worst pain) 30 minutes before and 30 minutes after tramadol administration. The NRS value of 3 or less will be considered as adequate analgesia. In case of inadequate analgesia morphine will be used according to the local protocol. (NCT04004481)
Timeframe: Before each dose of tramadol and 30 minutes after tramadol dose, up to 24 hours
| Intervention | score on scale (Median) | ||||
|---|---|---|---|---|---|
| 1st pain assessment | 2nd pain assessment | 3rd pain assessment | 4th pain assessment | 5th pain assessment | |
| Median NRS Score After Tramadol Administration | 5 | 3 | 2 | 2 | 2 |
| Median NRS Score Before Tramadol Administration | 7 | 5 | 3.5 | 4 | 3 |
The plasma concentrations of tramadol, O-desmethyltramadol (ODT) and N-desmethyltramadol (NDT) will be measured 1, 2 and 4 hours after the first dose of 100 mg tramadol i.v., and immediately before the 2nd, 3rd and 5th dose. There will therefore be 6 measurements of tramadol and its metabolites. (NCT04004481)
Timeframe: 1, 2, and 4 hours after first dose and immediately before 2nd, 3rd, and 5th dose, up to 24 hours
| Intervention | mcg/L (Median) | |||||
|---|---|---|---|---|---|---|
| 1st measurement | 2nd measurement | 3rd measurement | 4th measurement | 5th measurement | 6th measurement | |
| NDT Concentration in Extensive Metabolizers (EM) | 4.76 | 5.2 | 8.5 | 9.7 | 19 | 34.4 |
| NDT Concentration in Intermediate Metabolizers (IM) | 4.5 | 6.1 | 9.1 | 9.6 | 20.2 | 34.9 |
| NDT Concentration in Poor Metabolizers (PM) | 11.7 | 15.3 | 28.9 | 31.2 | 71.4 | 180.5 |
| NDT Concentration in Ultrafast Metabolizers (UM) | 3.5 | 3.5 | 3.5 | 3.5 | 9.8 | 18.1 |
| ODT Concentration in Extensive Metabolizers (EM) | 40.9 | 46.7 | 46.4 | 38.1 | 75.1 | 97.4 |
| ODT Concentration in Intermediate Metabolizers (IM) | 17.1 | 15.7 | 20.2 | 19.1 | 36.6 | 51.7 |
| ODT Concentration in Poor Metabolizers (PM) | 7.05 | 7.6 | 10 | 12.4 | 19.1 | 29.7 |
| ODT Concentration in Ultrafast Metabolizers (UM) | 13.8 | 19.4 | 26 | 25.1 | 58.2 | 61.9 |
| Tramadol Concentration | 372.7 | 270.6 | 232.1 | 181.2 | 300.1 | 408.5 |
This measure is observed by care team. Reported as vomiting, yes or no. (NCT02872935)
Timeframe: From the administration of the spinal anesthesia to delivery of baby; Total time 90minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo: Normal Saline | 4 |
| Glycopyrrolate Group | 2 |
Did the subject report nausea? The subject will respond with yes or no. (NCT02872935)
Timeframe: From the administration of the spinal anesthesia to delivery of baby - Total time 90minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo: Normal Saline | 8 |
| Glycopyrrolate Group | 7 |
43 reviews available for ondansetron and Emesis, Postoperative
| Article | Year |
|---|---|
[Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].
Topics: Adult; Analgesics, Non-Narcotic; Antiemetics; Child; Consensus; Female; Humans; Ondansetron; Postope | 2022 |
The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.
Topics: Antiemetics; Cytochrome P-450 CYP2D6; Humans; Ondansetron; Pharmacogenetics; Postoperative Nausea an | 2023 |
Evaluating the effect of anti-nausea drugs in IDO enzyme gene expression and preventing postoperative vomiting and nausea in patients undergoing general anesthesia: A Meta-analysis.
Topics: Anesthesia, General; Antiemetics; Gene Expression; Humans; Isoquinolines; Ondansetron; Palonosetron; | 2022 |
Efficacy of pharmacological therapies for preventing post-dural puncture headaches in obstetric patients: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Bayes Theorem; Cesarean Section; Female; Humans; Network Meta-Analysis; Ondansetron; Post-Dural Punc | 2023 |
The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis.
Topics: Antiemetics; Aprepitant; Dexamethasone; Humans; Morpholines; Ondansetron; Postoperative Nausea and V | 2023 |
Comparison of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials.
Topics: Adult; Benzimidazoles; Humans; Laparoscopy; Middle Aged; Ondansetron; Postoperative Nausea and Vomit | 2019 |
Postoperative Nausea and Vomiting After Craniotomy: An Evidence-based Review of General Considerations, Risk Factors, and Management.
Topics: Adult; Anesthesia, General; Antiemetics; Craniotomy; Humans; Ondansetron; Postoperative Nausea and V | 2021 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Techniques for preventing hypotension during spinal anaesthesia for caesarean section.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Colloids; Crystalloid So | 2020 |
Comparison of ondansetron and tropisetron in preventing postoperative nausea and vomiting: A meta-analysis of randomized controlled trials.
Topics: Antiemetics; Double-Blind Method; Humans; Ondansetron; Postoperative Nausea and Vomiting; Randomized | 2021 |
Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery.
Topics: Anesthesia, General; Antiemetics; Humans; Isoquinolines; Laparoscopy; Ondansetron; Palonosetron; Pos | 2018 |
Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2017 |
Pharmacogenetics of Postoperative Nausea and Vomiting.
Topics: Antiemetics; Cytochrome P-450 CYP2D6; Humans; Ondansetron; Pharmacogenetics; Polymorphism, Genetic; | 2019 |
Drugs for preventing post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: Network meta-analysis of randomized clinical trials and trial sequential analysis.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; Humans; Networ | 2019 |
Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts.
Topics: Antiemetics; Antineoplastic Agents; Haloperidol; Humans; Nausea; Ondansetron; Palliative Care; Posto | 2013 |
Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Benzimidazoles; Female; Humans; Male; Middle Aged; Odds | 2013 |
Ondansetron: a review of pharmacokinetics and clinical experience in postoperative nausea and vomiting.
Topics: Antiemetics; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response | 2014 |
Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: a meta-analysis of randomized controlled trials.
Topics: Antiemetics; Child; Dexamethasone; Drug Therapy, Combination; Humans; Ondansetron; Postoperative Nau | 2014 |
The effect of ondansetron on the efficacy of postoperative tramadol: a systematic review and meta-analysis of a drug interaction.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Drug Interactions; Humans; Ondansetr | 2015 |
Web Exclusives. The consult guys - twisted after surgery: what caused torsades?
Topics: Antiemetics; Craniotomy; Electrocardiography; Female; Humans; Hypotension; Intracranial Aneurysm; Mi | 2015 |
Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting; Randomized Cont | 2015 |
Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
Topics: Antiemetics; Aprepitant; Dose-Response Relationship, Drug; Humans; Morpholines; Neurokinin-1 Recepto | 2015 |
Dexamethasone versus ondansetron in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials.
Topics: Antiemetics; Dexamethasone; Humans; Laparoscopy; Ondansetron; Postoperative Nausea and Vomiting; Ran | 2015 |
Efficacy of palonosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
Topics: Antiemetics; Humans; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Qu | 2015 |
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Topics: Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Granisetron; Humans; Isoquinolines; Ondanse | 2016 |
Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.
Topics: Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination | 2016 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
Topics: Antiemetics; Cytochrome P-450 CYP2D6; Drug-Related Side Effects and Adverse Reactions; Genetic Testi | 2017 |
The effects of stimulation of acupressure point p6 on postoperative nausea and vomiting: a review of literature.
Topics: 2-Propanol; Acupressure; Acupuncture Points; Adult; Antiemetics; Child; Cholinergic Antagonists; Cos | 2008 |
The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative vomiting following craniotomy: two studies in children and young adults.
Topics: Antiemetics; Child; Child, Preschool; Clinical Nursing Research; Craniotomy; Drug Monitoring; Eviden | 2009 |
[Ondansetron: a meta-analysis on its efficacy to prevent postoperative nausea and vomiting after craniotomy in adults and children].
Topics: Adult; Age Factors; Anesthetics, Intravenous; Antiemetics; Brain Neoplasms; Child; Craniotomy; Dose- | 2010 |
Prevention of nausea and vomiting during termination of pregnancy.
Topics: Abortion, Therapeutic; Antiemetics; Benzimidazoles; Dexamethasone; Dilatation and Curettage; Droperi | 2010 |
Efficacy of ondansetron vs. metoclopramide in prophylaxis of postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Drug Administration Schedule; Female; Humans; Incidence; | 2012 |
Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Granisetron; Headache Disorders; Humans; Ondansetron; Po | 2013 |
The rise and withdrawal of droperidol.
Topics: Antiemetics; Dose-Response Relationship, Drug; Droperidol; Female; Forecasting; Humans; Male; Ondans | 2002 |
Postoperative nausea and vomiting: a review of current literature.
Topics: Antiemetics; Humans; Ondansetron; Postoperative Nausea and Vomiting; Premedication; Risk Assessment; | 2003 |
The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
Topics: Adult; Aged; Ambulatory Surgical Procedures; Antiemetics; Dimenhydrinate; Droperidol; Female; Humans | 2005 |
The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
Topics: Adult; Algorithms; Antiemetics; Child; Dexamethasone; Drug Administration Schedule; Drug Monitoring; | 2006 |
The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
Topics: Antiemetics; Craniotomy; Data Interpretation, Statistical; Granisetron; Humans; Indoles; Ondansetron | 2007 |
Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesia; Analgesics, Non-Narcotic; Analgesics, Opio | 1998 |
Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis.
Topics: Adult; Antiemetics; Child; Droperidol; Female; Humans; Male; Metoclopramide; Ondansetron; Postoperat | 1999 |
Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting.
Topics: Adult; Antiemetics; Humans; Ondansetron; Postoperative Nausea and Vomiting; Randomized Controlled Tr | 1999 |
Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness.
Topics: Antiemetics; Humans; MEDLINE; Motion Sickness; Ondansetron; Postoperative Nausea and Vomiting | 1999 |
Systematic review of ondansetron for the prevention and treatment of postoperative nausea and vomiting in adults.
Topics: Adult; Antiemetics; Double-Blind Method; Humans; Ondansetron; Patient Satisfaction; Postoperative Ca | 1999 |
Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review.
Topics: Antiemetics; Dexamethasone; Droperidol; Humans; Metoclopramide; Morphine; Ondansetron; Pain, Postope | 2001 |
293 trials available for ondansetron and Emesis, Postoperative
| Article | Year |
|---|---|
The incidence of torsades de pointes with peri-operative low-dose ondansetron administration.
Topics: Antiemetics; DNA-Binding Proteins; Humans; Incidence; Ondansetron; Postoperative Nausea and Vomiting | 2022 |
The Effect of Ondansetron on the Analgesic Efficacy of Tramadol in Patients Undergoing Laparoscopic Cholecystectomy.
Topics: Adult; Analgesics; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Humans; Middle A | 2022 |
Intravenous ondansetron reduced nausea but not pruritus following intrathecal morphine in children: Interim results of a randomized, double-blinded, placebo-control trial.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Child; Double-Blind Method; Female; Humans; Injections, | 2022 |
A randomized controlled trial comparing incidences of postoperative nausea and vomiting after laparoscopic cholecystectomy for preoperative intravenous fluid loading, ondansetron, and control groups in a regional hospital setting in a developing country.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Control Groups; Developing Countries; Doubl | 2022 |
Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Hospitals, Teachi | 2022 |
Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Hospitals, Teachi | 2022 |
Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Hospitals, Teachi | 2022 |
Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Hospitals, Teachi | 2022 |
Effect of Dexmedetomidine, Dexamethasone, and Ondansetron on Postoperative Nausea and Vomiting in Children Undergoing Dental Rehabilitation: A Randomized Controlled Trial.
Topics: Adult; Antiemetics; Child; Dexamethasone; Dexmedetomidine; Double-Blind Method; Granisetron; Humans; | 2023 |
Effects of ondansetron, metoclopramide and granisetron on perioperative nausea and vomiting in patients undergone bariatric surgery: a randomized clinical trial.
Topics: Antiemetics; Bariatric Surgery; Double-Blind Method; Granisetron; Humans; Metoclopramide; Ondansetro | 2023 |
Acupuncture combined with ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic gynaecological surgery: A randomised controlled trial.
Topics: Acupuncture Therapy; Antiemetics; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Onda | 2023 |
Olanzapine as an add-on, pre-operative anti-emetic drug for postoperative nausea or vomiting: a randomised controlled trial.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Double-Blind Method; Humans; Olanzapine; Ondanset | 2023 |
Preoperative versus intraoperative antiemetic strategies in patients undergoing laparoscopic cholecystectomy: A randomised double-blind study.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Humans; Ondansetron; Postoperative | 2023 |
Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial.
Topics: Adult; Anesthesia, Spinal; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combinatio | 2019 |
The effects of ondansetron versus dexamethasone on electrocardiographic markers of ventricular repolarization in children undergoing cochlear implant.
Topics: Antiemetics; Child; Cochlear Implantation; Cochlear Implants; Deafness; Dexamethasone; Double-Blind | 2020 |
Comparison of the Effects of Dexamethasone and Ondansetron on the Reduction of Postoperative Nausea and Vomiting following Cesarean Section under Spinal Anesthesia.
Topics: Anesthesia, Spinal; Cesarean Section; Dexamethasone; Female; Humans; Ondansetron; Postoperative Naus | 2021 |
Intravenous dextrose versus ondansetron for prevention of postoperative vomiting in children: a randomized non-inferiority trial.
Topics: Adult; Antiemetics; Child; Child, Preschool; Double-Blind Method; Glucose; Humans; Ondansetron; Post | 2020 |
A Single Prophylactic Dose of Ondansetron Given at Cessation of Postoperative Propofol Sedation Decreases Postoperative Nausea and Vomiting in Cardiac Surgery Patients: A Randomized Controlled Trial.
Topics: Aged; Antiemetics; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double | 2020 |
A Single Prophylactic Dose of Ondansetron Given at Cessation of Postoperative Propofol Sedation Decreases Postoperative Nausea and Vomiting in Cardiac Surgery Patients: A Randomized Controlled Trial.
Topics: Aged; Antiemetics; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double | 2020 |
A Single Prophylactic Dose of Ondansetron Given at Cessation of Postoperative Propofol Sedation Decreases Postoperative Nausea and Vomiting in Cardiac Surgery Patients: A Randomized Controlled Trial.
Topics: Aged; Antiemetics; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double | 2020 |
A Single Prophylactic Dose of Ondansetron Given at Cessation of Postoperative Propofol Sedation Decreases Postoperative Nausea and Vomiting in Cardiac Surgery Patients: A Randomized Controlled Trial.
Topics: Aged; Antiemetics; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double | 2020 |
The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial.
Topics: Aged; Antiemetics; Arthroscopy; Benzimidazoles; Female; Humans; Infusions, Intravenous; Male; Middle | 2020 |
Midazolam versus dexamethasone-ondansetron in preventing post-operative nausea-vomiting in patients undergoing laparoscopic surgeries.
Topics: Antiemetics; Dexamethasone; Double-Blind Method; Humans; Laparoscopy; Midazolam; Ondansetron; Postop | 2021 |
The intraperitoneal ondansetron for postoperative pain management following laparoscopic cholecystectomy: A proof-of-concept, double-blind, placebo-controlled trial.
Topics: Acetaminophen; Adjuvants, Pharmaceutic; Adult; Analgesics; Antiemetics; Cholecystectomy, Laparoscopi | 2021 |
Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial.
Topics: Acetaminophen; Antiemetics; Diphenhydramine; Double-Blind Method; Gastrectomy; Humans; Laparoscopy; | 2021 |
A randomised controlled trial of placebo, droperidol or ondansetron to prevent nausea and vomiting after tonsillectomy in children receiving dexamethasone.
Topics: Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Droperidol; Female; Humans | 2017 |
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Analgesics, Opioid; Antiemetics; Breast Neoplasms; Dexamethasone; Doubl | 2018 |
Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study.
Topics: Adolescent; Anesthesia, General; Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind M | 2017 |
The Comparative Study of Ondansetron and Metoclopramide Effects in Reducing Nausea and Vomiting After Laparoscopic Cholecystectomy.
Topics: Adult; Analysis of Variance; Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Double | 2017 |
The effect of ondansetron on analgesic efficacy of acetaminophen after hysterectomy: A randomized double blinded placebo controlled trial.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Double-Blind Method | 2017 |
Incidence of akathisia after postoperative nausea and vomiting prophylaxis with droperidol and ondansetron in outpatient surgery: A multicentre controlled randomised trial.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Surgical Procedures; Antiemetics; Double-Blind Method; Dr | 2018 |
Comparison of Ondansetron versus Clonidine efficacy for prevention of postoperative pain, nausea and vomiting after orthognathic surgeries: A triple blind randomized controlled trial.
Topics: Adolescent; Adult; Analgesics; Antiemetics; Clonidine; Double-Blind Method; Female; Humans; Male; On | 2018 |
Randomized trial of acupuncture with antiemetics for reducing postoperative nausea in children.
Topics: Acupuncture Points; Acupuncture Therapy; Adenoidectomy; Antiemetics; Child; Child, Preschool; Combin | 2019 |
Use of palonosetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in women 60 years of age or older undergoing laparoscopic cholecystectomy: A randomised double-blind study.
Topics: Aged; Aged, 80 and over; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Hu | 2019 |
Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients.
Topics: Administration, Intravenous; Adult; Anesthesia, General; Antiemetics; Bangladesh; Cholecystectomy, L | 2019 |
Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride.
Topics: Adult; Antiemetics; Female; Gastric Balloon; Humans; Male; Middle Aged; Obesity, Morbid; Ondansetron | 2019 |
Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial.
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Chewing Gum; Double-Blind Method; Feasibility S | 2019 |
Effect of ondansetron in preventing postoperative nausea and vomiting under different conditions of general anesthesia: a preliminary, randomized, controlled study.
Topics: Adult; Anesthesia, General; Humans; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Ser | 2013 |
The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial.
Topics: Adult; Analgesics, Opioid; Antiemetics; Brazil; Dexamethasone; Double-Blind Method; Drug Therapy, Co | 2013 |
[Effect of multimodal-antiemetic therapy on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy: a randomized controlled study].
Topics: Adult; Antiemetics; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Middle Aged; Ondan | 2013 |
P6 acupoint stimulation for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: study protocol for a randomized controlled trial.
Topics: Acupuncture Points; Acupuncture Therapy; Administration, Intravenous; Antiemetics; China; Clinical P | 2013 |
Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery.
Topics: Adult; Antiemetics; Aprepitant; Bariatric Surgery; Double-Blind Method; Drug Therapy, Combination; F | 2014 |
Ondansetron combined with ST36 (Zusanli) acupuncture point injection for postoperative vomiting.
Topics: Acupuncture Points; Adolescent; Adult; Antiemetics; Female; Humans; Male; Middle Aged; Ondansetron; | 2014 |
Comparison of efficacy of ondansetron and dexamethasone combination and ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Combinations; Female; H | 2014 |
Prevention versus treatment of intrathecal morphine-induced pruritus with ondansetron.
Topics: Adult; Analgesics, Opioid; Anesthesia, Spinal; Antipruritics; Cesarean Section; Double-Blind Method; | 2014 |
The efficacy of P6 acupressure with sea-band in reducing postoperative nausea and vomiting in patients undergoing craniotomy: a randomized, double-blinded, placebo-controlled study.
Topics: Acupressure; Adult; Aged; Anesthesia, General; Antiemetics; Craniotomy; Double-Blind Method; Female; | 2015 |
The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: a prospective, randomized, double-blinded study.
Topics: Adult; Aged; Aged, 80 and over; Demography; Double-Blind Method; Female; Humans; Injections, Intrave | 2014 |
A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Craniotomy; Double-Blind Method; Female; Humans; Male; Mid | 2014 |
Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study.
Topics: Adult; Antiemetics; Female; Humans; Isoquinolines; Male; Middle Aged; Ondansetron; Palonosetron; Pos | 2014 |
Analgesic interaction between ondansetron and acetaminophen after tonsillectomy in children: the Paratron randomized, controlled trial.
Topics: Acetaminophen; Adenoidectomy; Adjuvants, Anesthesia; Analgesics, Non-Narcotic; Analgesics, Opioid; A | 2015 |
Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study.
Topics: Adolescent; Adult; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Droperidol; E | 2015 |
Dexamethasone versus a combination of dexamethasone and ondansetron as prophylactic antiemetic in patients receiving intrathecal morphine for caesarean section.
Topics: Adult; Analgesia, Obstetrical; Analgesics, Opioid; Antiemetics; Bupivacaine; Cesarean Section; Dexam | 2014 |
Effects of prophylactic ramosetron and ondansetron on corrected QT interval during general anesthesia.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dose-R | 2014 |
Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron.
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Humans; Male; Mi | 2015 |
Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study.
Topics: Adult; Analgesia, Epidural; Analgesia, Patient-Controlled; Analgesics, Opioid; Androstanols; Antieme | 2015 |
Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study.
Topics: Adult; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Hypot | 2015 |
Effects of droperidol and ondansetron on dispersion of ventricular repolarization: A randomized double-blind clinical study in anesthetized adult patients.
Topics: Adult; Anesthesia, General; Anesthesia, Intravenous; Antiemetics; Double-Blind Method; Droperidol; E | 2015 |
Postdischarge Nausea and Vomiting Remains Frequent After Le Fort I Osteotomy Despite Implementation of a Multimodal Antiemetic Protocol Effective in Reducing Postoperative Nausea and Vomiting.
Topics: Adolescent; Adult; Age Factors; Anesthesia Recovery Period; Antiemetics; Cohort Studies; Diphenhydra | 2015 |
Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Morph | 2015 |
Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Morph | 2015 |
Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Morph | 2015 |
Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Morph | 2015 |
Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Belgium; Double-Blind Method; Drug Administra | 2016 |
Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Belgium; Double-Blind Method; Drug Administra | 2016 |
Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Belgium; Double-Blind Method; Drug Administra | 2016 |
Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Belgium; Double-Blind Method; Drug Administra | 2016 |
The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study.
Topics: Administration, Intravenous; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Fem | 2015 |
[Influence of dexamethasone on the incidence of postoperative nausea and vomiting in breast cancer patients with neoadjuvant chemotherapy].
Topics: Adolescent; Adult; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Antiemeti | 2015 |
Betahistine reduces postoperative nausea and vomiting after laparoscopic gynecological surgery.
Topics: Adult; Aged; Antiemetics; Betahistine; Double-Blind Method; Drug Administration Schedule; Drug Thera | 2016 |
Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Analgesia, Patient-Controlled; Analgesics, | 2016 |
Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind place
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Dexamethasone; Double-Blind Method; Female; Ga | 2016 |
Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.
Topics: Antiemetics; Benzimidazoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Biologi | 2016 |
Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients.
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Hu | 2016 |
The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study.
Topics: Adult; Antiemetics; Blood Glucose; Dexamethasone; Diabetes Mellitus, Type 2; Dose-Response Relations | 2016 |
Comparison of dexamethasone or intravenous fluids or combination of both on postoperative nausea, vomiting and pain in pediatric strabismus surgery.
Topics: Administration, Intravenous; Antiemetics; Child; Dexamethasone; Double-Blind Method; Drug Therapy, C | 2016 |
Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial.
Topics: Aged; Anesthesia, Spinal; Antiemetics; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit | 2017 |
Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Ele | 2017 |
Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial.
Topics: Adult; Aged; Antiemetics; Chewing Gum; Female; Humans; Middle Aged; Ondansetron; Pilot Projects; Pos | 2017 |
Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients.
Topics: Adult; Aged; Anesthesia, General; Dexamethasone; Dimenhydrinate; Double-Blind Method; Drug Therapy, | 2017 |
Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis.
Topics: Acute Disease; Administration, Oral; Adult; Antiemetics; Appendectomy; Appendicitis; Dexamethasone; | 2017 |
Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Dose-Response Relationship, Drug; | 2008 |
Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.
Topics: Administration, Oral; Adult; Ambulatory Surgical Procedures; Antiemetics; Dexamethasone; Double-Blin | 2008 |
Pediatric oncology sedation trial (POST): A double-blind randomized study.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Biopsy, Needle; Bone Marrow Examination; Child; Chil | 2008 |
Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Benzimidazoles; Double-Blind Method; Female; | 2008 |
Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy.
Topics: Anesthetics, Intravenous; Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind Method; | 2008 |
Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy.
Topics: Adult; Anesthesia, Intravenous; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Fem | 2008 |
Postoperative intravenous patient-controlled analgesia in thyroid surgery: comparison of fentanyl and ondansetron regimens with and without the nonsteriodal anti-inflammatory drug ketorolac.
Topics: Adult; Analgesia, Patient-Controlled; Anti-Inflammatory Agents, Non-Steroidal; Dizziness; Female; Fe | 2008 |
Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dexamethasone; Double | 2009 |
Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dexamethasone; Double | 2009 |
Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dexamethasone; Double | 2009 |
Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dexamethasone; Double | 2009 |
Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery.
Topics: Abdomen; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Double-Blind Method; | 2008 |
Retrospective outcomes evaluation of 100 parenteral moderate and deep sedations conducted in a general practice dental residency.
Topics: Adolescent; Adult; Anesthesia, Dental; Anesthetics, Dissociative; Anesthetics, Intravenous; Antiemet | 2008 |
Ondansetron has similar clinical efficacy against both nausea and vomiting.
Topics: Adult; Anesthesia, General; Antiemetics; Female; Humans; Male; Middle Aged; Ondansetron; Postoperati | 2009 |
Haloperidol versus haloperidol plus ondansetron for the prophylaxis of postoperative nausea and vomiting after ophthalmologic surgery.
Topics: Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Ondansetro | 2009 |
[Effect of ondansetron combined with dexamethasone on postoperative nausea & vomiting and pain of patients with laparoscopic hysterectomy].
Topics: Adult; Analgesia, Patient-Controlled; Analysis of Variance; Anesthesia, General; Antiemetics; Data I | 2009 |
Haloperidol plus ondansetron prevents postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Therapy, Combination; F | 2009 |
A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Topics: Administration, Cutaneous; Adult; Ambulatory Surgical Procedures; Antiemetics; Cholecystectomy, Lapa | 2009 |
Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study.
Topics: Administration, Oral; Adult; Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Double | 2009 |
Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.
Topics: Administration, Cutaneous; Adult; Ambulatory Surgical Procedures; Antiemetics; Cholinergic Antagonis | 2009 |
Optimization of anesthesia antiemetic measures versus combination therapy using dexamethasone or ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adult; Analgesics, Opioid; Anesthesia, Intravenous; Anesthetics, Intravenous; Antiemetics; Cholecyst | 2010 |
A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Topics: Adult; Antiemetics; Craniotomy; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; | 2009 |
Droperidol has comparable clinical efficacy against both nausea and vomiting.
Topics: Adult; Anesthesia, Inhalation; Antiemetics; Dexamethasone; Droperidol; Female; Humans; Male; Middle | 2009 |
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Gynecologic Surgical Procedur | 2009 |
Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Benzimidazoles; Chi-Square Distribution; Cholecystec | 2010 |
Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Clinical Nursing Research; Female; Hista | 2009 |
Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Clinical Nursing Research; Female; Hista | 2009 |
Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Clinical Nursing Research; Female; Hista | 2009 |
Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Clinical Nursing Research; Female; Hista | 2009 |
Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Cesarean Section; Double-Bli | 2010 |
Combination therapy in the prevention of PONV after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone.
Topics: Antiemetics; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; | 2009 |
Incidence and circumstances of cervical hematoma complicating thyroidectomy and its relationship to postoperative vomiting.
Topics: Adult; Aged; Chi-Square Distribution; Dexamethasone; Dose-Response Relationship, Drug; Drug Administ | 2010 |
Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery.
Topics: Adult; Aged; Bridged Bicyclo Compounds, Heterocyclic; Female; Gynecologic Surgical Procedures; Human | 2010 |
Ondansetron is as effective as diphenhydramine for treatment of morphine-induced pruritus after cesarean delivery.
Topics: Adult; Cesarean Section; Diphenhydramine; Double-Blind Method; Female; Histamine H1 Antagonists; Hum | 2010 |
Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement.
Topics: Aged; Aged, 80 and over; Antiemetics; Arthroplasty, Replacement, Knee; Benzimidazoles; Female; Human | 2010 |
Dexamethasone with either granisetron or ondansetron for postoperative nausea and vomiting in laparoscopic surgery.
Topics: Adult; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetr | 2010 |
Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Area Under Curve; Cytochrome P-450 C | 2010 |
Anti-emetic effect of midazolam added to morphine patient-controlled analgesia after total abdominal hysterectomy.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Female; Humans; Hysterectomy; | 2010 |
Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients.
Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Antiemetics; Cholecystectomy, Laparosc | 2010 |
A comparative study of the antiemetic efficacy of dexamethasone, ondansetron, and metoclopramide in patients undergoing gynecological surgery.
Topics: Adult; Anesthesia; Antiemetics; Dexamethasone; Female; Gynecologic Surgical Procedures; Humans; Hyst | 2010 |
Acupressure using ondansetron versus metoclopramide on reduction of postoperative nausea and vomiting after strabismus surgery.
Topics: Acupressure; Adolescent; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 2010 |
Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery.
Topics: Aged; Analgesia, Patient-Controlled; Anesthesia; Antiemetics; Benzimidazoles; Cardiac Surgical Proce | 2010 |
Comparison of ondansetron and metoclopramide antiemetic prophylaxis in maxillofacial surgery patients.
Topics: Adult; Anesthesia, Inhalation; Antiemetics; Follow-Up Studies; Humans; Injections, Intravenous; Intu | 2011 |
The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children.
Topics: Ambulatory Surgical Procedures; Antiemetics; Child, Preschool; Droperidol; Electrocardiography; Fema | 2010 |
Multimodal prevention of pain, nausea and vomiting after breast cancer surgery.
Topics: Acetaminophen; Aged; Amines; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Anesthesia, Intra | 2010 |
Multimodal prevention of pain, nausea and vomiting after breast cancer surgery.
Topics: Acetaminophen; Aged; Amines; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Anesthesia, Intra | 2010 |
Multimodal prevention of pain, nausea and vomiting after breast cancer surgery.
Topics: Acetaminophen; Aged; Amines; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Anesthesia, Intra | 2010 |
Multimodal prevention of pain, nausea and vomiting after breast cancer surgery.
Topics: Acetaminophen; Aged; Amines; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Anesthesia, Intra | 2010 |
Biphasic dosing regimen of meclizine for prevention of postoperative nausea and vomiting in a high-risk population.
Topics: Adult; Antiemetics; Drug Therapy, Combination; Female; Humans; Male; Meclizine; Ondansetron; Postope | 2010 |
A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy.
Topics: Adult; Aprepitant; Craniotomy; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female | 2011 |
A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adult; Anesthesia Recovery Period; Antiemetics; Conscious Sedation; Droperidol; Female; Gynecologic | 2011 |
Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Dose-Response Relatio | 2011 |
Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery.
Topics: Adult; Antiemetics; Cost-Benefit Analysis; Dexamethasone; Dose-Response Relationship, Drug; Female; | 2011 |
The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia.
Topics: Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Dexamethasone; Drug The | 2011 |
Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Ag | 2011 |
A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery.
Topics: Adult; Anesthesia; Antiemetics; Demography; Double-Blind Method; Female; Gynecologic Surgical Proced | 2011 |
Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron.
Topics: Acupuncture Therapy; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Secti | 2011 |
A randomised controlled trial of two analgesic techniques for paediatric tonsillectomy*.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anesthetics, Inhalation; Anesthetics, Intravenous; An | 2011 |
[Preventive efficacy of ondansetron and granisetron for postoperative nausea and vomiting in high risk patients].
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Male; Middle | 2011 |
Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery.
Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Aprepitant; Double-Blind Method; Drug Therapy, C | 2012 |
Examination of the effectiveness of peppermint aromatherapy on nausea in women post C-section.
Topics: Administration, Inhalation; Adult; Antiemetics; Aromatherapy; Cesarean Section; Female; Holistic Hea | 2012 |
Dexamethasone has additive effect when combined with ondansetron and droperidol for treatment of established PONV.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Antiemetics; Dexamethasone; Droperidol; Dru | 2011 |
Comparison of palanosetron, granisetron and ondansetron as anti-emetics for prevention of postoperative nausea and vomiting in patients undergoing middle ear surgery.
Topics: Adult; Antiemetics; Ear, Middle; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Onda | 2011 |
Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Double-Blind Method; Female; | 2012 |
Comparison of dexamethasone with ondansetron or haloperidol for prevention of patient-controlled analgesia-related postoperative nausea and vomiting: a randomized clinical trial.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Dexamethasone; Drug Therapy, | 2012 |
Prophylactic isopropyl alcohol inhalation and intravenous ondansetron versus ondansetron alone in the prevention of postoperative nausea and vomiting in high-risk patients.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Aromatherapy; Drug Therapy, Combination; | 2011 |
Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting.
Topics: Acupressure; Adult; Antiemetics; Chi-Square Distribution; Combined Modality Therapy; Dexamethasone; | 2012 |
Dexamethasone versus ondansetron in combination with dexamethasone for the prophylaxis of postoperative vomiting in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial.
Topics: Ambulatory Surgical Procedures; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Child; Child, | 2012 |
[Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section].
Topics: Administration, Intravenous; Adult; Cesarean Section; Female; Humans; Middle Aged; Ondansetron; Post | 2012 |
Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
Topics: Antiemetics; Aprepitant; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Humans; Morp | 2012 |
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
Topics: Adult; Aged; Antiemetics; Aprepitant; Dexamethasone; Female; Hematologic Neoplasms; Hematopoietic St | 2013 |
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
Topics: Adult; Aged; Antiemetics; Aprepitant; Dexamethasone; Female; Hematologic Neoplasms; Hematopoietic St | 2013 |
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
Topics: Adult; Aged; Antiemetics; Aprepitant; Dexamethasone; Female; Hematologic Neoplasms; Hematopoietic St | 2013 |
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
Topics: Adult; Aged; Antiemetics; Aprepitant; Dexamethasone; Female; Hematologic Neoplasms; Hematopoietic St | 2013 |
Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy.
Topics: Adult; Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Female; Humans; Male; Ondansetron | 2010 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Bilateral superficial cervical plexus block reduces postoperative nausea and vomiting and early postoperative pain after thyroidectomy.
Topics: Adult; Amides; Analgesics; Analysis of Variance; Anesthetics, Local; Antiemetics; Autonomic Nerve Bl | 2012 |
Comparison of the efficacy of ramosetron and ondansetron in the prophylaxis of postoperative vomiting in children receiving fentanyl by patient-controlled analgesia after orthopedic surgery: a randomized controlled trial.
Topics: Adolescent; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Benzimidazoles; Child; C | 2013 |
Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Headache; Humans; In | 2002 |
The addition of antiemetics to the morphine solution in patient controlled analgesia syringes used by children after an appendicectomy does not reduce the incidence of postoperative nausea and vomiting.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, General; Antiemetics; Appendectomy; C | 2002 |
Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
Topics: Ambulatory Surgical Procedures; Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind Me | 2002 |
Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Double-Blind Method; Female | 2002 |
Comparative efficacy of acustimulation (ReliefBand) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting.
Topics: Acupressure; Acupuncture Points; Adult; Aged; Antiemetics; Double-Blind Method; Electric Stimulation | 2002 |
Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Dose-Response | 2002 |
Postoperative nausea and vomiting in children and adolescents undergoing radiofrequency catheter ablation: a randomized comparison of propofol- and isoflurane-based anesthetics.
Topics: Adolescent; Anesthetics; Catheter Ablation; Child; Droperidol; Female; Humans; Incidence; Isoflurane | 2002 |
Comparison of acustimulation and ondansetron for the treatment of established postoperative nausea and vomiting.
Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Humans; Laparoscopy; Ondansetron; Pati | 2002 |
A comparison of the effects of droperidol and the combination of droperidol and ondansetron on postoperative nausea and vomiting for patients undergoing laparoscopic cholecystectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Cholecystectomy, Lapar | 2002 |
Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
Topics: Aged; Ambulatory Surgical Procedures; Antiemetics; Female; Humans; Indoles; Male; Middle Aged; Ondan | 2003 |
Ondansetron disintegrating tablets of 8 mg twice a day for 3 days did not reduce the incidence of nausea or vomiting after laparoscopic surgery.
Topics: Administration, Oral; Adult; Antiemetics; Cholecystectomy; Double-Blind Method; Female; Fundoplicati | 2003 |
The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron.
Topics: Antiemetics; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Ondan | 2003 |
Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Nalbuphi | 2003 |
Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Nalbuphi | 2003 |
Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Nalbuphi | 2003 |
Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Nalbuphi | 2003 |
Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Female; Humans; Injections, Intravenous; | 2003 |
Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Female; Humans; Injections, Intravenous; | 2003 |
Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Female; Humans; Injections, Intravenous; | 2003 |
Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea.
Topics: 2-Propanol; Administration, Inhalation; Adult; Antiemetics; Female; Humans; Injections, Intravenous; | 2003 |
A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery.
Topics: Aged; Analgesics, Opioid; Antiemetics; Dexamethasone; Double-Blind Method; Drug Combinations; Female | 2003 |
Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery.
Topics: Adolescent; Adult; Aged; Antiemetics; Breast; Breast Neoplasms; Dexamethasone; Female; Humans; Middl | 2003 |
A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery.
Topics: Ambulatory Surgical Procedures; Anesthesia, General; Child; Child, Preschool; Double-Blind Method; D | 2003 |
A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children.
Topics: Analgesics, Opioid; Antiemetics; Child, Preschool; Cyclizine; Double-Blind Method; Drug Administrati | 2003 |
Comparative study of the antiemetic efficacy of ondansetron, propofol and midazolam in the early postoperative period.
Topics: Abdomen; Adult; Antiemetics; Female; Gynecologic Surgical Procedures; Humans; Hypnotics and Sedative | 2003 |
Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Antiemetics; Cost-Benefit Analysis; Dexamethasone; Double-Blind Method; Dro | 2003 |
Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Antiemeti | 2003 |
Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control.
Topics: Adult; Analgesics, Opioid; Anesthesia, Epidural; Antiemetics; Double-Blind Method; Female; Humans; H | 2003 |
A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting.
Topics: Administration, Oral; Adult; Anesthesia, Inhalation; Antiemetics; Female; Humans; Injections, Intrav | 2004 |
Comparative study of the antiemetic efficacy of ondansetron, propofol and midazolam in the early postoperative period.
Topics: Abdomen; Adolescent; Adult; Aged; Anesthetics, Intravenous; Antiemetics; Dose-Response Relationship, | 2004 |
Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.
Topics: Antiemetics; Cost Savings; Double-Blind Method; Drug Costs; Female; Gynecologic Surgical Procedures; | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthesia, Local; Anesthetics, Intravenous; Antiemeti | 2004 |
Comparison of ondansetron, dexamethasone, ondansetron plus dexamethasone and placebo in the prevention of nausea and vomiting after laparoscopic tubal ligation.
Topics: Antiemetics; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Gynecologic Surgical Pro | 2003 |
Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Humans; Mastectomy, Modified Radical; Mastectomy, S | 2004 |
[Postoperative nausea and vomiting: cost and therapeutic algorithm. Part II: high-risk patients and late PONV].
Topics: Adult; Aged; Algorithms; Antiemetics; Costs and Cost Analysis; Droperidol; Drug Therapy, Combination | 2004 |
Midazolam: an effective antiemetic after cardiac surgery--a clinical trial.
Topics: Aged; Anesthesia; Antiemetics; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double-Blind Met | 2004 |
A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Antiemetics; Cholecystectomy, Laparoscopic | 2004 |
Minimum effective dose of dexamethasone after tonsillectomy.
Topics: Analysis of Variance; Anesthesia, General; Anti-Anxiety Agents; Anti-Inflammatory Agents; Child; Chi | 2004 |
Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron.
Topics: Adult; Analgesia, Obstetrical; Analgesics, Opioid; Double-Blind Method; Female; Fentanyl; Humans; In | 2004 |
The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients.
Topics: Administration, Oral; Ambulatory Surgical Procedures; Analgesics, Opioid; Anesthetics, Inhalation; A | 2004 |
A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Analgesia; Antiemetics; Breast Neoplasms; Electroacupuncture; Female; Humans; Middle Ag | 2004 |
A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Analgesia; Antiemetics; Breast Neoplasms; Electroacupuncture; Female; Humans; Middle Ag | 2004 |
A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Analgesia; Antiemetics; Breast Neoplasms; Electroacupuncture; Female; Humans; Middle Ag | 2004 |
A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Analgesia; Antiemetics; Breast Neoplasms; Electroacupuncture; Female; Humans; Middle Ag | 2004 |
Prevention of nausea and vomiting after middle ear surgery: combination of ondansetron and dexamethasone is the right choice.
Topics: Adult; Antiemetics; Chi-Square Distribution; Dexamethasone; Double-Blind Method; Drug Therapy, Combi | 2004 |
Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Anesthesia, General; Antiemetics; Double-Bl | 2005 |
Optimal timing of acustimulation for antiemetic prophylaxis as an adjunct to ondansetron in patients undergoing plastic surgery.
Topics: Activities of Daily Living; Adult; Anesthesia Recovery Period; Anesthesia, General; Antiemetics; Ele | 2005 |
[A factorial trial of six interventions for the prevention of postoperative nausea and vomiting].
Topics: Analgesics, Opioid; Anesthetics, Inhalation; Anesthetics, Intravenous; Antiemetics; Clinical Protoco | 2005 |
Prospective application of a simplified risk score to prevent postoperative nausea and vomiting.
Topics: Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; | 2005 |
Prevention of PONV by acustimulation with capsicum plaster is comparable to ondansetron after middle ear surgery.
Topics: Acupuncture Therapy; Adult; Capsicum; Double-Blind Method; Ear, Middle; Female; Humans; Incidence; M | 2005 |
Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy.
Topics: Adenoidectomy; Anesthesia Recovery Period; Antiemetics; Chemistry, Pharmaceutical; Child; Child, Pre | 2005 |
Transcutaneous electrical acupoint stimulation versus ondansetron in the prevention of postoperative vomiting following pediatric tonsillectomy.
Topics: Antiemetics; Child; Child Welfare; Child, Preschool; Electroacupuncture; Female; Humans; Male; Ondan | 2005 |
A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia.
Topics: Anesthesia, General; Antiemetics; Double-Blind Method; Female; Humans; Infant; Male; Odds Ratio; Ond | 2005 |
Postoperative nausea and vomiting in patients undergoing total abdominal hysterectomy under spinal anaesthesia: a randomized study of ondansetron prophylaxis.
Topics: Analgesia, Patient-Controlled; Anesthesia, Spinal; Antiemetics; Female; Hemodynamics; Humans; Hyster | 2005 |
A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy.
Topics: Adult; Aged; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Hum | 2005 |
Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting, and pruritus in young males.
Topics: Administration, Oral; Adult; Humans; Injections, Intravenous; Injections, Spinal; Male; Morphine; On | 2005 |
The efficacy of postoperative ondansetron (Zofran) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Double-Blind Method; Female; Humans; Male; Middle Ag | 2005 |
Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: a randomized, double-blinded, placebo-controlled study.
Topics: Adult; Aged; Analgesics, Opioid; Double-Blind Method; Female; Humans; Indoles; Injections, Spinal; M | 2005 |
Ondansetron and tropisetron do not prevent intraspinal morphine- and fentanyl-induced pruritus in elective cesarean delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Spinal; Anti-Inflammatory Agents, Non-S | 2006 |
Supplemental 80% oxygen does not attenuate post-operative nausea and vomiting after breast surgery.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Antiemetics; Female; Humans; Mammaplasty; Mastecto | 2006 |
Efficacy and costs of 3 anesthetic regimens in the prevention of postoperative nausea and vomiting.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intrav | 2006 |
The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
Topics: Administration, Cutaneous; Adult; Antiemetics; Double-Blind Method; Drug Therapy, Combination; Femal | 2006 |
The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
Topics: Administration, Oral; Adult; Anesthesia Recovery Period; Antiemetics; Double-Blind Method; Female; G | 2006 |
Comparison of the antiemetic effects of ondansetron and dexamethasone on middle ear surgery.
Topics: Adult; Antiemetics; Dexamethasone; Double-Blind Method; Ear, Middle; Humans; Middle Aged; Ondansetro | 2006 |
Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine.
Topics: Adult; Cesarean Section; Double-Blind Method; Droperidol; Female; Follow-Up Studies; Humans; Injecti | 2006 |
Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Blood Press | 2006 |
Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Blood Press | 2006 |
Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Blood Press | 2006 |
Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Blood Press | 2006 |
Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
Topics: Adult; Analysis of Variance; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Gynecolo | 2007 |
Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, General; Antiemetics; Chemoprevention | 2006 |
A factorial study of ondansetron, metoclopramide, and dexamethasone for emesis prophylaxis after adenotonsillectomy in children.
Topics: Adenoidectomy; Antiemetics; Child; Child, Preschool; Dexamethasone; Dose-Response Relationship, Drug | 2006 |
The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting.
Topics: Adolescent; Adult; Droperidol; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Female; | 2006 |
[Controlled trial of dexamethasone compared with droperidol and ondansetron for the treatment of postoperative nausea and vomiting].
Topics: Adult; Analysis of Variance; Antiemetics; Dexamethasone; Double-Blind Method; Droperidol; Female; Hu | 2006 |
Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Aged; Anesthesia Recovery Period; Anesthesia, General; Ane | 2007 |
Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.
Topics: Adjuvants, Anesthesia; Administration, Cutaneous; Adolescent; Adult; Aged; Antiemetics; Bariatric Su | 2007 |
Scheduled prophylactic ondansetron administration did not improve its antiemetic efficacy after intracranial tumour resection surgery in children.
Topics: Adolescent; Adult; Antiemetics; Brain Neoplasms; Child; Child, Preschool; Craniotomy; Double-Blind M | 2007 |
Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Antiemetics; Dexamethasone; Double-Blind Method; | 2007 |
[A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Granisetron; | 2007 |
Antiemetic effect of ondansetron 0.2 mg mL-1 in PCA morphine solution.
Topics: Analgesia, Patient-Controlled; Anesthesia, Spinal; Antiemetics; Female; Humans; Hysterectomy; Middle | 2007 |
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aprepitant; Double-Blind Method; Female; Humans; Male; M | 2007 |
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aprepitant; Double-Blind Method; Female; Humans; Male; M | 2007 |
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aprepitant; Double-Blind Method; Female; Humans; Male; M | 2007 |
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aprepitant; Double-Blind Method; Female; Humans; Male; M | 2007 |
Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Inhalation; Antiemetics; Double- | 2007 |
Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study.
Topics: Adult; Cross-Over Studies; Female; Granisetron; Humans; Middle Aged; Ondansetron; Pilot Projects; Po | 2007 |
Epidural ondansetron is more effective to prevent postoperative pruritus and nausea than intravenous ondansetron in elective cesarean delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Epidural; Animals; Antiemetics; Cesarean Section; Female; Hum | 2007 |
Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Aprepitant; Dose-Response Relation | 2007 |
The effects of preoperative rofecoxib, metoclopramide, dexamethasone, and ondansetron on postoperative pain and nausea in patients undergoing elective laparoscopic cholecystectomy.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Cyclooxygenase 2 Inhibitors; Dexamethasone; Double-Blind | 2007 |
Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy.
Topics: Adenoidectomy; Antiemetics; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Ma | 2007 |
Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
Topics: Administration, Cutaneous; Analgesia, Obstetrical; Analgesics, Opioid; Antiemetics; Cesarean Section | 2007 |
Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Antiemetics; Craniotomy; Double-Blind Method; Female; Hum | 2007 |
Combination of antiemetics for the prevention of postoperative nausea and vomiting in high-risk patients.
Topics: Adult; Anesthetics; Antiemetics; Dexamethasone; Female; Humans; Incidence; Korea; Middle Aged; Ondan | 2007 |
Ondansetron, granisetron, and dexamethasone compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy : A randomized placebo-controlled study.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Dose-Response Relationship, | 2008 |
Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study.
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Mastectomy, | 2007 |
Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Chi-Square Distribution; Cholecystectomy, Laparoscop | 2007 |
Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Elective Surgical Procedures; Female; Haloperidol; Heart Conduction System | 2008 |
Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Drug Therapy, Combination; Elective Surgical Procedur | 2008 |
Resumption of daily physical activity after day-case laparoscopic cholecystectomy.
Topics: Activities of Daily Living; Adult; Ambulatory Surgical Procedures; Analgesics; Cholecystectomy, Lapa | 2009 |
Timing of ondansetron administration to prevent postoperative nausea and vomiting.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Humans; Male; Ondansetron; Postoperative Nausea and | 2008 |
Prevention of post-operative nausea and vomiting in children--a prospective randomized double-blind study.
Topics: Adolescent; Anesthetics, Inhalation; Antiemetics; Child; Double-Blind Method; Female; Humans; Infant | 2008 |
Ondansetron versus metoclopramide in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy: a prospective double-blind randomized study.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Male; Metoclopramid | 2008 |
[Ondansetron. Prophylaxis and therapy of nausea and vomiting following major gynecologic procedures. Results of a national multicenter study].
Topics: Antiemetics; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Nervous System Physiologi | 1998 |
Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Arthroplasty, Replacement, Hip; Arthroplasty, Replaceme | 1998 |
Effects of ondansetron on postoperative emesis in Chinese children.
Topics: Antiemetics; Child; Child, Preschool; China; Female; Humans; Injections, Intravenous; Male; Ondanset | 1998 |
High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Double-Blind Method; Droperid | 1998 |
Tropisetron or ondansetron compared with placebo for prevention of postoperative nausea and vomiting.
Topics: Abdomen; Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Humans; Indoles; Male; M | 1998 |
Efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting in patients following infratentorial surgery: a placebo-controlled prospective double-blind study.
Topics: Adolescent; Adult; Anesthesia Recovery Period; Antiemetics; Cerebellum; Consciousness; Diarrhea; Dou | 1999 |
Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Antiemetics; Female; Humans; Injections, Intravenous; | 1999 |
Comparison of ondansetron with ondansetron and dexamethasone in prevention of PONV in diagnostic laparoscopy.
Topics: Adult; Ambulatory Care; Antiemetics; Dexamethasone; Double-Blind Method; Drug Combinations; Female; | 1999 |
Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Gastrointestinal Diseases; Humans | 1999 |
Ondansetron with propofol reduces the incidence of emesis in children following tonsillectomy.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anesthetics, Inhalation; Anesthetics, Intraveno | 1999 |
Prophylactic anti-emetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia. A randomised, double-blind comparison with droperidol, metoclopramide and placebo.
Topics: Adult; Anesthesia, Intravenous; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Dro | 1999 |
The use of tramadol following day--case oral surgery.
Topics: Adult; Ambulatory Surgical Procedures; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; | 1999 |
Treating "rebound" emesis following outpatient gynecologic laparoscopy: the efficacy of a two-dose regimen of droperidol and ondansetron.
Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Double-Blind Method; Droperidol; Drug Therapy, C | 1999 |
Prophylactic use of ondansetron for emesis after craniofacial operations in children.
Topics: Antiemetics; Child; Craniofacial Abnormalities; Craniotomy; Double-Blind Method; Humans; Ondansetron | 1999 |
Comparison of ondansetron and tropisetron combined with droperidol for the prevention of emesis in women with a history of post-operative nausea and vomiting.
Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Drug Therapy, Combination; | 1999 |
Antiemetic efficacy of ondansetron in laparoscopic cholecystectomy. A randomized, double-blind, placebo-controlled study.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1999 |
The effect of preoperative ondansetron on the incidence of postoperative nausea and vomiting in patients undergoing outpatient dentoalveolar surgery and general anesthesia.
Topics: Adolescent; Adult; Alveolar Process; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, | 1999 |
Prevention of postoperative nausea and vomiting in gynaecological laparotomies: a comparison of tropisetron and ondansetron.
Topics: Antiemetics; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Indoles; Laparoto | 1999 |
Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.
Topics: Adolescent; Adult; Antiemetics; Child; Double-Blind Method; Female; Humans; Injections, Intravenous; | 1999 |
Tropisetron or ondansetron for the prevention of post-operative nausea and vomiting (PONV)
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Ondansetron; Po | 1999 |
The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind M | 1999 |
Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Analgesics, Opioid; Anesthesia Recovery Per | 1999 |
Comparison of ondansetron and cyclizine for prevention of nausea and vomiting after day-case gynaecological laparoscopy.
Topics: Adult; Ambulatory Surgical Procedures; Analysis of Variance; Antiemetics; Cyclizine; Double-Blind Me | 1999 |
Ondansetron and droperidol in the prevention of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Biliary Tract Surgical Procedures; Double-Blind | 1999 |
Antiemetic prophylaxis in cardiac surgery: comparison of metoclopramide and ondansetron.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Double-Blind Method; England; Female; Human | 1999 |
Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery.
Topics: Adolescent; Anesthesia, General; Antiemetics; Child; Child, Preschool; Double-Blind Method; Drug Adm | 2000 |
Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Fe | 1999 |
Assessment of ondansetron and droperidol for the prevention of post-operative nausea and vomiting after cholecystectomy and minor gynaecological surgery performed by laparoscopy.
Topics: Adult; Antiemetics; Cholecystectomy; Double-Blind Method; Droperidol; Female; Gynecologic Surgical P | 1999 |
Ondansetron versus placebo for prophylaxis of nausea and vomiting in patients undergoing ambulatory laparoscopic cholecystectomy.
Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Meth | 2000 |
Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo.
Topics: Adolescent; Adult; Aged; Antiemetics; Cost-Benefit Analysis; Double-Blind Method; Droperidol; Female | 2000 |
Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study.
Topics: Anesthesia, General; Antiemetics; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Met | 2000 |
Postoperative nausea and vomiting after breast surgery: efficacy of prophylactic ondansetron and droperidol in a randomized placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antiemetics; Breast; Double-Blind Method; Droperidol; Female; Humans; Middl | 2000 |
Intrathecal fentanyl is superior to intravenous ondansetron for the prevention of perioperative nausea during cesarean delivery with spinal anesthesia.
Topics: Adjuvants, Anesthesia; Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Antie | 2000 |
A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.
Topics: Ambulatory Surgical Procedures; Antiemetics; Costs and Cost Analysis; Double-Blind Method; Humans; I | 2000 |
Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy.
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Droperidol; Drug Therapy, Combination; Fe | 2000 |
A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Topics: Adolescent; Adult; Aged; Anesthesia, Intravenous; Antiemetics; Craniotomy; Double-Blind Method; Drop | 2000 |
Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Meth | 1999 |
Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Meth | 1999 |
Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Meth | 1999 |
Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Meth | 1999 |
Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures.
Topics: Administration, Oral; Adult; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Dru | 2000 |
Postoperative nausea and vomiting after sevoflurane with or without ondansetron compared with propofol in female patients undergoing breast surgery.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Antiemetics; Breast; Female; Humans; Methyl Ether | 2000 |
Small-dose droperidol effectively reduces nausea in a general surgical adult patient population.
Topics: Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Humans; Male; Middle Aged | 2000 |
Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Double-Blind Method; Droperidol; Drug Thera | 2000 |
A comparison of commonly used anti-emetics for the prevention of emetic sequelae after a major gynaecological surgery.
Topics: Adult; Aged; Antiemetics; Chi-Square Distribution; Double-Blind Method; Droperidol; Female; Gynecolo | 2000 |
Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial inpatients undergoing laparoscopic cholecystectomy.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Dimenhydrinate; Female; Humans; Male; Middle Aged; Ondan | 2000 |
Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery.
Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Cyclizine; Double-Blind Method; Drug Therapy, Co | 2000 |
Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting.
Topics: Adult; Antiemetics; Dose-Response Relationship, Drug; Drinking; Eating; Female; Gynecologic Surgical | 2001 |
Randomised double-blind comparison of ondansetron and droperidol to prevent postoperative nausea and vomiting associated with patient-controlled analgesia.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Chi-Square Distribution; Doub | 2001 |
A randomized controlled trial of the antiemetic effect of three doses of ondansetron after strabismus surgery in children.
Topics: Antiemetics; Child; Child, Preschool; Double-Blind Method; Humans; Ondansetron; Postoperative Nausea | 2001 |
Patient-controlled analgesia and postoperative nausea and vomiting: efficacy of a continuous infusion of ondansetron.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Double-Blin | 2001 |
Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Antiemetics; Cholinesterase Inhibitors; Double-Blind Metho | 2001 |
The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron.
Topics: Adult; Analgesics, Opioid; Antiemetics; Drug Interactions; Female; Humans; Laminectomy; Male; Middle | 2001 |
Failure of prevention against postoperative vomiting by ondansetron or prochlorperazine in patients undergoing gynecological laparoscopy.
Topics: Adult; Antiemetics; Female; Humans; Laparoscopy; Ondansetron; Postoperative Nausea and Vomiting; Pro | 2000 |
Combination of droperidol and ondansetron reduces PONV after pediatric strabismus surgery more than single drug therapy.
Topics: Adolescent; Anesthesia, Inhalation; Antiemetics; Child; Child, Preschool; Double-Blind Method; Drope | 2001 |
Metoclopramide versus ondansetron in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Incidence; M | 2001 |
Prophylactic ondansetron does not improve patient satisfaction in women using PCA after Caesarean section.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Anti | 2001 |
Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Dexamethasone; Double-Blind | 2001 |
Acupuncture versus ondansetron in the prevention of postoperative vomiting. A study of children undergoing dental surgery.
Topics: Acupuncture Analgesia; Anesthesia, Dental; Anesthesia, General; Antiemetics; Child; Child, Preschool | 2001 |
Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Antiemetics; Cesarean Section; Double-Blind Me | 2001 |
Prevention of vomiting after strabismus surgery in children: dexamethasone alone versus dexamethasone plus low-dose ondansetron.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Humans; Ondans | 2001 |
Comparison of cyclizine and ondansetron for the prevention of postoperative nausea and vomiting in laparoscopic day-case gynaecological surgery.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Antiemetics; Cyclizine; Double-Bl | 2002 |
Prospective randomized, double-blind comparative study of dexamethasone, ondansetron, and ondansetron plus dexamethasone as prophylactic antiemetic therapy in patients undergoing day-case gynaecological surgery.
Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy | 2001 |
Randomized prospective double-blind placebo-controlled trial of effect of intravenous ondansetron on intraocular pressure during ophthalmic surgery.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Cataract Extraction; Double-Blind Method; Hemodynamic | 2001 |
Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies.
Topics: Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans | 2002 |
A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy.
Topics: Adolescent; Adult; Aged; Antiemetics; Craniotomy; Double-Blind Method; Female; Humans; Infratentoria | 2002 |
Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen - comparison with propofol or placebo.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Breast; Dexamethasone; Dr | 2002 |
Ondansetron in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cholecystectomy; Female; Humans; Injections, Intravenou | 2002 |
Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery.
Topics: Administration, Oral; Adult; Aged; Ambulatory Surgical Procedures; Antiemetics; Humans; Middle Aged; | 2002 |
Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery.
Topics: Adrenergic alpha-Agonists; Aged; Anesthesia, General; Antiemetics; Blood Pressure; Breast Neoplasms; | 2002 |
Oral ondansetron, tropisetron or metoclopramide to prevent postoperative nausea and vomiting: a comparison in high-risk patients undergoing thyroid or parathyroid surgery.
Topics: Adult; Analgesics, Opioid; Antiemetics; Double-Blind Method; Female; Humans; Indoles; Male; Metoclop | 2002 |
Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine.
Topics: Adult; Anesthesia, Obstetrical; Antiemetics; Bupivacaine; Cesarean Section; Double-Blind Method; Fem | 2002 |
Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans.
Topics: Acute Disease; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Drug Interactio | 2002 |
The prevention of emesis in plastic surgery: a randomized, prospective study.
Topics: Analgesics, Opioid; Antiemetics; Conscious Sedation; Double-Blind Method; Female; Fentanyl; Humans; | 2002 |
[Postoperative vomiting].
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; F | 2002 |
[Clinical observation on ondansetron in preventing nausea and vomiting after cholecystectomy under abdominoscope].
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Male; Ondansetron; | 1999 |
117 other studies available for ondansetron and Emesis, Postoperative
| Article | Year |
|---|---|
Predictors of Postoperative Nausea and Vomiting After Endoscopic Skull Base Surgery.
Topics: Antiemetics; Double-Blind Method; Female; Humans; Ondansetron; Postoperative Nausea and Vomiting; Re | 2022 |
Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.
Topics: Child; Cytochrome P-450 CYP2D6; DNA Copy Number Variations; Humans; Ondansetron; Postoperative Nause | 2023 |
Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy under General Anaesthesia in a Tertiary Care Centre: A Descriptive Cross-sectional Study.
Topics: Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Cross-Sectional Studies; Double-Bli | 2022 |
Impact of Emend on Perioperative Bariatric Surgery Antiemetic Utilization, Patient Satisfaction, and Costs.
Topics: Antiemetics; Aprepitant; Bariatric Surgery; Humans; Ondansetron; Patient Satisfaction; Postoperative | 2023 |
Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study.
Topics: Antiemetics; Dexamethasone; Double-Blind Method; Humans; Ondansetron; Postoperative Nausea and Vomit | 2023 |
Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study).
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Dexamethasone; Female; Gastrectomy; Gastroesophageal Re | 2023 |
Comparison of metoclopramide and promethazine for the treatment of postoperative nausea and vomiting in the post-anesthesia care unit: A retrospective database analysis.
Topics: Anesthesia; Antiemetics; Double-Blind Method; Humans; Metoclopramide; Ondansetron; Postoperative Nau | 2020 |
Reducing postoperative nausea and vomiting in pediatric patients undergoing anterior cruciate ligament reconstruction: A quality report.
Topics: Adolescent; Anterior Cruciate Ligament Reconstruction; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2020 |
A specific enhanced recovery protocol decreases opioid use after thyroid and parathyroid surgery.
Topics: Adult; Aged; Analgesics, Opioid; Drug Utilization; Enhanced Recovery After Surgery; Female; Health P | 2021 |
The impact of multimodal therapies on the comfort and safety of patients in the immediate post-anaesthetic period following gynaecological procedures - part I.
Topics: Adult; Analgesics, Opioid; Anesthetics; Antiemetics; Female; Gynecologic Surgical Procedures; Humans | 2021 |
Preanesthetic nebulized ketamine vs preanesthetic oral ketamine for sedation and postoperative pain management in children for elective surgery: A retrospective analysis for effectiveness and safety.
Topics: Analgesics; Antiemetics; Child; Child, Preschool; Elective Surgical Procedures; Female; Humans; Keta | 2021 |
Preventing Postoperative Nausea and Vomiting During an Ondansetron Shortage.
Topics: Anesthesia; Antiemetics; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2021 |
Acute symptomatic peri-lead edema 33 hours after deep brain stimulation surgery: a case report.
Topics: Anti-Inflammatory Agents; Brain Edema; Deep Brain Stimulation; Dexamethasone; Headache; Humans; Male | 2017 |
Post-discharge nausea and vomiting after total intravenous anaesthesia and standardised PONV prophylaxis for ambulatory surgery.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, Intravenous; Anesthetics, Intravenous; Antiemetic | 2017 |
The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
Topics: Adult; Aged; Antiemetics; Aprepitant; Bariatric Surgery; Chemoprevention; Dexamethasone; Double-Blin | 2018 |
Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery.
Topics: Adult; Antiemetics; Bariatric Surgery; Chemoprevention; Critical Pathways; Dexamethasone; Drug Admin | 2018 |
Simplified algorithm for the prevention of postoperative nausea and vomiting: a before-and-after study.
Topics: Aged; Algorithms; Anesthesia, General; Antiemetics; Dexamethasone; Droperidol; Drug Therapy, Combina | 2018 |
A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis.
Topics: Adult; Aged; Aged, 80 and over; Databases as Topic; Demography; Humans; Middle Aged; Morpholines; On | 2017 |
Cutaneous refractile foreign body microemboli with intravascular injection of oral medication.
Topics: Adult; Antiemetics; Diverticulitis, Colonic; Embolism; Foreign Bodies; Humans; Injections, Intra-Art | 2018 |
Postoperative nausea and vomiting (PONV) in outpatient repair of inguinal hernia.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthesia, L | 2018 |
Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy.
Topics: Acetaminophen; Analgesia; Analgesics; Analgesics, Non-Narcotic; Anesthesia, Conduction; Antiemetics; | 2018 |
Association of anti-emetic efficacy of Ondansetron with 18792A>G polymorphism in a drug target gene 5-HT3B in Pakistani population.
Topics: Adult; Anesthesia, General; Antiemetics; Asian People; Case-Control Studies; Cholecystectomy, Laparo | 2018 |
[Adding Ondansetron in Morphine Intravenous Analgesia Pump for Prevention of Postoperative Nausea and Vomiting in Women].
Topics: Administration, Intravenous; Analgesia; Antiemetics; Female; Humans; Morphine; Ondansetron; Postoper | 2018 |
CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
Topics: Amplified Fragment Length Polymorphism Analysis; Antiemetics; Cytochrome P-450 CYP2D6; Female; Genot | 2018 |
Early Rehydration in Surgical Patients With Prolonged Fasting Decreases Postoperative Nausea and Vomiting.
Topics: Adult; Anesthesia, General; Antiemetics; Dexamethasone; Fasting; Female; Fluid Therapy; Humans; Inci | 2018 |
Prospective evaluation of anesthetic protocols during pediatric ophthalmic surgery.
Topics: Acetaminophen; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Intravenous; Anti-Anxiety Agen | 2019 |
Digital Quality Improvement Approach Reduces the Need for Rescue Antiemetics in High-Risk Patients: A Comparative Effectiveness Study Using Interrupted Time Series and Propensity Score Matching Analysis.
Topics: Adolescent; Adult; Aged; Algorithms; Anesthesia, General; Antiemetics; Child; Comparative Effectiven | 2019 |
An exploratory study of the relationship between postoperative nausea and vomiting and postdischarge nausea and vomiting in children undergoing ambulatory surgery.
Topics: Ambulatory Surgical Procedures; Anesthesia Recovery Period; Anesthesia, General; Antiemetics; Child; | 2019 |
[Postoperative nausea and vomiting in neurosurgery: the approaches are varied but the problem remains unsolved].
Topics: Antiemetics; Double-Blind Method; Humans; Neurosurgical Procedures; Ondansetron; Postoperative Nause | 2019 |
Is ramosetron superior to ondansetron?
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Benzimidazoles; Female; Fentanyl; Hu | 2013 |
Incidence and predictors of postdischarge nausea and vomiting in a 7-day population.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, General; Antiemetics; Female; Humans; Incidence; | 2013 |
Low doses of haloperidol combined with ondansetron are not effective for prophylaxis of postoperative nausea and vomiting in susceptible patients.
Topics: Adolescent; Adult; Aged; Antiemetics; Cohort Studies; Drug Therapy, Combination; Female; Haloperidol | 2015 |
Prevention of postoperative nausea and vomiting: a thought on ondansetron.
Topics: Antiemetics; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Ondansetron; Postoper | 2014 |
Postoperative nausea and vomiting in the post-anesthetic care unit, a 5-year survey of a quality assurance program in surgical cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesiology; Anesthetics; Antiemetics | 2015 |
Association of Anti-Emetic Efficacy of Ondansetron with G2677T Polymorphism in a Drug Transporter Gene ABCB1 in Pakistani Population.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antiemetics; Asian People; ATP Binding Cassett | 2015 |
Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Cholecystectomy, Laparoscopic; Female; Genome, Human; | 2015 |
Gender-Specific Differences in Low-Dose Haloperidol Response for Prevention of Postoperative Nausea and Vomiting: A Register-Based Cohort Study.
Topics: Aged; Analgesics, Opioid; Anesthesia, General; Antiemetics; Cohort Studies; Female; Haloperidol; Hum | 2016 |
[PONV after strabismus surgery : Risk adapted prophylaxis?].
Topics: Adolescent; Adult; Aged; Anesthesia; Anesthesia, Intravenous; Anesthetics, Intravenous; Antiemetics; | 2016 |
Response to comment "Cox: alternative therapies and postoperative vomiting".
Topics: Antiemetics; Complementary Therapies; Humans; Ondansetron; Postoperative Nausea and Vomiting; Vomiti | 2016 |
[Postoperative inconveniences after breast cancer surgery].
Topics: Acetaminophen; Amines; Analgesics; Antiemetics; Antitussive Agents; Breast Neoplasms; Celecoxib; Cyc | 2008 |
[Multimodal treatment of pain and nausea in breast cancer surgery].
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Antiemetics; Antitussive Agents; Breast Neoplasm | 2008 |
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Topics: Animals; Antiemetics; Binding Sites; Calcium; Cell Line; Granisetron; Isoquinolines; Ondansetron; Pa | 2008 |
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Topics: Animals; Antiemetics; Binding Sites; Calcium; Cell Line; Granisetron; Isoquinolines; Ondansetron; Pa | 2008 |
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Topics: Animals; Antiemetics; Binding Sites; Calcium; Cell Line; Granisetron; Isoquinolines; Ondansetron; Pa | 2008 |
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Topics: Animals; Antiemetics; Binding Sites; Calcium; Cell Line; Granisetron; Isoquinolines; Ondansetron; Pa | 2008 |
Smoking and nalbuphine may reduce postoperative emesis.
Topics: Morphine; Nalbuphine; Ondansetron; Postoperative Nausea and Vomiting; Scopolamine; Smoking | 2008 |
Extrapyramidal reaction to ondansetron and propofol.
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemetics; Basal Ganglia Diseases; Di | 2009 |
Coronary vasospasm and atrial fibrillation associated with ondansetron therapy.
Topics: Antiemetics; Atrial Fibrillation; Coronary Vasospasm; Humans; Injections, Intravenous; Male; Middle | 2009 |
Letter to the editor regarding article, "A challenging problem that concerns the aesthetic surgeon".
Topics: Antiemetics; Blindness; Eye Hemorrhage; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2009 |
Ondansetron-induced headache in a parturient mimicking postdural puncture headache.
Topics: Adult; Antiemetics; Cesarean Section; Diagnostic Errors; Female; Headache; Humans; Ondansetron; Post | 2010 |
Matching groups for studying postoperative nausea and vomiting: should we care?
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting; Risk Factors | 2010 |
Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as high risk for developing PONV.
Topics: 2-Propanol; Antiemetics; Humans; Ondansetron; Postoperative Nausea and Vomiting; Preanesthetic Medic | 2009 |
Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome.
Topics: Antiemetics; Child; Dimenhydrinate; Drug Therapy, Combination; Electrocardiography; Female; Humans; | 2010 |
Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting?
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Aprepitant; Arthroplasty, Replacement, Hip; Arthroplast | 2010 |
Does the added benefit of ondansetron over dexamethasone, to control post-operative nausea and vomiting, justify the added cost in patients undergoing tonsillectomy and adenotonsillectomy?
Topics: Adenoids; Adolescent; Adult; Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Dexamethas | 2010 |
Ondansetron-induced migraine-type headache.
Topics: Adult; Anesthesia; Antiemetics; Debridement; Dexamethasone; Female; Humans; Migraine Disorders; Onda | 2010 |
Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting.
Topics: Adult; Anesthesia, General; Antiemetics; ATP Binding Cassette Transporter, Subfamily B; ATP Binding | 2010 |
Post-operative nausea and vomiting prevention with perphenazine: long overdue.
Topics: Administration, Oral; Antiemetics; Drug Therapy, Combination; Humans; Ondansetron; Perphenazine; Pos | 2011 |
Enantioselective determination of ondansetron and 8-hydroxyondansetron in human plasma from recovered surgery patients by liquid chromatography-tandem mass spectrometry.
Topics: Antiemetics; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Molec | 2010 |
Why no casopitant-only arm?
Topics: Antiemetics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ondansetron; Piper | 2011 |
Human plasma quantification of droperidol and ondansetron used in preventing postoperative nausea and vomiting with a LC/ESI/MS/MS method.
Topics: Chromatography, Liquid; Droperidol; Humans; Linear Models; Ondansetron; Postoperative Nausea and Vom | 2011 |
Postoperative nausea and vomiting in pediatric patients.
Topics: Adult; Antiemetics; Child; Circumcision, Male; Dexamethasone; Female; Humans; Hypospadias; Infant; M | 2011 |
Discomfort, delirium, and PONV in infants and young children undergoing strabismus surgery.
Topics: Analgesics; Antiemetics; Delirium; Dexamethasone; Droperidol; Hospitals, University; Humans; Minneso | 2011 |
Post-operative nausea and vomiting following paediatric day-case tonsillectomy: audit of the Epsom protocol.
Topics: Adenoidectomy; Adolescent; Ambulatory Surgical Procedures; Analgesics; Anesthesia, General; Antiemet | 2011 |
The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Dexamethasone; Drug Therapy, Combination; Fentany | 2011 |
Comment on Ekinci et al.: A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting.
Topics: Antiemetics; Droperidol; Female; Humans; Indoles; Metoclopramide; Ondansetron; Postoperative Nausea | 2011 |
[Prophylactic anti-emetic strategy: prevention among obstetrician-gynaecologists anaesthesia].
Topics: Adolescent; Adult; Aged; Anesthesia, Obstetrical; Antiemetics; Dexamethasone; Droperidol; Female; Fr | 2011 |
Dexamathasone and ondansetron in paediatric tonsillectomy.
Topics: Antiemetics; Child; Dexamethasone; Humans; Ondansetron; Postoperative Hemorrhage; Postoperative Naus | 2012 |
Is palonosetron also effective for opioid-induced and post-discharge nausea and vomiting?
Topics: Antiemetics; Female; Humans; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomi | 2012 |
The effect of ondansetron and intrathecal diamorphine on length of stay after caesarean section: an impact audit cycle.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Antiemetics; Cesarean Section; Female; Heroin; H | 2013 |
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; | 2013 |
Acute dystonic reaction to general anesthesia with propofol and ondansetron: a graded response.
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Antiemetics; Dystonia; Female; Humans; Ondanse | 2013 |
In sickness and pain.
Topics: Analgesics; Antiemetics; Child; Dexamethasone; Humans; Ondansetron; Pain, Postoperative; Postoperati | 2002 |
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
Topics: Antiemetics; Arrhythmias, Cardiac; Atrial Fibrillation; Droperidol; Electrocardiography; Humans; Ind | 2003 |
Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report.
Topics: Antiemetics; Atrial Fibrillation; Female; Humans; Middle Aged; Ondansetron; Postoperative Nausea and | 2003 |
Ondansetron-induced multifocal encephalopathy.
Topics: Antiemetics; Brain Diseases; Dystonia; Female; Hand; Humans; Mandible; Middle Aged; Mouth; Ocular Mo | 2003 |
A response to 'A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children' O'Brien CM, Titley G, Whitehurst P, Anaesthesia 2003; 58: 707-11.
Topics: Antiemetics; Child; Cyclizine; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2003 |
Ondansetron for prevention of intrathecal opioids-induced pruritus, nausea and vomiting after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Female; Humans; Morphine; Ondansetron; Pos | 2004 |
Comment on "A comparison of the effects of droperidol and the combination of droperidol and ondansetron on postoperative nausea and vomiting for patients undergoing laparoscopic cholecystectomy".
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Droperidol; Drug Therapy, Combination; Humans; Ondansetr | 2003 |
Reducing postprocedure emesis.
Topics: Anesthetics, Intravenous; Antiemetics; Clinical Nursing Research; Humans; Ondansetron; Postoperative | 2004 |
Prevention of postoperative nausea and vomiting.
Topics: Anesthetics, Intravenous; Antiemetics; Cost Savings; Dexamethasone; Droperidol; Drug Therapy, Combin | 2004 |
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Topics: Adolescent; Adult; Antiemetics; Cytochrome P-450 CYP2D6; Female; Gene Dosage; Humans; Middle Aged; O | 2005 |
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Topics: Adolescent; Adult; Antiemetics; Cytochrome P-450 CYP2D6; Female; Gene Dosage; Humans; Middle Aged; O | 2005 |
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Topics: Adolescent; Adult; Antiemetics; Cytochrome P-450 CYP2D6; Female; Gene Dosage; Humans; Middle Aged; O | 2005 |
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Topics: Adolescent; Adult; Antiemetics; Cytochrome P-450 CYP2D6; Female; Gene Dosage; Humans; Middle Aged; O | 2005 |
Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting.
Topics: Antiemetics; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cost-Benefit Analysis; | 2005 |
Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.
Topics: Adult; Droperidol; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Ondanse | 2005 |
Economic evaluation of ondansetron vs dimenhydrinate for prevention of postoperative vomiting in children undergoing strabismus surgery.
Topics: Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Drug Costs; Female; Health Personnel; H | 2005 |
Transient blindness following intravenous ondansetron.
Topics: Adult; Antiemetics; Blindness; Female; Humans; Ondansetron; Postoperative Complications; Postoperati | 2005 |
Blood-borne factors possibly associated with post-operative nausea and vomiting: an explorative study in women after breast cancer surgery.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Antiemetics; Blood | 2005 |
Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets.
Topics: Animals; Antiemetics; Arginine Vasopressin; Ferrets; Male; Morphine; Nausea; Ondansetron; Postoperat | 2005 |
Interaction between tramadol and two anti-emetics on nociception and gastrointestinal transit in mice.
Topics: Analgesics, Opioid; Animals; Antiemetics; Disease Models, Animal; Dose-Response Relationship, Drug; | 2006 |
Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
Topics: Antiemetics; Conflict of Interest; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; | 2005 |
Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch.
Topics: Administration, Topical; Adult; Antiemetics; Dexamethasone; Dopamine Antagonists; Dystonia; Emergenc | 2006 |
Ethics, marketing, and the medical literature.
Topics: Antiemetics; Conflict of Interest; Drug Industry; Humans; Indoles; Marketing; Ondansetron; Postopera | 2006 |
Clinical experience with small-dose granisetron and dexamethasone for prevention of postoperative nausea and vomiting.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Hysterectomy; Ondansetron; Po | 2006 |
Study flaw in comparisons of aprepitant and ondansetron.
Topics: Antiemetics; Aprepitant; Clinical Trials as Topic; Humans; Morpholines; Ondansetron; Postoperative N | 2007 |
A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis.
Topics: Adult; Anesthesia, General; Antiemetics; Antipruritics; Female; Humans; Male; Medical Records; Middl | 2007 |
Midazolam vs ondansetron for preventing postoperative nausea and vomiting.
Topics: Antiemetics; Humans; Midazolam; Ondansetron; Postoperative Nausea and Vomiting; Research Design; Ris | 2007 |
Changing patterns of postoperative nausea and vomiting prophylaxis drug use in an academic anesthesia practice.
Topics: Adolescent; Antiemetics; Child; Dexamethasone; Droperidol; Female; Humans; Male; Metoclopramide; Ond | 2007 |
Comparisons of aprepitant and ondansetron.
Topics: Antiemetics; Aprepitant; Chemoprevention; Clinical Trials, Phase III as Topic; Humans; Morpholines; | 2007 |
Ondansetron and carpopedal spasm.
Topics: Adult; Diagnosis, Differential; Dystonia; Female; Hand; Humans; Hyperventilation; Leg; Muscle Rigidi | 2008 |
Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel?
Topics: Antiemetics; Cost-Benefit Analysis; Droperidol; Drug Approval; Drug Costs; Drug Labeling; Drug Thera | 2008 |
A significant reduction in paediatric post-tonsillectomy vomiting through audit.
Topics: Antiemetics; Child; Dexamethasone; Female; Glucocorticoids; Humans; Male; Medical Audit; Ondansetron | 2008 |
Universal PONV prophylaxis in general anesthesia: should we consider its immediate implementation?
Topics: Analgesics; Anesthesia, General; Animals; Antiemetics; Dexamethasone; Droperidol; Drug Interactions; | 2008 |
The impact of audit in a district general hospital on post-operative nausea and vomiting after major gynaecological surgery.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia Department, Hospital; Antiemetics; Att | 1998 |
A comparison of the antiemetic effect of ondansetron and droperidol on patients undergoing gynecologic laparoscopy.
Topics: Antiemetics; Droperidol; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Ondansetron; | 1998 |
Surrogate outcomes: meaningful not!
Topics: Anesthesia; Antiemetics; Granisetron; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomitin | 1999 |
Ondansetron versus droperidol for postoperative nausea and vomiting.
Topics: Administration, Oral; Antiemetics; Dose-Response Relationship, Drug; Droperidol; Humans; Injections, | 1999 |
Cost-effectiveness of ondansetron for postoperative nausea and vomiting.
Topics: Antiemetics; Cohort Studies; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Humans; Ondans | 1999 |
[Ondansetron in the prophylaxis of postoperative nausea and vomiting in ambulatory cataract surgery].
Topics: Aged; Ambulatory Surgical Procedures; Antiemetics; Cataract Extraction; Cohort Studies; Female; Huma | 1999 |
Masked bleeding posttonsillectomy with ondansetron.
Topics: Antiemetics; Child; Female; Hemorrhage; Humans; Ondansetron; Postoperative Complications; Postoperat | 1999 |
[Prevention of postoperative nausea and vomiting in ambulatory cataract surgery].
Topics: Ambulatory Surgical Procedures; Antiemetics; Cataract Extraction; Humans; Hypnotics and Sedatives; M | 1999 |
Ondansetron and evidence-based medicine.
Topics: Antiemetics; Evidence-Based Medicine; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2000 |
Impact of an antiemetic protocol on postoperative nausea and vomiting in children.
Topics: Adolescent; Anesthesia, General; Antiemetics; Child; Child, Preschool; Clinical Protocols; Cyclizine | 2001 |
Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Female; Humans; Hysterectomy; Indoles; Injections | 2001 |
Postoperative nausea and vomiting in female patients.
Topics: Adolescent; Adult; Aged; Female; Humans; Menstruation; Middle Aged; Ondansetron; Oxygen; Postoperati | 2001 |
Analgesic efficacy of tramadol if coadministered with ondansetron.
Topics: Analgesics, Opioid; Antiemetics; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Ondansetron; Pa | 2001 |
Applying the results of quantitative systematic reviews to clinical practice.
Topics: Antiemetics; Bias; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Ondansetron; Postoperati | 2002 |
Ondansetron after Caesarian section.
Topics: Antiemetics; Breast Feeding; Cesarean Section; Female; Humans; Ondansetron; Postoperative Nausea and | 2001 |
Paediatric tonsillectomy and PONV -- big little problem remains big!
Topics: Adolescent; Anesthetics; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Child; Child, Prescho | 2002 |
Using imprecise probabilities to address the questions of inference and decision in randomized clinical trials.
Topics: Antiemetics; Clinical Protocols; Computer Simulation; Decision Support Techniques; Droperidol; Ethic | 2002 |
Pharmacology review: the role of ondansetron in the management of children's nausea and vomiting following posterior fossa neurosurgical procedures.
Topics: Antiemetics; Cerebellar Neoplasms; Child; Cranial Fossa, Posterior; Humans; Male; Medulloblastoma; N | 2002 |